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 Nitrogen-containing organic molecules with adjacent stereocenters represent one of the 
most common motifs in modern pharmaceuticals and agrochemicals. Therefore, there have been 
tremendous efforts focusing on general, efficient, selective, and atom-economical syntheses of 
enantiopure amides and amines. However, the direct enantioselective synthesis of β-branched 
amides and γ-branched amines still requires multiple steps including asymmetric hydrogenation. 
As a result, these methods are very substrate dependent, meaning that a minor change on the 
stereocenter often requires re-examining of metal/ligand scaffolds. In this thesis, we will describe 
methods developed in our lab to address these challenges.  
We have first developed a tandem isomerization/oxidative amidation approach from 
allylic alcohols or aldehydes to synthesize β-branched amides using acetone or styrene as the 
hydrogen acceptor. The conditions are general, affording the products in good to excellent yields 
with a wide array of amine and aniline nucleophiles, and chemoselective, other alcohols do not 
participate in the oxidation reaction. Utilization of biphasic conditions is critical, as they promote 
an equilibrium between the imine/enamine intermediate and the hemiaminal, which can then 
undergo oxidation to the amide.  
The enantioselective isomerization/amidation was then achieved utilizing allylic amine as 
the precursor. After the known asymmetric isomerization, the chiral enamine intermediate, 
instead of being oxidized to the undesired byproduct, undergoes an exchange with exogenous 
amine nucleophile followed by oxidation to afford the chiral β-branched amide in one step. The 
enamine exchange allows for a rapid and modular synthesis of various amides, including 
 iii 
challenging β-diaryl and β-cyclic. These kinds of substrates often require privileged ligands in 
asymmetric hydrogenation.  
We have further extended this method to synthesize amines with remote stereocenters in 
a reductive fashion. By intercepting the aforementioned chiral enamine intermediate with a 
highly chemoselective reduction, a general asymmetric route for the one-pot synthesis of chiral 
γ-branched amines was developed. This protocol is suitable for establishing various tertiary 
stereocenters, including those containing dialkyl, diaryl, cyclic, trifluoromethyl, difluoromethyl, 
and silyl substituents. To demonstrate the synthetic utility of this method, Terikalant and 
Tolterodine are synthesized using this method with high levels of enantioselectivity. 
Finally, an alternative method for γ-branched amine synthesis was realized through 
photoredox-catalyzed hydroaminomethylation of alkenes. The reaction conditions are very mild, 
and tolerate various functional groups, such as alkyl alkene, ester, ketone, lactone, indole, and 
tertiary amine, a great improvement compared to two-electron hydroaminomethylation. This 
reaction is also regiospecific: only linear amine products are formed regardless of the electronic 
property of alkene substrates. Three bioactive pheniramines are synthesized using this method on 
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Chapter 1: Rhodium-Catalyzed Asymmetric Synthesis of Beta-Branched Amides* 
1.1 Introduction 
Enantiopure β-branched amides are common motifs in natural products and biologically 
active molecules (Scheme 1.1)1,2 and are useful synthetic intermediates upon reduction for the 
construction of γ-branched chiral amines.3,4 However, examples of the direct asymmetric 
synthesis of chiral β-branched amides are rare. Although asymmetric hydrogenation or conjugate 
addition of α,β-unsaturated carbonyls are common strategies toward β-stereocenters, α,β-



























Scheme 1.1 Biologically active molecules containing chiral β-branched amides. 
For a general and modular synthesis of enantiopure β-branched amides, a multistep 
sequence is often required via carboxylic acid intermediates.2 For example, asymmetric 
hydrogenation of β,β-disubstituted unsaturated acrylic acid or ester has been extensively studied 
to reach high conversion and excellent enantioselectivity via Rh, Ir, and Ru catalysis (Eqn 1, 
Scheme 1.2).6,7 The same chiral carbonyl intermediate could be prepared through a copper-
catalyzed asymmetric 1,4-addition of an alkylzinc to a unsaturated N-acyloxazolidione (Eqn 2, 
                                                
* Portions of this chapter are reprinted with permission from Wu, Z.; Hull, K. L. Chem. Sci. 2016, 
7, 969-975. Copyright 2018 Royal Society of Chemistry and Wu, Z.; Laffoon, S. D.; Nguyen, T. 
T.; McAlpin, J. D.; Hull, K. L. Angew. Chem. Int. Ed. 2017, 56 1371-1375. Copyright 2018 John 
Wiley & Sons, Inc.  
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Scheme 1.2).8 For the synthesis of the desired amide products, two more steps (hydrolysis and 
amide coupling) are required, leading to poor atom economy for the whole process. 
Stoichiometric coupling reagents and byproducts from the amidation step often complex the 








































































Scheme 1.2 Enantioselective syntheses of β-branched amides and common coupling reagent 
for amide bond formation.  
 
Despite of the drawbacks associated with these coupling methods, they are the most 
common reactions performed in the modern pharmaceutical industry, accounting for 16% of all 
reactions based on an analyzed data set of medicinal chemistry campaigns.11 In 2005, the ACS 
GCI Pharmaceutical Roundtable identified “amide formation avoiding poor atom economy 
reagents” as a critical area for research.10 Since then, there are emerging efforts and methods 
towards the catalytic formation amide bonds.  
The transition metal-catalyzed oxidative amidation of alcohols is a promising alternative 
to traditional coupling methods, as it allows for the generation of amides along with molecular 
 3 
hydrogen as the only by-product (Scheme 1.3). For example, Milstein12 and Madsen13 reported 
an acceptorless oxidative amidation of alcohols using Ru catalysis with pincer and NHC ligands, 
respectively. Although no hydrogen acceptor is needed, substrate scopes are limited to 
unhindered alcohols and amines. Secondary cyclic amines require a less-hindered pincer ligand14 
and acyclic amines are still challenging. Moreover, elevated temperatures (> 110 °C) and 
refluxing solvents are needed to favor the evolution of H2 gas.12,15–17  

































Scheme 1.3 Acceptorless oxidative amidation of alcohols and a descriptive mechanism. 
Direct amidation of aryl aldehydes with external oxidants have been reported by Rh18 and 
Cu19 catalysis. However, yields are usually low when enolizable aldehydes are used due to the 
formation of amine byproducts.18 Recently, Dong reported a Ni-catalyzed C–H activation of 
aldehydes followed by coupling with alcohols or amines to form esters and amides 
respectively.20 A variety of aldehydes and amines are shown to be reactive, but an additional 
equivalent aldehyde or trifluoroacetophenone is required as the hydrogen acceptor. 
In seeking to develop general conditions for chiral β-branched amide synthesis, we 
proposed that allylic alcohols could serve as an aldehyde precursor (Scheme 1.4). Such a system 
would be advantageous as allylic alcohols have been previously shown to isomerize to a 
enantiopure aldehyde in the presence of a chiral [Rh]-catalyst.21,22 Then, the in situ generated 
aldehydes could undergo a Rh-catalyzed oxidative amidation with an amine to afford the amide 
 4 
and a [Rh(H)2] complex. Subsequent reductive elimination or transfer hydrogenation would 
regenerate the Rh(I) species.18 
R1 OH












Scheme 1.4 Proposed asymmetric isomerization/amidation of allylic alcohols. 
 
1.2 Oxidative Amidation of Allylic Alcohols and Aldehydes via Rhodium-Catalyzed 
Transfer Hydrogenation 
1.2.1 Reaction Optimization 
Initial efforts focused on developing a Rh-catalyzed oxidative amidation of cinnamyl 
alcohol and N-methylpiperazine. When they are combined with a cationic rhodium catalyst, the 
enamine byproduct 2 predominates, suggesting that isomerization/condensation is significantly 
faster than the subsequent oxidation of the hemiaminal (vide infra). Moreover, hydrogenated 
starting material 3 was also observed, indicating that the cinnamyl alcohol was acting as the 
hydrogen acceptor. As such, two main challenges in optimization of the desired oxidative 
amidation reaction were to identify: 1) conditions that promote amide over enamine formation 
and 2) a hydrogen acceptor that is selectively reduced over the allylic alcohol.  
As summarized in Table 1.1, and further elaborated in Table 1.7-1.14, a variety of 
reaction conditions were explored: varying solvent systems, bases, and oxidants. As enamine 
byproducts do not undergo the oxidative amidation, it was postulated that adding water to the 
reaction might promote reformation of the hemiaminal; indeed, the addition of an equal volume 
of H2O to non-polar solvents like benzene and toluene significantly suppressed the formation of 
the enamine 2 (Table 1.1, entries 1-4; Table 1.9) and favored the formation of the amide 1. Since 
acidic or basic aqueous conditions are known to promote enamine/imine hydrolysis, we next  
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3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
hydrogen accept, base




















1 DME none acetone 9 18 0 
2 DME/H2O none acetone 14 0 0 
3 C6H6/H2O none acetone 42 0 20 
4 Tol/H2O none acetone 38 1 19 
5 C6H6/H2O KOH acetone 24 0 19 
6 C6H6/H2O NEt3 acetone 41 0 19 
7 C6H6/H2O K2CO3 acetone 51 0 24 
8 C6H6/H2O CsOAc acetone 56 0 22 
9 C6H6/H2O CsOAc cyclohexanone 63 1 22 
10 C6H6/H2O CsOAc norbornene 62 0 23 
11 C6H6/H2O CsOAc styrene 80 1 9 
12 C6H6/H2O CsOAc MMAb 65 0 12 
13 C6H6/H2O CsOAc styrenec 68 0 20 
14 C6H6/H2O CsOAc styrened 91 0 5 
15 C6H6/H2O CsOAce styrene 84 0 10 
16 C6H6/H2O CsOAcf styrene 90 0 10 
a Unless otherwise noted, reaction conditions are: allyl alcohol (0.25 mmol, 1.0 equiv), amine (3.0 equiv), base (1.5 
equiv), hydrogen acceptor (3.0 equiv), solvent (0.2 mL, 1.2 M), DI H2O (0.2 mL). Yields are determined by GC 
analysis and comparison to an internal standard. b MMA = methyl methacrylate. c 1.0 equiv. d 5.0 equiv. e 2.0 equiv. 
f 2.5 equiv. 
 
investigated bases as the additive (Table 1.1, entries 5-8; Table 1.10): amine bases like Et3N do 
not affect yields; stronger bases lead to lower yields of the desired amide, with KOH only 
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affording 1 in 24%. Weaker inorganic bases such as K2CO3 and CsOAc give 51% and 56% yield 
respectively (entries 7-8), which are slightly better than neutral aqueous condition (entries 3-4).  
Upon addition of equal volume of basic water solution, the yields of allylic alchols 
amidation are increased to 56%, with 22% of hydrogenated starting material (3) as the major by-
product (entry 8). This indicates that more efficient and selective hydrogen acceptors are 
required to avoid the reduction of allylic alcohols. Then, different types of hydrogen acceptors 
were screened: including ketones cyclohexanone (63%, entry 9), alkenes such as cyclohexene 
(39%) and tert-butyl ethylene (28%, Table 1.10), strained alkene norbornene (62%, entry 10), 
and conjugated alkenes such as methyl methacrylate (65%, entry 12), stilbene (58%, Table 1.10) 
and styrene (80%, entry 11). Conjugated alkenes prove to be the most selective hydrogen 
acceptors over the allylic alcohol, only about 10% 3 formed. Styrene is the most superior one 
over other conjugated alkenes, affording 80% of desired product. Finally, increasing the 
equivalents of styrene and CsOAc slightly improved yields and shortened the reaction time to 4 
hours (Table 1.1, entries 13-16; Table 1.11 & 1.13). 
Interestingly, under the optimized conditions primary amines like benzyl amine give only 
11% yield of the amide 4 and 89% yield of the imine 5 (Table 1.2, entry 1). Fortunately, when 
stronger bases are applied, the imine byproduct 5 decreases significantly and the desired amide is 
increased. However, the reduction of the starting allylic alcohol remains as a problem (Table 1.2, 
entries 2-3; Table 1.14). Since the byproduct 3 becomes the major problem, other hydrogen 
acceptors were reexamined. Surprisingly, acetone, the poor oxidant for 2° amines, becomes the 




Table 1.2 Selected optimization of amidation of allyl alcohol with primary amine. a 
+
3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
hydrogen accept, base




















1 CsOAc styrene 11 89 0 
2 Cs2CO3 styrene 50 30 20 
3 KOH styrene 51 19 30 
4 KOH norbornene 56 10 26 
5 KOH NMO 48 6 37 
6 KOH acetone 82 0 6 
7 Cs2CO3 acetone 60 11 18 
8 KOH acetoneb 84 0 4 
a Unless otherwise noted, reaction conditions are: allyl alcohol (0.25 mmol, 1.0 equiv), amine (3.0 equiv), base (1.5 
equiv), oxidant (3.0 equiv), solvent (0.2 mL, 1.2 M), DI H2O (0.2 mL). Yields are determined by GC analysis and 
comparison to an in-ternal standard. b 5.0 equiv. 
 
The optimization experiments suggest that the allylic alcohol rapidly converts into the 
aldehyde under the reaction conditions, which could then go on to form the amide. To test this 
hypothesis, we investigated the kinetic profile of the reaction. As shown in Figure 1.1, under 
standard conditions, enamine 2 forms very rapidly: about 70 % after 30 minutes.  Then enamine 
decreases with the increasing amide formation. Amide is formed up to 70% yield in first 2 hours, 
then slowly increased to 90% in 4 hours.  This suggested that: under the optimized conditions, 
aldehydes are formed very rapidly then condense with amines to generate enamine, followed by 
transfer hydrogenation under biphasic conditions to generate amides. Base on these results, we 
assume that aldehydes should be effective substrates for the oxidative coupling reaction. Indeed, 
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when 3-phenylpropanal is subjected to the optimized conditions amide 1 is formed in a 76% 
yield, which is nearly identical to the 81% yield from the cinnamyl alcohol (Table 1.3). 
 
Figure 1.1 Kinetic profile of allylic alcohol amidation. 
 
1.2.2 Substrate Scope 
With the optimized conditions in hand, we examined the substrate scope for our oxidative 
amidation of both allylic alcohols and aldehydes. The amine substrate scope is shown in Table 
1.3. Secondary cyclic amines, including 1-methylpiperazine (1), morpholine, piperidine, 
pyrrolidine, tetrahydroisoquinoline (6-9) and more sterically hindered acyclic amines, such as 
dimethyl amine (10) and N-benzylmethyl amine (11) are incorporated in very good, and nearly 
equivalent, yields from either the allylic alcohol or aldehyde under secondary amine conditions 
(Table 1.3). Likewise, primary alkyl amines afforded the corresponding amides 4, 12-15 in good 
to excellent yields when acetone and KOH are applied as oxidant and base. The reaction is 
sensitive to steric hindrance of the amine, as cyclohexylamine affords 54%/48% yield of the  
 9 
Table 1.3 Amine substrate scope of allylic alcohol and aldehyde amidation. a 
Ph OH or Ph O + HN
R2
R1
3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
hydrogen accept, base





































































































allylic alcohol or aldehyde
 
a Alcohol or aldehyde (0.25 mmol, 1.0 equiv), amine (3.0 equiv), [Rh(COD)2]BF4 (3.0 mol %), BINAP (3.0 mol %), 
hydrogen acceptor (3.0-5.0 equiv): styrene (2° amine and aniline) or acetone (1° amine), base(1.5-2.5 equiv), 
benzene (0.2 mL, 1.2 M), DI H2O (0.2 mL). 
 
amide 13 while n-butylamine affords amide 12 in 72%/63% yield. It is worth noting that 
heteroaryl amine 14 and primary amine tethering a tertiary nitrogen 15 both afford products in 
good yields under identical conditions, giving amides with motifs commonly found in drug 
molecules. Unlike other oxidative amidation processes,13,15–17,23 electron rich and electron poor 
aniline derivatives (17-21) were all effective nucleophiles in the coupling reaction without 
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requiring higher temperatures or specialized reaction conditions. It is important to note that for 
all substrates, the allylic alcohol and the aldehyde gave similar yields. 
Table 1.4 Allylic alcohol scope with primary and secondary amine nucleophiles. a 
R1 OH + HN
R5
R4
3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
hydrogen accept, base




























































































































a Alcohol or aldehyde (0.25 mmol, 1.0 equiv), amine (3.0 equiv), [Rh(COD)2]BF4 (3.0 mol %), BINAP (3.0 mol 
%), hydrogen acceptor (3.0-5.0 equiv): styrene for 2° amine or acetone for 1° amine, benzene (0.2 mL, 1.2 M), DI 
H2O (0.2 mL). 
The allylic alcohols that undergo the oxidative amidation reaction were explored, as seen 
in Table 1.4, with both secondary and primary amine as nucleophiles. Electron rich and poor 
cinnamyl alcohols both give similar yields (23-23, 32-33). Products bearing active aryl bromides 
could be synthesized in good yields (22, 32), allowing for facile subsequent coupling reactions to 
increase molecule complexity. Different substitution patterns are examined: 1,1-di, 1,2-di-, tri-, 
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and tetra-substituted allylic alcohols give the corresponding α- or/and β- branched secondary 
(32-41) and tertiary (22-31) amides in moderate to good yields with primary and secondary 
amines. Notably, products with α- or β-substituents, which are known to be challenging 
substrates for other dehydrogenative coupling methods, could be synthesized from the 
corresponding trisubstituted allylic alcohols in good yields (27-30 and 37-40). Moreover, 
geraniol was coupled to afford 30 and 40 in 64% and 65% yield, respectively; neither reduction 
nor isomerization of the distal alkene was observed. Tetrasubstituted allylic alcohols react, 
affording 31 and 41 in 41% and 31% yields, respectively, along with unreacted starting material. 
Unfortunately, the diastereoselectivity of these reactions was poor, affording the amines in only 
1.6:1 and 1:1 dr. 






































































3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
3.0-5.0 equiv styrene
1.0-2.5 equiv CsOAc








a Aldehyde (0.25 mmol, 1.0 equiv), amine (3.0 equiv), [Rh(COD)2]BF4 (3.0 mol %), BINAP (3.0 mol %), styrene 
(3.0-5.0 equiv), CsOAc (1.5-2.5 equiv), benzene (0.2 mL, 1.2 M), DI H2O (0.2 mL).  
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Finally, as seen in Table 1.5, the scope of aldehydes that undergo the oxidative amidation 
re-action was investigated.  The reactions are tolerant of a variety of functionalities, including 
ethers (43), acetals (44), aryl bromides (45), aryl fluorides (46), trifluromethyls (47), nitriles 
(48), and heteroaromatics (51). Benzaldehyde derivatives with electron donating groups, such as 
p-MeO, afford the desire amide in excellent yield; electron poor benzaldehydes, such as p-CN or 
p-CF3, undergo the oxidative amidation to afford 47 and 48, albeit in reduced yields. Steric 
hindrance of the aldehyde did not affect its reactivity, as 2,6-dimethylbenzaldehyde afforded 
amide 50 in 88% yield. Aliphatic aldehydes, which have proven challenging for other oxidative 
amidation reactions, also afford the desired amides in good to very good yields (52 and 53). 
 
1.2.3 Mechanistic Investigations 
Competition Studies 
The synthetic utility of this oxidative amidation reaction would be significantly increased 
if the reaction proved to be chemoselective for allylic alcohols and aldehydes over other 
oxidizable functionalities, i.e., simple primary alcohols. To explore the chemoselectivity of the 
reaction condition, a series of competition studies were carried out (Scheme 1.5).   
In Competition Experiment 1, cinnamyl alcohol competes against hexanal to compare the 
relative rates of the two coupling partners. Unsurprisingly, given the rapid rate of 1,3-hydride 
shift,24 the reaction is unselective, affording a 33% yield of 1 and a 25% yield of 52 after four 
hours. This lack of selectivity supports the rapid Rh-catalyzed isomerization of the cinnamyl 
alcohol to the corresponding aldehyde; the oxidative amidation of the two, similar aliphatic 
aldehydes, then occur at similar rates. 































































3. Allylic vs. benzylic alcohol:
4. Allylic vs homoallylic alcohol:













































Scheme 1.5 Competition studies of allylic alcohol amidation.  
a Standard conditions are: allylic alcohol (1.0 equiv), amine (3.0 equiv), [Rh(COD)2]BF4 (3.0 mol %), BINAP (3.0 
mol %), styrene (3.0 equiv), CsOAc (2.5 equiv), benzene (0.2 mL, 1.2 M), DI H2O (0.2 mL), 80°C, 4 hours. b benzyl 
3-phenylpropanoate was formed in 7% yield. c hexyl 3-phenyl-propanoate was formed in 8% yield. 
 
alcohols was explored. Under the standard reaction conditions, cinnamyl alcohol reacts 
selectively over cyclohex-1-en-1-ylmethanol. This excellent chemoselectivity is consistent with 
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the known rates of the Rh-catalyzed isomerization of allylic alcohols.24 Importantly, the 
cyclohexenyl alcohol was observed, unisomerized, at the end of the reaction. 
Competition Experiments 3-5 investigate the chemo-selectivity of the oxidative 
amidation reaction with respect to benzylic alcohols, homoallylic alcohols, and aliphatic 
alcohols. When equimolar amounts of cinnamyl alcohol and benzyl alcohol were treated with 3.0 
equivalents of amine under the standard reaction conditions, product 1 was formed in 93% yield 
while 54 was not observed. This indicates that our conditions are highly selective for allylic 
alcohols over easily oxidizable benzylic alcohols.15,25 Moreover, in Competition Experiment 4, 
less than 5% amide product 55 was observed when cinnamyl alcohol and 3-buten-1-ol are 
subjected to the reaction conditions, which afforded an 82% yield of 1. Notably, 3-buten-1-ol 
affords <5% yield of 55 under the standard reaction conditions, in the absence of cinnamyl 
alcohol. Finally, Competition Experiment 5 demonstrates that cinnamyl alcohol reacts selectively 
over hexan-1-ol, to afford an 88% yield of 1; 52 was not observed. These experiments exhibit the 
excellent chemoselectivity of this Rh-catalyzed oxidative amidation reaction for coupling allylic 
alcohols and aldehydes selectively. 
Control Reactions 
To understand the roles of water and base in the catalytic amidation reactions, we carried 
out a series of control reactions compared to the optimized conditions in Table 1.6. When both 
water and base are taken out of standard conations, only about 50% of starting material converts, 
with 44% enamine formation (Table 1.6, entry 2). Upon the addition of water, all the enamine 2 
is transformed into amide product, with moderate yields (entries 3-4). In entry 5, only CsOAc is 
added. The yield of product significant increases along with reaction crude turns homogeneous 
compared to entry 2, which indicates the acetate anion might interact with metal to generate  
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Table 1.6 Control reactions of oxidative amidation of allylic alcohols with 2° amines. a 
3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
3.0 equiv styrene

























1 C6H6/H2O 1:1 CsOAc 88 0 < 5 
2 C6H6 - none 1 44 < 5 
3 C6H6/H2O 1:1 none 59 0 < 5 
4 C6H6/H2O 1:2 none 68 0 < 5 
5 C6H6 - CsOAc 60 38 < 5 
6 C6H6 1:1 CsOAc solutionb 78 0 < 5 
7 C6H6 2:1 CsOAc solutionb 86 0 < 5 
8 C6H6 3:1 CsOAc solutionb 93 0 < 5 
9 C6H6 4:1 CsOAc solutionb 96 0 < 5 
 
a Standard conditions are: cinnamyl alcohol (1.0 equiv) amine (3.0 equiv), [Rh(COD)2]BF4 (3.0 mol %), BINAP (3.0 
mol %), styrene (3.0 equiv), benzene (0.2 mL, 1.2 M), 80°C, 4 hours. b CsOAc solution: 1.2M in DI water. 
 
some active complexes that are soluble in benzene. Finally, when a CsOAc water solution is 
prepared and injected into the reaction, similar but slightly better yields are obtained when less 
solution is added (entry 6-9). There is only 0.25 equivalence of CsOAc is used in entry 9, which 
is consistent with our hypothesis: the acetate anion might interact with catalytic rhodium 
complexes to form active species. Overall, the addition of water and acetate base both 
dramatically increase the yield of amide product. The presence of water completely converts 
enamine byproducts, however only adding water gives moderate yields. The addition of acetate 
base increases the yield to be quantitative when combined with water, so the acetate solution is 
the most atom economy way to carry out this reaction. 
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Deuterium Studies 
To study the role of water in the mechanism of this reaction, we conducted an isotope in-
corporation experiment, replacing H2O with D2O. After the reaction had gone to completion, 
83% deuterium was incorporated at the α-position of the product (Scheme 1.6). Importantly, in 
the absence of catalyst and N-methylpiperazine, no deuterium incorporation is observed into 
amide 1 or 3-phenylpropanal. This suggests that water reacts with the enamine/imine to reform 
the reactive hemiaminal, which is different from many Ru-catalyzed dehydrogenative coupling 
of alcohols with amines, where in situ formed aldehydes stay bounded to metal center to avoid 
the imine formation.12-17,26,27 Comparison of the initial rate of the reaction in H2O and D2O 
revealed a kH/kD = 2.2, indicating the enamine-hemiaminal equilibrium occurs at or before the 
turnover-limiting step. Alternatively, the primary k.i.e. could be attributed to cleavage of N-H(D) 
bond in hemiaminal formation, due to the exchange of amine proton with D2O. 
C6H6/D2O (1:1), 80 °C
Ph N
O3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
N Me
5.0 equiv Styrene
2.5 equiv CsOAc D D
1-d2










Scheme 1.6 Deuterium studies. 
Catalytic Cycle 
The proposed catalytic cycle for this oxidative amidation reaction is shown in Scheme 1.7. 
First, a Rh-mediated 1,3- hydride shift28,29 occurs to form an aldehyde from the allylic alcohol. 
The aldehyde then condenses with the amine to generate the enamine/imine, which is in 
equilibrium with the hemiaminal (Scheme 1.7, 56). The mechanism of hemiaminal oxidation to 
amide in the presence of rhodium catalyst is currently unknown. There are two possible 
pathways, one is the oxidative addition of hemiaminal O-H bond followed by β-hydride 
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eliminate to form Rh(III) dihydride species (57, L=H), which reduces the hydrogen acceptors to 
regenerate Rh(I) complex.  The other way is the ligand exchange and β-hydride eliminate to form 
Rh(I) monohydride species (57, L=dative ligand), followed by Rh-H insertion into hydrogen 




















































Scheme 1.7 Proposed catalytic cycle. 
In conclusion, conditions have been developed for the chemoselective oxidative 
amidation of allylic alcohols or aldehydes, using styrene or acetone as hydrogen acceptors. This 
methodology presents a general protocol for the synthesis of amides, which is effective for both 







1.2.4 Experimental Procedures 
General Information 
General Experimental Procedures: All reactions were carried out in flame-dried (or oven-
dried at 140 °C for at least 2 h) glassware under an atmosphere of nitrogen unless otherwise 
indicated. Nitrogen was dried using a drying tube equipped with Drierite™ unless otherwise 
noted. Air- and moisture-sensitive reagents were handled in a nitrogen-filled glovebox (working 
oxygen level ~ 0.1 ppm). Column chromatography was performed with silica gel from Grace 
Davison Discovery Sciences (35-75 µm) with a column mixed as a slurry with the eluent and 
was packed, rinsed, and run under air pressure. Analytical thin-layer chromatography (TLC) was 
performed on precoated glass silica gel plates (by EMD Chemicals Inc.) with F-254 indicator. 
Visualization was either by short wave (254 nm) ultraviolet light, or by staining with potassium 
permanganate followed by brief heating on a hot plate or by a heat gun. Distillations were 
performed using a 3 cm short-path column under reduced pressure or by using a Hickman still at 
ambient pressure. 
Instrumentation: 1H NMR and 13C NMR were recorded on a Varian Unity 400/500 MHz 
(100/125 MHz respectively for 13C) or a VXR-500 MHz spectrometer. Spectra were referenced 
using either CDCl3 or C6D6 as solvents (unless otherwise noted) with the residual solvent peak as 
the internal standard (1H NMR: δ 7.26 ppm, 13C NMR: δ 77.00 ppm for CDCl3 and 1H NMR: δ 
7.15 ppm, 13C NMR: δ 128.60 ppm for C6D6). Chemical shifts were reported in parts per million 
and multiplicities are as indicated: s (singlet,) d (doublet,) t (triplet,) q (quartet,) p (pentet,) m 
(multiplet,) and br (broad). Coupling constants, J, are reported in Hertz and integration is 
provided, along with assignments, as indicated. Analysis by Gas Chromatography-Mass 
Spectrometry (GC-MS) was performed using a Shimadzu GC-2010 Plus Gas chromatograph 
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fitted with a Shimadzu GCMS-QP2010 SE mass spectrometer using electron impact (EI) 
ionization after analytes traveled through a SHRXI–5MS- 30m x 0.25 mm x 0.25 µm column 
using a helium carrier gas.  Data are reported in the form of m/z (intensity relative to base peak = 
100). Gas Chromatography (GC) was performed on a Shimadzu GC-2010 Plus gas 
chromatograph with SHRXI–MS- 15m x 0.25 mm x 0.25 µm column with nitrogen carrier gas 
and a flame ionization detector (FID). Low-resolution Mass Spectrometry and High Resolution 
Mass Spectrometry were performed in the Department of Chemistry at University of Illinois at 
Urbana-Champaign. The glove box, MBraun LABmaster sp, was maintained under nitrogen 
atmosphere. Melting points were recorded on a Thomas Hoover capillary melting point 
apparatus and are uncorrected. 
Materials: Solvents used for extraction and column chromatography were reagent grade and 
used as received. Reaction solvents tetrahydrofuran (Fisher, unstabilized HPLC ACS grade), 
diethyl ether (Fisher, BHT stabilized ACS grade), methylene chloride (Fisher, unstabilized 
HPLC grade), dimethoxyethane (Fisher, certified ACS), toluene (Fisher, optima ACS grade), 
1,4-dioxane (Fisher, certified ACS), acetonitrile (Fisher, HPLC grade), and hexanes (Fisher, 
ACS HPLC grade) were dried on a Pure Process Technology Glass Contour Solvent Purification 
System using activated Stainless Steel columns while following manufacture’s recommendations 
for solvent preparation and dispensation unless otherwise noted. All amines were distilled and 
degassed by the freeze-pump-thaw method, and were stored under an atmosphere of nitrogen in 
glove box before use. All liquid aldehydes were distilled prior to use, and ketones, benzophenone 




Optimization Tables for Reaction Conditions  
Table 1.7 Varying the ligand in optimizing the Rh-catalyzed oxidative amidation reaction.a 
Benzene/H2O (1:1), 80 °C, 8 h
3.0 mol % [Rh(COD)2]BF4

















Entry Ligand % Yield 1 % Yield 2 
1 dppp 72 22 
2 dppb 57 32 
3 dpppent 9 70 
4 dppf 31 64 
5 bipyridine 4 2 
6 DPEphos 11 75 
7 Xantphos 17 68 
8 Davephos 18 34 
9 BINAP 87 2 
10 None 9 10 
a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 8 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 









Table 1.8 Varying the solvent in optimizing the Rh-catalyzed oxidative amidation reaction.a 
Solvent/H2O (1:1), 80 °C, 8 h
3.0 mol % [Rh(COD)2]BF4

















Entry Solvent % Yield 1 % Yield 2 
1 Benzene 91 3 
2 Toluene 79 7 
3 Hexanes 88 2 
4 DME 80 0 
5 Et2O 83 0 
6 1,4-dioxane 75 0 
7 THF 82 0 
 8b MeCN 43 0 
a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 8 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 












Table 1.9 Varying the concentration, and benzene/H2O ratio in optimizing the Rh-
catalyzed oxidative amidation reaction.a 
Benzene/H2O, 80 °C, 8 h
3.0 mol % [Rh(COD)2]BF4

















a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 8 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 







Entry Concentration (M) Benzene: H2O % Yield 1 % Yield 2 
1 0.31 1 : 1 35 14 
2 0.62 1 : 1 60 5 
3 1.2 1 : 1 89 0 
4 2.5 1 : 1 88 7 
5 1.2 2 : 1 78 15 
6 1.2 3 : 1 66 34 
7 1.2 4 : 1 68 32 
8 1.2 10 : 1 70 30 
9 1.2 1 : 0 49 51 
10 1.2 1 : 2 62 0 
11 1.2 1 : 3 34 13 
 23 
Table 1.10 Varying the hydrogen acceptor and bases in optimizing the Rh-catalyzed 
oxidative amidation reaction.a 
Benzene/H2O (1:1), 80 °C, 8 h
3.0 mol % [Rh(COD)2]BF4
3.0 mol % BINAP
















a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 8 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 
diphenylmethane (20 µL, 0.12 mmol, 0.48 equiv.) as an internal standard. 
Entry Base Hydrogen Acceptor % Yield 1 % Yield 2 
1 Na2CO3 styrene 36 49 
2 K2CO3 styrene 47 31 
3 Cs2CO3 styrene 31 58 
4 NaOAc styrene 89 0 
5 KOAc styrene 88 0 
6 CsOAc styrene 89 0 
7 NaOtBu styrene 17 47 
8 KOtBu styrene 13 27 
9 Et3N styrene 18 38 
10 Py styrene 63 0 
11 none styrene 39 15 
12 CsOAc norbornene 56 0 
13 CsOAc cyclohexene 39 21 
14 CsOAc tert-butylethylene 28 31 
15 CsOAc methyl-methacrylate 25 2 
16 CsOAc NMO 65 0 
17 CsOAc trans-stilbene 58 7 
18 CsOAc acetone 58 0 
19 CsOAc cyclohexanone 65 0 
20 CsOAc none 41 5 
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Table 1.11. Varying the equivalences of oxidants and bases in optimizing the Rh-catalyzed 
oxidative amidation reaction.a 
Benzene/H2O (1:1), 80 °C, 4 h
3.0 mol % [Rh(COD)2]BF4

















a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 4 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 







Entry X equiv styrene Y equiv CsOAc % Yield 1 % Yield 2 
1 5.0 0.20 48 0 
2 5.0 0.50 61 0 
3 5.0 1.0 63 0 
4 5.0 1.5 76 0 
5 5.0 2.0 81 0 
6 5.0 2.5 87 0 
7 5.0 3.0 85 0 
8 1.0 2.5 61 0 
9 2.0 2.5 73 0 
10 3.0 2.5 78 0 
11 4.0 2.5 80 0 
12 8.0 2.5 83 0 
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Table 1.12 Varying the equivalence of catalyst/ligand, allylic alcohol, and amine in 
optimizing the Rh-catalyzed oxidative amidation reaction.a 
Benzene/H2O (1:1), 80 °C, 4 h
Z mol % [Rh(COD)2]BF4
















X equiv Y equiv  
a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 4 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 






Entry X equiv alcohol Y equiv amine Z mol% catalyst % Yield 1 % Yield 2 
1 1.0 1.0 3.0 20 13 
2 1.0 2.0 3.0 63 0 
3 1.0 3.0 3.0 87 0 
4 1.0 4.0 3.0 87 0 
5 1.0 5.0 3.0 85 0 
6 2.0 1.0 3.0 16 35 
7 3.0 1.0 3.0 15 45 
8 1.0 3.0 1.0 14 65 
9 1.0 3.0 2.0 62 11 
10 1.0 3.0 4.0 87 0 
11 1.0 3.0 5.0 90 0 
12 1.0 3.0 3.0 91 0 
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Table 1.13 Varying the temperature and reaction time in optimizing the Rh-catalyzed 
oxidative amidation reaction.a 
Benzene/H2O (1:1), X °C, Y h
3.0 mol % [Rh(COD)2]BF4
















X equiv Y equiv  
a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine. Amine was distilled prior to use. In situ yields 
were determined by GC analysis of the crude reaction mixture and comparison to diphenylmethane (20 µL, 0.12 







Entry X (°C) Y (h) % Yield 1 % Yield 2 
1 rt 8 9 46 
2 40 8 10 36 
3 60 8 76 16 
4 80 8 91 0 
5 100 8 91 0 
6 120 8 86 0 
7 80 0.5 43 50 
8 80 1 68 15 
9 80 2 75 10 
10 80 4 83 1 
11 80 6 83 1 
12 80 8 84 0 
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Table 1.14 Optimization of primary amine nucleophiles.a 
+
3.0 mol % [Rh(COD)2]BF4











5.0 equiv Hydrogen Acceptor
1.0 equiv Base
Benzene/H2O (1:1), 80 °C, 24 h  
a Unless otherwise specified, all reactions were set up in oven-dried 4mL vials and performed with 3.0 mol % 
catalyst at 1.25 M in alcohol (0.25 mmol) with 3.0 equiv of amine for 24 h at 80 °C. Amine was distilled prior to 
use. In situ yields were determined by GC analysis of the crude reaction mixture and comparison to 









Entry Base Hydrogen Acceptor % Yield 4 % Yield 3 
1 CsOAc styrene 4 0 
2 Cs2CO3 styrene 35 20 
3 KOH styrene 34 26 
4 CsOH.H2O styrene 37 29 
5 KOH norbornene 56 26 
6 KOH NMO 48 37 
7 KOH acetone 84 4 
8 KOH acetone (3equiv) 82 6 
9 LiOH acetone (3equiv) 64 5 
10 NaOH acetone (3equiv) 74 6 
11 CsOH.H2O acetone (3equiv) 77 6 
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Deuterium Incorporation Study 
C6H6/D2O (1:1), 80 °C
Ph N
O3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
N Me
5.0 equiv Styrene
2.5 equiv CsOAc D D
1-d2









1-(4-methylpiperazin-1-yl)-3-phenylpropan-1-one-2,2-d2 (1-d2):  [Rh(COD)2]BF4 (3.1 mg, 
0.0075 mmol, 3.0 mol %), BINAP (4.7 mg, 0.0075 mmol, 3.0 mol %), and CsOAc (120 mg, 0.62 
mmol, 2.5 equiv) were added to a 4 mL vial equipped with a stir bar. After purging with 
nitrogen, to the vial was added sequentially benzene (0.2 mL), 1-methylpiperazine (65 µL, 0.75 
mmol, 3.0 equiv), styrene (145 µL, 1.25 mmol, 5.0 equiv), cinnamyl alcohol (32 µL, 0.25 mmol, 
1.0 equiv), and D2O (0.2 mL). The resulting solution was allowed to stir for 30 h at 80 °C. Then, 
the reaction vial was cooled to room temperature followed by the addition of diphenylmethane as 
an internal standard for analysis of the crude reaction mixture. The biphasic solution was added 
EtOAc, extracted with 1 M HCl solution three times. The combined water layer was basified by 
adding 2 M NaOH solution until pH > 10, then extracted with DCM three times. The combine 
organic layers was dried over anhydrous MgSO4, filtered and concentrated in vacuo to afford a 


































































































Figure 1.3  2H NMR of 1-d2. 
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Kinetic Isotope Effect Study 
C6H6/D2O (1:1), 80 °C
Ph N
O3 mol % [Rh(COD)2]BF4
3 mol % (±)-BINAP
N Me
5.0 equiv Styrene









H2O: A serial of reactions were set up according to standard procedure. After 2, 4, 6, 8, 10, and 
12 min, one reaction was stopped and diluted with EtOAc, followed by the addition of 
diphenymethane as an internal standard. The in situ yield of product 1 was determined by GC 
analysis and comparison to diphenylmethane as an internal standard for analysis of the crude 
reaction mixture. The yield vs. time are plotted in Figure 1.4.  
D2O: Same procedures were applied to D2O, and reaction time and yield of product 1-d2 were 
plotted in Figure 1.4 as well.  
 





Experimental Procedure, Isolation, and Characterization 
Benzene/H2O (1:1), 80 °C, 4 h
3.0 mol % [Rh(COD)2]BF4













General Procedure A (2° amine): [Rh(COD)2]BF4 (3.1 mg, 0.0075 mmol, 3.0 mol %), BINAP 
(4.7 mg, 0.0075 mmol, 3.0 mol %), and CsOAc (120 mg, 0.62 mmol, 2.5 equiv) were added to a 
4 mL vial equipped with a stir bar. After purging with nitrogen, to the vial was added 
sequentially benzene (0.2 mL), amine (0.75 mmol, 3.0 equiv), styrene (145 µL, 1.25 mmol, 5.0 
equiv), allylic alcohol (0.25 mmol, 1.0 equiv) and DI water (0.2 mL). The resulting solution was 
allowed to stir for 4 h at 80 °C. Then, the reaction vial was cooled to room temperature followed 
by the addition of diphenylmethane as an internal standard for analysis of the crude reaction 
mixture. The biphasic solution was added EtOAc, dried over anhydrous MgSO4, and filtered. 
The solution was concentrated in vacuo and then purified by silica gel chromatography to afford 
the desired product.  
 
Benzene/H2O (1:1), 80 °C, 24 h
3.0 mol % [Rh(COD)2]BF4











General Procedure B (1° amine): [Rh(COD)2]BF4 (3.1 mg, 0.0075 mmol, 3.0 mol %), BINAP 
(4.7 mg, 0.0075 mmol, 3.0 mol %), and KOH (28 mg, 0.50 mmol, 2.0 equiv) were added to a 4 
mL vial equipped with a stir bar. After purging with with nitrogen, to the vial was added 
sequentially benzene (0.2 mL), 1° amine (0.75 mmol, 3.0 equiv), acetone (36 µL, 0.50 mmol, 2.0 
equiv), allylic alcohol (0.25 mmol, 1.0 equiv) and DI water (0.2 mL). The resulting solution was 
allowed to stir for 24 h at 80 °C. Then, the reaction vial was cooled to room temperature 
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followed by the addition of diphenylmethane as an internal standard for analysis of the crude 
reaction mixture. The biphasic solution was added EtOAc, dried over anhydrous MgSO4, and 
filtered. The solution was concentrated in vacuo and then purified by silica gel chromatography 
to afford the desired product.  
 
1-(4-methylpiperazin-1-yl)-3-phenylpropan-1-one (1, Table 1.3): 
Prep-ared according to General procedure A in 81% (from allylic 
alcohol) and 76% (from aldehyde) isolated yields. (Acid-base extraction) 
1H NMR (400 MHz, CDCl3) δ: 7.32 – 7.26 (m, 2H), 7.24 – 7.17 (m, 3H), 3.64 (dd, J = 6.3, 4.2 
Hz, 2H), 3.39 (dd, J = 5.8, 4.3 Hz, 2H), 2.97 (dd, J = 9.2, 6.7 Hz, 2H), 2.69 – 2.55 (m, 2H), 2.35 
(t, J = 5.2 Hz, 2H), 2.27 (m, 5H, overlapping peaks) ppm. 13C NMR (101 MHz, CDCl3) δ: 
170.75, 141.39, 128.66, 128.59, 126.32, 55.12, 54.81, 46.15, 45.55, 41.65, 35.17, 31.65 ppm. IR: 
ν 2940, 2795, 1643, 1440 cm-1. HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H21N2O, 
233.1654; found, 233.1661. 
 
1-morpholino-3-phenylpropan-1-one (6, Table 1.3): Prepared according 
to General procedure A in 91% (from allylic alcohol) and 88% (from 
aldehyde) isolated yields.  
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.15 
1H NMR (400 MHz, CDCl3) δ: 7.33 – 7.27 (m, 2H), 7.25 – 7.18 (m, 3H), 3.70 – 3.58 (m, 4H), 
3.51 (dd, J = 5.7, 4.0 Hz, 2H), 3.36 (dd, J = 5.7, 4.0 Hz, 2H), 2.98 (t, J = 7.8Hz, 2H), 2.62 (t, J = 
7.8 Hz, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ: 170.98, 141.17, 128.67, 128.58, 126.39, 
Ph N
O






66.97, 66.58, 46.07, 42.04, 34.94, 31.60 ppm. IR: ν 2927, 2857, 1642, 1455, 1435, 1227, 1333 
cm-1. HRMS (ESI-TOF) m/z: [M+H+] calculated for C13H17NO2, 220.1338; found, 220.1342.  
 
3-phenyl-1-(piperidin-1-yl)propan-1-one (7, Table 1.3): Prepared 
according to General procedure A in 84% (from allylic alcohol) and 73% 
(from aldehyde) isolated yields.  
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.2  
1H NMR (400 MHz, CDCl3) δ: 7.29 (dd, J = 8.1, 6.8 Hz, 2H), 7.25 – 7.16 (m, 3H), 3.61 – 3.51 
(m, 2H), 3.38 – 3.29 (m, 2H), 3.03 – 2.91 (m, 2H), 2.67 – 2.57 (m, 2H), 1.61 (dtt, J = 7.6, 4.7, 
2.9 Hz, 2H), 1.56 – 1.41 (m, 4H) ppm.  13C NMR (101 MHz, CDCl3) δ: 170.53, 141.61, 128.57, 
126.20, 46.74, 42.84, 35.35, 31.76, 26.52, 25.68, 24.66 ppm.  IR: ν 2937, 2858, 1639, 1441, 
1252, 1218 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO, 218.1545; found, 
218.1550. 
 
3-phenyl-1-(pyrrolidin-1-yl)propan-1-one (8, Table 1.3): Prepared 
according to General procedure A in 81% (from allylic alcohol) and 83% 
(from aldehyde) isolated yields.  
Column Chromatography Condition: 2:1 hexanes/EtOAc. Rf = 0.1  
1H NMR (400 MHz, CDCl3) δ: 7.33 – 7.25 (m, 2H), 7.25 – 7.16 (m, 3H), 3.46 (t, J = 6.7 Hz, 
2H), 3.28 (t, J = 6.6 Hz, 2H), 3.06 – 2.91 (m, 2H), 2.64 – 2.50 (m, 2H), 1.96 – 1.75 (m, 4H) ppm. 








31.31, 26.15, 24.48 ppm. IR: ν 2974, 2877, 1638, 1436 cm-1. HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C13H18NO, 204.1388; found, 204.1396. 
 
1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-phenylpropan-1-one (9, Table 
1.3): Prepared according to General procedure A in 83% (from allylic 
alcohol) and 72% (from aldehyde) isolated yields.  
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.15  
1H NMR (500 MHz, DMSO-d6, 60 °C) δ: 7.32 – 7.22 (m, 4H), 7.20 – 7.10 (m, 5H), 4.61 (s, 2H), 
3.73 – 3.60 (br, 2H), 2.87 (t, J = 7.8 Hz, 2H), 2.83 – 2.74 (m, 2H), 2.71 (t, J = 7.7 Hz, 2H) ppm. 
13C NMR (101 MHz, CDCl3) δ: 171.25, 171.13, 141.45, 135.21, 134.19, 133.68, 132.62, 129.03, 
128.64, 128.61, 128.56, 128.54, 128.35, 126.99, 126.80, 126.70, 126.63, 126.42, 126.29, 126.27, 
126.14, 47.38, 44.38, 43.29, 39.81, 35.95, 35.67, 31.55, 31.49, 29.55, 28.65 ppm (mixture of 
amide rotamers, two carbon resonances are coincidental).  IR: ν 2937, 2858, 1639, 1441, 1252, 
1218 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H20NO, 266.1545; found, 
266.1550. 
 
N,N-dimethyl-3-phenylpropanamide (10, Table 1.3): Prepared according 
to General procedure A in 64% (from allylic alcohol) and 57% (from 
aldehyde) isolated yields.  
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.25  
1H NMR (400 MHz, CDCl3) δ: 7.32 – 7.26 (m, 2H), 7.24 – 7.17 (m, 3H), 3.00-2.96 (m, 2H), 










141.60, 128.57, 128.54, 126.20, 37.28, 35.56, 35.45, 31.48 ppm.  IR: ν 2936, 1644, 1496, 1455 
cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C11H26NO, 178.1232; found, 178.1236. 
 
 N-benzyl-N-methyl-3-phenylpropanamide (11, Table 1.3): Prepared 
according to General procedure A in 76% (from allylic alcohol) and 76% 
(from aldehyde) isolated yields.  
Column Chromatography Condition: 6:1 hexanes/EtOAc. Rf = 0.15  
1H NMR (400 MHz, CDCl3, mixture of amide rotamers) δ: 7.42 – 7.15 (m, 9H), 7.13 – 7.05 (m, 
1H), 4.61 (s, 1.1H), 4.47 (s, 0.8H), 3.09 – 2.98 (m, 2H), 2.96 (s, 1.1H), 2.85 (s, 1.8H), 2.74 – 
2.65 (m, 2H) ppm.  13C NMR (101 MHz, CDCl3, mixture of amide rotamers)2 δ: 172.69, 172.36, 
141.49, 141.41, 137.47, 136.64, 129.02, 128.67, 128.59, 128.57, 128.15, 127.68, 127.42, 126.33, 
126.24, 126.22, 53.34, 50.96, 35.52, 35.09, 34.85, 34.10, 31.66, 31.49 ppm.  IR: ν 2926, 2856, 
1644, 1495, 1453 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H20NO, 254.1545; 
found, 254.1547. 
 
 N-benzyl-3-phenylpropanamide (4, Table 1.3): Prepared according to 
General procedure B in 80% (from allylic alcohol) and 72% (from 
aldehyde) isolated yields.  
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.25; mp = 80-83 °C  
1H NMR (400 MHz, CDCl3) δ: 7.33 – 7.23 (m, 5H), 7.23 – 7.18 (m, 3H), 7.18 – 7.12 (m, 2H), 
5.59 (bs, 1H), 4.40 (d, J = 5.7 Hz, 2H), 3.00 (t, J = 7.6 Hz, 2H), 2.52 (t, J = 7.6 Hz, 2H) ppm.  













126.40, 43.73, 38.71, 31.87 ppm.  IR: ν 3293, 3031, 2928, 1639, 1545 cm-1.  HRMS (ESI-TOF) 
m/z: [M+H+] calculated for C16H18NO, 240.1388; found, 240.1393. 
 
N-Butyl-3-phenylpropanamide (12, Table 1.3): Prepared according to 
General procedure B in 72% (from allylic alcohol) and 63% (from aldehyde) 
isolated yields.  
Column Chromatography Condition: 3:1 hexanes/EtOAc. Rf = 0.2  
1H NMR (400 MHz, CDCl3) δ: 7.30 – 7.24 (m, 2H), 7.21 – 7.14 (m, 3H), 5.28 (bs, 1H), 3.18 (td, 
J = 7.2, 5.7 Hz, 2H), 2.94 (t, J = 7.7 Hz, 2H), 2.44 (t, J = 7.7 Hz, 2H), 1.46 – 1.30 (m, 2H), 1.31 – 
1.16 (m, 2H), 0.86 (t, J = 7.3 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 172.12, 141.03, 
128.62, 128.47, 126.32, 39.35, 38.74, 31.94, 31.74, 20.10, 13.86 ppm.  IR: ν 3301, 2962, 2932, 
1643, 1554 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C13H20NO, 206.1545; found, 
206.1548. 
 
N-Cyclohexyl-3-phenylpropanamide (13, Table 1.3): Prepared 
according to General procedure B in 54% (from allylic alcohol) and 48% 
(from aldehyde) isolated yields.  
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.2; mp = 107-108 °C 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.26 (m, 2H), 7.23 – 7.17 (m, 3H), 5.12 (s, 1H), 3.79– 
3.69 (m, 1H), 2.96 (t, J = 7.7 Hz, 2H), 2.43 (t, J = 7.6 Hz, 2H), 1.87 – 1.78 (m, 2H), 1.69 – 1.61 
(m, 2H), 1.58 (ddd, J = 7.8, 3.9 Hz, 1H), 1.39 – 1.28 (m, 2H), 1.11 (ddt, J = 12.8, 3.5 Hz, 1H), 











128.55, 126.34, 48.17, 39.00, 33.27, 32.04, 25.65, 24.95 ppm.  IR: ν 3303, 2939, 2850, 1636, 
1543 cm-1. HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H22NO, 232.1701; found, 
232.1704. 
 
N-(furan-2-ylmethyl)-3-phenylpropanamide (14, Table 1.3): Prepared 
according to General procedure B in 73% (from allylic alcohol) and 66% 
(from aldehyde) isolated yields.  
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.1; mp = 51-53 °C 
1H NMR (400 MHz, CDCl3) δ: 7.46 – 7.10 (m, 6H), 6.46 – 6.21 (m, 1H), 6.16 (d, J = 3.3 Hz, 
1H), 5.62 (bs, 1H), 4.41 (d, J = 5.6 Hz, 2H), 2.98 (t, J = 7.7 Hz, 2H), 2.49 (t, J = 7.7 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ: 171.88, 151.32, 142.30, 140.87, 128.67, 128.47, 126.37, 110.57, 
107.57, 38.52, 36.60, 31.74.  IR: ν 3311, 2961, 2930, 2869, 1638, 1534.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C13H20NO, 230.1181; found, 230.1174. 
 
N-(2-(diethylamino)ethyl)-3-phenylpropanamide (15, Table 1.3): 
Prepared according to General procedure B in 73% (from allylic 
alcohol) and 65% (from aldehyde) isolated yield (acid-base extraction). 
1H NMR (400 MHz, Benzene-d6) δ: 7.15 – 7.09 (m, 2H), 7.09 – 7.00 (m, 3H), 5.39 (bs, 1H), 
3.20 (q, J = 5.7 Hz, 2H), 2.95 (t, J = 7.6 Hz, 2H), 2.19 (q, J = 7.1 Hz, 4H), 2.15 – 2.08 (m, 4H), 
0.78 (t, J = 7.1 Hz, 6H).  13C NMR (101 MHz, CDCl3) δ: δ 172.09, 141.12, 128.60, 128.47, 
126.28, 51.41, 46.70, 38.64, 36.91, 31.91, 11.84.  IR: ν 3304, 2971, 2937, 1647, 1554.  HRMS 












1-(indolin-1-yl)-3-phenylpropan-1-one (16, Table 1.3): Prepared 
according to General procedure A in 73% (from allylic alcohol) and 83% 
(from aldehyde) isolated yields.  
Column Chromatography Condition: 10:1 hexanes/EtOAc. Rf = 0.1; mp =112-113 °C 
1H NMR (500 MHz, CDCl3, mixture of amide rotamers)9 δ: 8.27 (d, J = 8.0 Hz, 1H), 7.43 – 7.25 
(m, 4H), 7.20 (m, 3H, overlapping peaks), 7.01 (t, J = 7.4 Hz, 1H), 4.16 (t, J = 7.9 Hz, 0.2H, 
minor rotamer), 3.97 (t, J = 8.5 Hz, 2H, major rotamer), 3.15 (t, J = 8.5 Hz, 2H), 3.08 (t, J = 7.8 
Hz, 2H, major rotamer), 2.99 (t, J = 8.0 Hz, 0.2H minor rotamer).2.74 (t, J = 7.9 Hz 2H).  13C 
NMR (126 MHz, CDCl3) (major rotamer) δ: 170.50, 143.12, 141.37, 131.16, 128.68, 128.59, 
127.69, 126.33, 124.63, 123.71, 117.16, 48.08, 38.07, 30.92, 28.16.  IR: ν 3064, 2929, 1654, 
1483.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H18NO, 252.1388; found, 252.1390. 
 
N,3-diphenylpropanamide (17, Table 1.3): Prepared according to 
General procedure A in 55% (from allylic alcohol) and 59% (from 
aldehyde) isolated yields.  
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.3; mp = 92-94 °C. 
1H NMR (500 MHz, CDCl3) δ: 7.43 (d, J = 8.0 Hz, 2H), 7.34 – 7.27 (m, 4H), 7.25 – 7.20 (m, 
3H), 7.10 (t, J = 7.4 Hz, 1H), 6.96 (bs, 1H), 3.07 (t, J = 7.6 Hz, 2H), 2.67 (t, J = 7.6 Hz, 2H) ppm.  
13C NMR (101 MHz, CDCl3) δ: 170.49, 140.82, 137.88, 129.18, 128.86, 128.61, 126.61, 124.51, 
120.07, 39.74, 31.77 ppm. IR: ν 3325, 3030, 2930, 2861, 1652, 1600, 1528, 1441 cm-1.  HRMS 









3-phenyl-N-(p-tolyl)propanamide (18, Table 1.3): Prepared 
according to General procedure A in 64% (from allylic alcohol) and 
53% (from aldehyde) isolated yields.  
Column Chromatography Condition: 10:1 hexanes/EtOAc. Rf = 0.1; mp =126-129 °C  
1H NMR (500 MHz, CDCl3) δ: 7.33 – 7.28 (m, 4H), 7.26 – 7.20 (m, 3H), 7.10 (d, J = 8.0 Hz, 
2H), 6.93 (bs, 1H), 3.06 (t, J = 7.6 Hz, 2H), 2.65 (t, J = 7.6 Hz, 2H), 2.30 (s, 3H) ppm. 13C NMR 
(126 MHz, CDCl3) δ: 170.38, 140.83, 135.28, 134.06, 129.57, 128.76, 128.53, 126.49, 120.18, 
39.57, 31.75, 20.98 ppm. IR: ν 3320, 3027, 2926, 2867, 1654, 1595, 1564 cm-1. HRMS (ESI-
TOF) m/z: [M+H+] calculated for C16H18NO, 240.1388; found, 240.1391 
 
N-(4-methoxyphenyl)-3-phenylpropanamide (19, Table 1.3): 
Prepared according to General procedure A in 53% (from allylic 
alcohol) and 59% (from aldehyde) isolated yields.  
Column Chromatography Condition: 10:1 hexanes/EtOAc. Rf = 0.15; mp =127-130 °C  
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.28 (m, 4H), 7.26 – 7.20 (m, 3H), 6.88 (bs, 1H), 6.86 – 
6.80 (m, 2H), 3.78 (s, 3H), 3.05 (t, J = 7.6 Hz, 2H), 2.64 (t, J = 7.6 Hz, 2H) ppm.  13C NMR (126 
MHz, CDCl3) δ: 170.36, 156.58, 140.84, 130.91, 128.76, 128.54, 126.50, 122.05, 114.25, 55.61, 
39.46, 31.81 ppm.  IR: ν 3288, 2998, 2948, 2845, 1651, 1606, 1508 cm-1.  HRMS (ESI-TOF) 















N-(4-fluorophenyl)-3-phenylpropanamide (20, Table 1.3): Prepared 
according to General procedure A in 66% (from allylic alcohol) and 
56% (from aldehyde) isolated yields.  
Column Chromatography Condition: 10:1 hexanes/EtOAc. Rf = 0.2; mp =116-118 °C  
1H NMR (400 MHz, CDCl3) δ: 7.42 – 7.34 (m, 2H), 7.34 – 7.27 (m, 1H), 7.27 – 7.19 (m, 3H), 
7.07 – 6.86 (m, 3H), 3.05 (t, J = 7.6 Hz, 2H), 2.65 (t, J = 7.6 Hz, 2H) ppm.  13C NMR (126 MHz, 
CDCl3) δ: 170.47, 159.78 (d, 1JCF = 242.5 Hz), 140.66, 133.76, 128.81, 128.53, 126.59, 121.94 
(d, 3JCF= 8.8 Hz), 115.72 (d, 2JCF = 21.8 Hz), 39.48, 31.70 ppm.  19F NMR (470 MHz, CDCl3) δ: 
-118.98 (t, 2JFH = 7.8 Hz) ppm.  IR: ν 3293, 3072, 3036, 2958, 1652, 1507 cm-1.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C15H15NOF, 244.1138; found, 244.1143. 
 
3-phenyl-N-(4-(trifluoromethyl)phenyl)propanamide (21, Table 
1.3): Prepared according to General procedure A in 41% (from allylic 
alcohol) and 37% (from aldehyde) isolated yields.  
Column Chromatography Condition: 10:1 hexanes/EtOAc. Rf = 0.1; mp =147-150 °C  
1H NMR (500 MHz, CDCl3) δ: 7.55 (s, 4H), 7.36 – 7.28 (m, 2H), 7.26 – 7.20 (m, 3H), 7.08 (bs, 
1H), 3.07 (t, J = 7.5 Hz, 2H), 2.70 (t, J = 7.6 Hz, 2H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
170.75, 140.82, 140.44, 128.88, 128.51, 126.69, 126.38 (q, 3JCF = 3.8 Hz), 125.92 (q, 2JCF  = 
31.2 Hz), 124.17 (q, 1JCF = 270.0 Hz), 119.48, 39.66, 31.55 ppm.  19F NMR (470 MHz, CDCl3) 
δ: -62.20 (s) ppm.   IR: ν 3329, 3031, 2931, 1673, 1600, 1524 cm-1.   HRMS (ESI-TOF) m/z: 















3-(4-bromophenyl)-1-morpholinopropan-1-one (22, Table 1.4): 
Prepared according to General procedure A in 76% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.1; 
mp = 69-71°C  
1H NMR (500 MHz, CDCl3) δ: 7.46 – 7.36 (m, 2H), 7.11 – 7.05 (m, 2H), 3.71 – 3.59 (m, 4H), 
3.57 (t, J = 4.9 Hz, 2H), 3.44 – 3.32 (m, 2H), 2.94 (t, J = 7.7 Hz, 2H), 2.58 (t, J = 7.7 Hz, 2H).  
13C NMR (126 MHz, CDCl3) δ: 170.56, 140.25, 131.71, 130.39, 120.14, 67.02, 66.64, 46.03, 
42.11, 34.67, 30.81.  IR: ν 2973, 2920, 2850, 1632.  HRMS (ESI-TOF) m/z: [M+H+] calculated 
for C13H17NOBr, 298.0443; found, 298.0455. 
 
3-(4-methoxyphenyl)-1-morpholinopropan-1-one (23, Table 
1.4): Prepared according to General procedure A in 72% isolated 
yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.1 
1H NMR (400 MHz, CDCl3) δ: 7.18 – 7.08 (m, 2H), 6.89 – 6.76 (m, 2H), 3.78 (s, 3H), 3.74 – 
3.56 (m, 4H), 3.67 – 3.46 (m, 2H), 3.42 – 3.30 (m, 2H), 2.91 (t, J = 7.7 Hz, 2H), 2.58 (t, J = 7.8 
Hz, 2H).  13C NMR (101 MHz, CDCl3) δ: 171.08, 158.18, 133.19, 129.51, 114.03, 66.99, 66.62, 
55.14, 46.09, 42.03, 35.20, 30.71.  IR: ν 2963, 2929, 2860, 1639, 1512.  HRMS (ESI-TOF) m/z: 
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1-morpholinobutan-1-one (24, Table 1.4): Prepared according to General 
procedure A in 77% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (500 MHz, CDCl3) δ: 3.66 (dd, J = 5.7, 3.9 Hz, 4H), 3.63 – 3.43 (m, 4H), 2.29 (t, J = 
7.6 Hz, 2H), 1.66 (h, J = 7.4 Hz, 2H), 0.97 (t, J = 7.4 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ: 
171.82, 67.05, 66.84, 46.15, 41.96, 35.15, 18.79, 14.11.  IR: ν 2965, 2934, 2861, 1642, 1433.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C8H16NO2, 158.1181; found, 158.1180. 
 
1-morpholino-2-phenylpropan-1-one (25, Table 1.4): Prepared according to 
General procedure A in 61% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (400 MHz, CDCl3) δ: 7.35 – 7.28 (m, 2H), 7.26 – 7.20 (m, 3H), 3.83 (q, J = 6.9 Hz, 
1H), 3.78 (dd, J = 9.4, 3.6 Hz, 1H), 3.66 (dd, J = 9.4, 4.6 Hz, 1H), 3.57 – 3.43 (m, 3H), 3.39 
(ddd, J = 13.5, 7.4, 3.2 Hz, 1H), 3.29 (ddd, J = 13.9, 6.1, 3.4 Hz, 1H), 3.09 (ddd, J = 10.8, 7.3, 
3.1 Hz, 1H), 1.45 (d, J = 6.8 Hz, 3H).  13C NMR (101 MHz, CDCl3) δ: 172.28, 141.93, 129.12, 
127.25, 127.01, 66.90, 66.40, 46.11, 43.37, 42.48, 20.76.  IR: ν 2974, 2932, 2858, 1642, 1430.   
HRMS (ESI-TOF) m/z: [M+H+] calculated for C13H18NO2, 220.1338; found, 220.1340. 
 
2-methyl-1-morpholino-3-phenylpropan-1-one (26, Table 1.4): Prepared 
according to General procedure A in 61% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.35 
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1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.26 (m, 2H), 7.24 – 7.13 (m, 3H), 3.74 – 3.54 (m, 2H), 
3.52 – 3.38 (m, 3H), 3.30 (ddd, J = 13.5, 7.5, 3.2 Hz, 1H), 3.15 (ddd, J = 13.4, 5.9, 3.0 Hz, 1H), 
3.01 (ddd, J = 11.9, 7.9, 3.6 Hz, 1H), 2.98 – 2.93 (m, 2H), 2.78 – 2.62 (m, 1H), 1.18 (d, J = 6.0 
Hz, 3H).  13C NMR (126 MHz, CDCl3) δ: 174.55, 140.02, 129.18, 128.55, 126.53, 66.94, 66.52, 
46.11, 42.19, 40.94, 37.43, 18.15.  IR: ν 2971, 2929, 2859, 1636, 1433.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C14H20NO2, 234.1494; found, 234.1493. 
 
1-morpholino-3-phenylbutan-1-one (27, Table 1.4): Prepared according 
to General procedure A in 86% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.15 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.27 (m, 2H), 7.25 – 7.18 (m, 3H), 3.71 – 3.58 (m, 2H), 
3.56 – 3.42 (m, 3H), 3.39 – 3.28 (m, 2H), 3.28 – 3.16 (m, 2H), 2.62 (dd, J = 14.5, 7.0 Hz, 1H), 
2.50 (dd, J = 14.5, 7.4 Hz, 1H), 1.35 (d, J = 7.0 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ: 
170.55, 146.14, 128.67, 127.04, 126.62, 66.96, 66.55, 46.33, 42.02, 41.54, 37.06, 21.77.  IR: ν 
2966, 2926, 2860, 1638, 1455, 1429.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO2, 
234.1494; found, 234.1499. 
 
2-methyl-1-morpholino-3-phenylpropan-1-one (28, Table 1.4): Prepared 
according to General procedure A in 52% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.1 
1H NMR (400 MHz, CDCl3) δ: 7.32 – 7.25 (m, 2H), 7.24 – 7.14 (m, 3H), 3.74 – 3.55 (m, 2H), 













(m, 1H), 1.18 (d, J = 6.0 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ: 174.55, 139.99, 129.16, 
128.53, 126.52, 66.92, 66.50, 46.10, 42.17, 40.93, 37.41, 18.14.  IR: ν 2972, 2928, 2859, 1635, 
1434.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO2, 234.1494; found, 234.1496. 
 
 cyclohexyl(morpholino)methanone (29, Table 1.4): Prepared according to 
General procedure A in 54% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2; mp = 
54-55 °C 
1H NMR (400 MHz, CDCl3) δ: 3.73 – 3.63 (m, 4H), 3.64 – 3.41 (m, 4H), 2.43 (tt, J = 11.6, 3.4 
Hz, 1H), 1.91 – 1.76 (m, 2H), 1.76 – 1.60 (m, 3H), 1.60 – 1.46 (m, 2H), 1.33 – 1.21 (m, 3H).  
13C NMR (101 MHz, CDCl3) δ: 174.90, 67.16, 67.03, 46.04, 42.06, 40.40, 29.45, 25.96, 25.93.  
IR: ν 2923, 2852, 1642, 1454, 1452. HRMS (ESI-TOF) m/z: [M+H+] calculated for C11H20NO2, 
198.1494; found, 198.1495. 
 
3,7-dimethyl-1-(piperidin-1-yl)oct-6-en-1-one (30, Table 1.4): 
Prepared according to General procedure A in 64% isolated yield. 
Column Chromatography Condition: 3:1 hexanes/EtOAc. Rf = 
0.35 
1H NMR (400 MHz, CDCl3) δ: 5.23 – 4.88 (m, 1H), 3.61 – 3.47 (m, 2H), 3.45 – 3.31 (m, 2H), 
2.32 (dd, J = 14.3, 5.9 Hz, 1H), 2.12 (dd, J = 14.3, 8.4 Hz, 1H), 2.08 – 1.90 (m, 3H), 1.67 (d, J = 
1.3 Hz, 3H), 1.65 – 1.61 (m, 1H), 1.60 (d, J = 1.3 Hz, 3H), 1.57 – 1.48 (m, 4H), 1.38 (dddd, J = 











13C NMR (101 MHz, CDCl3) δ: 171.07, 131.51, 124.65, 47.09, 42.79, 40.85, 37.27, 30.26, 
29.83, 26.76, 25.83, 25.66, 24.75, 19.95, 17.82.  IR: ν 2929, 2856, 1642, 1443.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C15H28NO, 238.2171; found, 238.2179. 
 
2-methyl-1-morpholino-3-phenylbutan-1-one (31, Table 1.4): Prepared 
according to General procedure A in 41% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (500 MHz, CDCl3) δ major diastereomer: 7.30 – 7.23 (m, 2H), 7.22 – 7.16 (m, 3H), 
3.64 – 3.48 (m, 2H), 3.45 – 3.35 (m, 1H), 3.28 – 3.13 (m, 3H), 3.10 – 2.97 (m, 2H), 2.85 – 2.76 
(m, 1H), 2.76 – 2.70 (m, 1H), 1.32 (d, J = 7.1 Hz, 2H), 1.21 (d, J = 6.6 Hz, 2H); minor 
diastereomer: 7.34 – 7.28 (m, 2H), 7.25 – 7.17 (m, 3H), 3.72 – 3.67 (m, 4H), 3.66 – 3.61 (m, 
2H), 3.59 – 3.51 (m, 2H), 3.04 (dq, J = 9.8, 6.8 Hz, 1H), 2.84 (dq, J = 9.7, 6.7 Hz, 1H), 1.22 (d, J 
= 6.9 Hz, 3H), 0.89 (d, J = 6.7 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ major diastereomer: 
174.67, 145.80, 128.48, 127.52, 126.65, 66.85, 66.42, 46.12, 43.01, 42.55, 41.97, 18.06, 16.13; 
minor diastereomer: 174.85, 145.09, 128.61, 127.82, 126.58, 67.25, 66.97, 46.43, 43.74, 42.33, 
41.86, 20.57, 17.25.  IR: ν 2967, 2929, 2680, 1621.  HRMS (ESI-TOF) m/z: [M+H+] calculated 
for C15H22NO2, 248.1651; found, 248.1657. 
 
N-benzyl-3-(4-bromophenyl)propanamide (32, Table 1.4): Pre-
pared according to General procedure B in 60% isolated yield. 
Column Chromatography Condition: 2:1 hexanes/EtOAc. Rf = 
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1H NMR (500 MHz, CDCl3) δ: 7.43 – 7.36 (m, 2H), 7.34 – 7.26 (m, 3H), 7.15 – 7.11 (m, 2H), 
7.10 – 7.04 (m, 2H), 5.59 (bs, 1H), 4.39 (d, J = 5.7 Hz, 2H), 2.95 (t, J = 7.5 Hz, 2H), 2.48 (t, J = 
7.4 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ: 171.49, 139.86, 138.14, 131.73, 130.37, 128.84, 
127.86, 127.69, 120.20, 43.73, 38.41, 31.18.  IR: ν 3296, 3035, 2934, 1635, 1539.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C16H17NOBr, 318.0494; found, 318.0491. 
 
N-benzyl-3-(4-methoxyphenyl)propanamide (33, Table 1.4): 
Prepared according to General procedure B in 70% isolated yield. 
Column Chromatography Condition: 2:1 hexanes/EtOAc. Rf = 
0.1; mp = 91-92 °C 
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.24 (m, 3H), 7.19 – 7.04 (m, 4H), 6.87 – 6.72 (m, 2H), 
5.58 (bs, 1H), 4.40 (d, J = 5.7 Hz, 2H), 3.79 (s, 3H), 2.94 (t, J = 7.5 Hz, 2H), 2.48 (t, J = 7.5 Hz, 
2H).  13C NMR (126 MHz, CDCl3) δ: 172.05, 158.21, 138.29, 132.90, 129.50, 128.78, 127.89, 
127.60, 114.08, 55.39, 43.69, 38.98, 31.01.  IR: ν 3292, 3067, 2938, 1635, 1512.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C17H20NO2, 270.1494; found, 270.1501. 
 
N-benzylbutyramide (34, Table 1.4): Prepared according to General 
procedure B in 87% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.2; mp 
= 48-50 °C 
1H NMR (400 MHz, CDCl3) δ: 7.54 – 7.09 (m, 5H), 5.76 (bs, 1H), 4.44 (d, J = 5.7 Hz, 2H), 2.19 












CDCl3) δ: 172.93, 138.53, 128.83, 127.95, 127.62, 43.70, 38.84, 19.32, 13.94.  IR: ν 3282, 2927, 
2853, 1641, 1551.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C11H16NO, 178.1232; found, 
178.1237. 
 
N-benzyl-2-phenylpropanamide (35, Table 1.4): Prepared according to 
General procedure B in 74% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.25; mp 
= 74-75 °C 
1H NMR (400 MHz, CDCl3) δ: 7.39 – 7.20 (m, 8H), 7.18 – 7.11 (m, 2H), 5.60 (bs, 1H), 4.47 – 
4.32 (m, 2H), 3.60 (q, J = 7.2 Hz, 1H), 1.56 (d, J = 7.2 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ: 
174.14, 141.40, 138.43, 129.10, 128.76, 127.81, 127.60, 127.50, 127.47, 47.34, 43.71, 18.70.  
IR: ν 3308, 3033, 2970, 2926, 1637, 1538.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C16H18NO, 240.1388; found, 240.1396. 
 
N-benzyl-2-methyl-3-phenylpropanamide (36, Table 1.4): Prepared 
according to General procedure B in 70% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.2; mp = 
84-86 °C 
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.12 (m, 8H), 7.10 – 6.95 (m, 2H), 5.44 (bs, 1H), 4.40 
(dd, J = 14.8, 6.0 Hz, 1H), 4.28 (dd, J = 14.7, 5.4 Hz, 1H), 2.99 (dd, J = 13.4, 8.7 Hz, 1H), 2.71 
(dd, J = 13.4, 6.2 Hz, 1H), 2.46 (dq, J = 8.8, 6.7 Hz, 1H), 1.23 (d, J = 6.8 Hz, 3H).  13C NMR 














44.25, 43.51, 40.69, 18.04.  IR: ν 3283, 3030, 2960, 2930, 1637, 1550.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C17H20NO, 254.1545; found, 254.1549. 
 
N-benzyl-3-phenylbutanamide (32, Table 1.4): Prepared according to 
General procedure B in 74% isolated yield. 
Column Chromatography Condition: 5:1 hexanes/EtOAc. Rf = 0.15 
1H NMR (400 MHz, CDCl3) δ: 7.35 – 7.22 (m, 8H), 7.13 – 6.83 (m, 2H), 5.66 (bs, 1H), 4.40 
(dd, J = 14.8, 6.0 Hz, 1H), 4.30 (dd, J = 14.8, 5.4 Hz, 1H), 3.36 (h, J = 7.2 Hz, 1H), 2.49 (d, J = 
7.5 Hz, 2H), 1.35 (d, J = 7.0 Hz, 3H).  13C NMR (101 MHz, CDCl3) δ: 171.57, 145.84, 138.19, 
128.74, 128.69, 127.68, 127.44, 126.95, 126.56, 45.97, 43.52, 37.21, 21.95.  IR: ν 3289, 3032, 
2965, 2920, 1642, 1549.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H20NO, 254.1545; 
found, 251.1546. 
 
N-benzyl-2-methyl-3-phenylpropanamide (38, Table 1.4): Prepared 
according to General procedure B in 60% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.1; mp 
= 88-89 °C 
1H NMR (400 MHz, CDCl3) δ: 7.32 – 7.21 (m, 6H), 7.21 – 7.14 (m, 2H), 7.06 – 6.99 (m, 2H), 
5.44 (bs, 1H), 4.40 (dd, J = 14.8, 6.0 Hz, 1H), 4.28 (dd, J = 14.7, 5.3 Hz, 1H), 2.99 (dd, J = 13.4, 
8.8 Hz, 1H), 2.71 (dd, J = 13.4, 6.2 Hz, 1H), 2.46 (dp, J = 8.9, 6.7 Hz, 1H), 1.23 (d, J = 6.8 Hz, 
















127.45, 126.39, 44.19, 43.47, 40.66, 18.02.  IR: ν 3284, 3030, 2960, 1637, 1549.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C17H20NO, 254.1545; found, 251.1547. 
 
N-benzylcyclohexanecarboxamide (39, Table 1.4): Prepared according to 
General procedure B in 67% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.4; mp = 
109-110 °C 
1H NMR (400 MHz, CDCl3) δ: 7.38 – 7.30 (m, 2H), 7.30 – 7.26 (m, 3H), 5.70 (bs, 1H), 4.44 (d, 
J = 5.6 Hz, 2H), 2.11 (tt, J = 11.8, 3.5 Hz, 1H), 1.94 – 1.85 (m, 2H), 1.83 – 1.76 (m, 2H), 1.71 – 
1.63 (m, 1H), 1.47 (qd, J = 12.0, 3.3 Hz, 2H), 1.34 – 1.16 (m, 3H).  13C NMR (101 MHz, 
CDCl3) δ: 176.00, 138.66, 128.83, 127.87, 127.59, 45.73, 43.52, 29.87, 25.88 (overlap).  IR: ν 
3285, 2927, 2853, 1641, 1550.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO, 
218.1545; found, 218.1546. 
 
N-benzyl-3,7-dimethyloct-6-enamide (40, Table 1.4): Prepared 
according to General procedure B in 65% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 
0.2; mp = 39-42 °C 
1H NMR (400 MHz, CDCl3) δ: 7.38 – 7.31 (m, 2H), 7.30 – 7.26 (m, 3H), 5.68 (br, 1H), 5.27 – 
4.85 (m, 1H), 4.53 – 4.36 (m, 2H), 2.27 – 2.21 (m, 1H), 2.10 – 1.91 (m, 4H), 1.67 (d, J = 1.2 Hz, 
3H), 1.59 (d, J = 1.4 Hz, 3H), 1.43 – 1.33 (m, 1H), 1.24 – 1.15 (m, 1H), 0.95 (d, J = 6.2 Hz, 3H).  














43.75, 37.05, 30.65, 25.86, 25.59, 19.72, 17.81.  IR: ν 3285, 2967, 2920, 2856, 1633, 1550.  
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26NO, 260.2014; found, 260.2012. 
 
N-benzyl-2-methyl-3-phenylbutanamide (41, Table 1.4): Prepared 
according to General procedure B in 31% isolated yield. 
Column Chromatography Condition: 6:1 hexanes/EtOAc. Rf = 0.1 
1H NMR (500 MHz, CDCl3) δ diastereomer I: 7.32 – 7.27 (m, 3H), 7.25 – 7.16 (m, 5H), 6.85 – 
6.72 (m, 2H), 5.22 (bs, 1H), 4.26 (dd, J = 14.8, 6.3 Hz, 1H), 4.09 (dd, J = 14.8, 5.0 Hz, 1H), 3.02 
(dq, J = 9.8, 7.1 Hz, 1H), 2.30 (dq, J = 9.8, 6.8 Hz, 1H), 1.30 (d, J = 7.1 Hz, 3H), 1.27 (d, J = 6.8 
Hz, 3H); diastereomer II: 7.39 – 7.32 (m, 2H), 7.31 – 7.26 (m, 5H), 7.24 – 7.14 (m, 3H), 5.78 – 
5.62 (m, 1H), 4.56 – 4.36 (m, 2H), 2.97 (dq, J = 9.9, 6.8 Hz, 1H), 2.30 (dq, J = 9.8, 6.8 Hz, 1H), 
1.27 (d, J = 6.9 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H).  13C NMR (126 MHz, CDCl3) δ diastereomer 
I: 175.32, 145.92, 138.19, 128.66, 128.62, 127.67, 127.47, 127.32, 126.51, 49.72, 43.35, 43.14, 
18.66, 15.79; diastereomer II: 175.67, 144.91, 138.49, 128.88, 128.59, 128.05, 127.72, 127.69, 
126.54, 49.09, 43.73, 43.58, 20.47, 17.07.  IR: ν 3279, 2968, 2932, 2878, 1645.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C18H22NO, 268.1701; found, 268.1706. 
 
 phenyl(piperidin-1-yl)methanone (42, Table 1.5): Prepared according to 
General procedure A in 91% isolated yield. 
Column Chromatography Condition: 2:1 hexanes/EtOAc. Rf = 0.4 
1H NMR (400 MHz, CDCl3) δ: 7.39 (m, 5H), 3.81 – 3.60 (m, 2H), 3.42 – 3.24 (m, 2H), 1.82 – 













43.22, 26.65, 25.73, 24.71.  IR: ν 2938, 2857, 1627, 1431.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C12H16NO, 190.1232; found, 190.1236. 
 
(4-methoxyphenyl)(morpholino)methanone (43, Table 1.5): Prepared 
according to General procedure A in 99% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (400 MHz, CDCl3) δ: 7.51 – 7.33 (m, 2H), 6.98 – 6.82 (m, 2H), 3.83 (s, 3H), 3.75 – 
3.50 (m, 8H).  13C NMR (101 MHz, CDCl3) δ: 170.52, 160.99, 129.31, 127.41, 113.88, 67.04, 
55.50, 55.46, 29.81.  IR: ν 2924, 2854, 1629, 1610, 1514.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C12H16NO3, 222.1130; found, 222.1133. 
 
 benzo[d][1,3]dioxol-5-yl(morpholino)methanone (44, Table 1.5): 
Prepared according to General procedure A in 99% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.25 
1H NMR (500 MHz, CDCl3) δ: 6.92 (dd, J = 7.9, 1.7 Hz, 1H), 6.90 (d, J = 1.5 Hz, 1H), 6.82 (d, J 
= 7.9 Hz, 1H), 6.00 (s, 2H), 3.86 – 3.38 (m, 8H).  13C NMR (101 MHz, CDCl3) δ: 170.09, 
149.10, 147.80, 128.96, 121.82, 108.40, 108.21, 101.61, 67.02, 48.03, 42.89.  IR: ν 2973, 2925, 














(2-bromophenyl)(morpholino)methanone (45, Table 1.5): Prepared 
according to General procedure A in 64% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2; mp = 
85-88 °C  
1H NMR (400 MHz, CDCl3) δ: 7.58 (dd, J = 8.4, 1.1 Hz, 1H), 7.37 (td, J = 7.5, 1.2 Hz, 1H), 7.31 
– 7.22 (m, 2H), 3.92 – 3.83 (m, 1H), 3.83 – 3.69 (m, 4H), 3.59 (ddd, J = 11.6, 6.2, 3.3 Hz, 1H), 
3.29 (ddd, J = 13.4, 6.2, 3.2 Hz, 1H), 3.20 (ddd, J = 13.4, 6.7, 3.3 Hz, 1H).  13C NMR (101 MHz, 
CDCl3) δ: 167.88, 137.68, 132.98, 130.59, 127.95, 127.87, 119.27, 66.90, 66.81, 47.29, 42.14.  
IR: ν 2966, 2927, 2867, 1625, 1427.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C11H13NO2Br, 270.0130; found, 270.0135. 
 
(4-fluorophenyl)(morpholino)methanone (46, Table 1.5): Prepared 
according to General procedure A in 85% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (400 MHz, CDCl3) δ: 7.47 – 7.38 (m, 2H), 7.16 – 7.05 (m, 2H), 4.08 – 3.02 (m, 8H).  
13C NMR (101 MHz, CDCl3) δ: 169.63, 163.59 (d, JCF = 250.1 Hz), 131.39, 129.56 (d, JCF= 8.7 
Hz), 115.79 (d, JCF = 21.8 Hz), 66.97, 48.05, 42.61.  19F NMR (470 MHz, CDCl3) δ: -110.92 (t, 
JCF = 6.8 Hz).  IR: ν 2974, 2928, 2960, 1631, 1619, 1511.  HRMS (ESI-TOF) m/z: [M+H+] 













 morpholino(4-(trifluoromethyl)phenyl)methanone (47, Table 1.5): 
Prepared according to General procedure A in 72% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (400 MHz, CDCl3) δ: 7.69 (d, J = 8.0 Hz, 2H), 7.52 (d, J = 8.0 Hz, 2H), 3.88 – 3.57 
(m, 6H), 3.53 – 3.26 (m, 2H).  13C NMR (101 MHz, CDCl3) δ: 169.14, 139.07, 132.07 (q, JCF = 
32.8 Hz), 127.69, 125.92 (q, JCF = 3.8 Hz), 123.86 (q, JCF = 272.5 Hz), 67.02, 48.31, 42.76.  19F 
NMR (470 MHz, CDCl3) δ: 62.98 (s).  IR: ν 2974, 2924, 2864, 1637, 1434.  HRMS (ESI-TOF) 
m/z: [M+H+] calculated for C12H13NO2F3, 260.0898; found, 260.0905. 
 
4-(morpholine-4-carbonyl)benzonitrile (48, Table 1.5): Prepared 
according to General procedure A in 48% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2; mp 
= 138-140 °C 
1H NMR (400 MHz, CDCl3) δ: 7.79 – 7.68 (m, 2H), 7.57 – 7.47 (m, 2H), 3.88 – 3.55 (m, 6H), 
3.46 – 3.32 (m, 2H).  13C NMR (101 MHz, CDCl3) δ: 168.45, 139.77, 132.66, 127.96, 118.13, 
113.90, 66.89, 48.12, 42.67.  IR: ν 2927, 2863, 2227, 1621, 1441.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C12H13N2O2, 217.0977; found, 217.0983. 
 
 morpholino(o-tolyl)methanone (49, Table 1.5): Prepared according to 
General procedure A in 84% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.15 
O
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1H NMR (400 MHz, CDCl3) δ: 7.32 – 7.26 (m, 1H), 7.25 – 7.13 (m, 3H), 3.92 – 3.73 (m, 4H), 
3.65 – 3.51 (m, 2H), 3.31 – 3.18 (m, 2H), 2.32 (s, 3H).  13C NMR (101 MHz, CDCl3) δ: 170.20, 
135.72, 134.28, 130.61, 129.16, 126.12, 125.92, 67.12, 67.07, 47.37, 42.02, 19.15.  IR: ν 2923, 
2854, 1635, 1427.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C12H16NO2, 206.1181; found, 
206.1183. 
 
(2,6-dimethylphenyl)(morpholino)methanone (50, Table 1.5): Prepared 
according to General procedure A in 88% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (500 MHz, CDCl3) δ: 7.15 (t, J = 7.6 Hz, 1H), 7.03 (d, J = 7.6 Hz, 2H), 3.85 (dd, J = 
5.8, 3.7 Hz, 2H), 3.77 (dd, J = 5.5, 4.1 Hz, 2H), 3.61 – 3.55 (m, 2H), 3.18 (dd, J = 5.5, 4.2 Hz, 
2H), 2.26 (s, 6H).  13C NMR (101 MHz, CDCl3) δ: 169.82, 135.65, 133.71, 128.67, 127.71, 
67.18, 67.06, 46.49, 41.59, 19.23.  IR: ν 2972, 2925, 2856, 1633, 1435.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C13H18NO2, 220.1338; found, 220.1339. 
 
(1-methyl-1H-pyrrol-2-yl)(morpholino)methanone (51, Table 1.5): 
Prepared according to General procedure A in 97% isolated yield. 
Column Chromatography Condition: 1:1 hexanes/EtOAc. Rf = 0.3; mp 
=80-83 °C  
1H NMR (400 MHz, C6D6) δ: 6.28 (t, J = 2.1 Hz, 1H), 6.21 (dd, J = 3.9, 1.7 Hz, 1H), 6.10 (dd, J 
= 3.8, 2.6 Hz, 1H), 3.47 (s, 3H), 3.43 (dd, J = 5.6, 4.0 Hz, 4H), 3.27 – 3.19 (m, 4H).  13C NMR 












2930, 2863, 1602, 1534.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C12H13N2O2, 195.1134; 
found, 195.1131. 
 
1-(piperidin-1-yl)hexan-1-one (52, Table 1.5): Prepared according to 
General procedure A in 78% isolated yield. 
Column Chromatography Condition: 3:1 hexanes/EtOAc. Rf = 0.2 
1H NMR (400 MHz, CDCl3) δ: 6.54 – 6.39 (m, 4H), 2.30 (td, J = 7.8, 1.5 Hz, 2H), 1.66 – 1.57 
(m, 4H), 1.57 – 1.48 (m, 4H), 1.39 – 1.26 (m, 4H), 0.88 (t, J = 6.8 Hz, 3H).  13C NMR (126 
MHz, CDCl3) δ: 171.66, 46.84, 42.70, 33.58, 31.84, 26.70, 25.72, 25.32, 24.72, 22.62, 14.10.  
IR: ν 2934, 2857, 2960, 1641, 1435.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C11H22NO, 
184.1701; found, 184.1705. 
 
3,7-dimethyl-1-(piperidin-1-yl)oct-6-en-1-one (53, Table 1.5): 
Prepared according to General procedure A in 63% isolated yield. 
Column Chromatography Condition: 4:1 hexanes/EtOAc. Rf = 0.35 
1H NMR (400 MHz, CDCl3) δ: 5.23 – 4.88 (m, 1H), 3.55 (br, 2H), 3.39 (br, 2H), 2.32 (dd, J = 
14.3, 5.9 Hz, 1H), 2.12 (dd, J = 14.3, 8.4 Hz, 1H), 2.08 – 1.90 (m, 3H), 1.67 (t, J = 1.3 Hz, 3H), 
1.65 – 1.61 (m, 1H), 1.60 (d, J = 1.3 Hz, 3H), 1.57 – 1.48 (m, 4H), 1.38 (dddd, J = 13.4, 9.3, 6.5, 
5.4 Hz, 1H), 1.21 (dddd, J = 13.6, 9.3, 7.9, 5.8 Hz, 1H), 0.94 (d, J = 6.5 Hz, 3H).  13C NMR (101 
MHz, CDCl3) δ: 171.07, 131.51, 124.65, 47.09, 42.79, 40.85, 37.27, 30.26, 29.83, 26.76, 25.83, 
25.66, 24.75, 19.95, 17.82.  IR: ν 2929, 2856, 1642, 1443.  HRMS (ESI-TOF) m/z: [M+H+] 











1.3 Asymmetric Synthesis of Beta-Branched Amides via Oxidative Amidation of Allylic 
Amines 
1.3.1 Reaction Design and Optimization 
We started the asymmetric version of this isomerization/oxidative amidation reaction by 
investigating the use of enantiopure BINAP since it is the optimized ligand for the amidation of 
allylic alcohol and BINAP derivatives are relatively easily accessible. As summarized in Table 
1.15, when (R)-BINAP was applied under the standard conditions, 86% desired product 23 was 
formed (Table 1.15, entry 1) from the starting trisubstituted allylic alcohol. However, only 
moderate enantiometric ratio (e.r.) 69:31 wass obtained, consistent with the literature of 
asymmetric allylic alcohol isomerization.22,30 Substituents on the phenyl rings of phosphine 
ligand slightly decreased the yields and gave the same enantioselectivity (entries 2-3). Applying 
(R)-SEGPhos (L4) as the electron rich derivative of BINAP rendered diminished e.r. (entry 4) 
and (R)-DTBM-SEGPhos L5 only gave 35% yield for product with no enantioselectivity. (R)-
MeO-BIPHEP L6, another axially chiral BINAP derivative, shown promising results at lower 
temperature (entries 6-7). Unfortunately, reactions run under 60 °C afforded poor conversion. 
Screening and synthesis of more axially chiral phosphine ligands was under investigation in the 







Table 1.15 Ligand screen for asymmetric isomerization/amidation of allylic alcohol. a 
+
Benzene/H2O (1:1), T °C, 18 h
3.0 mol % [Rh(COD)2]BF4
3.0 mol % Ligand
5.0 equiv Styrene
2.5 equiv CsOAc







Entry Ligand Temperature (°C) % Yield 23 e.r. 
1 L1 80 86 69 : 31 
2 L2 80 80 70 : 30 
3 L3 80 75 70 : 30 
4 L4 60 88 64 : 36 
5 L5 80 38 50 : 50 
6 L6 80 75 66 : 34 






















a Reaction conditions are: allyl alcohol (0.25 mmol, 1.0 equiv), amine (3.0 equiv), CsOAc (2.5 equiv), styrene (5.0 
equiv), benzene (0.2 mL, 1.2 M), DI H2O (0.2 mL). Yields are determined by column chromatography isolation and 
e.r.’s are determined by high-performance liquid chromatography with chiral columns.  
 
As an enamine intermediate is formed over the course of the allylic alcohol amidation 
(Figure 1.1), we hypothesized that utilizing Noyori’s asymmetric isomerization of allyl amines, a 
highly enantioselective process and the key step in the Takasago Process, could allow for the 
formation of identical intermediates with improved enantioselectivity.28,31 To avoid pre-
installation of the amine functionality on the substrate, we further proposed a domino process: 
enantioselective isomerization of an allylic amine, enamine exchange with an external amine 
 58 










































Scheme 1.8 Proposed allylic amine amidation. 
The key challenge for this tandem process is identifying an appropriate allyl amine 
precursor, as it must: isomerize with high enantioselectivity, afford an enamine (57) which is 
slow to oxidize and instead undergo enamine exchange with an external amine nucleophile to 
afford the desired intermediate (56, Scheme 1.8). We hypothesized that acyclic dialkyl amines 
could serve as precursors as they are good substrates in related Rh-catalyzed asymmetric 
isomerization reactions28,31 and are not reactive in the oxidative amidation of allyl alcohols.32 
Several allylic dialkyl amines were screened for this tandem process (Table 1.16). Under slightly 
modified conditions from the allylic alcohol amidation,32 the desired morpholine amide (6) was 
formed in moderate yields from all the allylic amine precursors. Only cinnamyl dimethylamine 
provided 9% byproduct 58a, consistent with dimethyl amine being an effective nucleophile in 
our allylic alcohol amidation.32 We chose to further optimize this reaction with cinnamyl 
diethylamine, as it forms a low molecular weight byproduct (NHEt2), which is easily removable, 
and it is excellent substrate for asymmetric isomerziation.31 
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1.5 mol % [Rh(COD)Cl]2
3.0 mol % (±)-BINAP
3.0 mol % NaBArF4
1.5 equiv styrene
1.5 equiv CsOAc






6 58a-d  
Entry R % Yield 6 b % Yield 58 a-d b 
1 Me 64 9 
2 Et 77 <1% 
3 i-Pr 71 <1% 
4 Bn 74 <1% 
a General reaction conditions: cinnamyl dialkylamine (0.12 mmol, 1.0 equiv), morpholine (1.5 equiv), CsOAc (1.5 
equiv), styrene (1.5 equiv), THF (1.2 M), DI H2O. b In situ yield determined by GC analysis.  
 
The further optimization of reaction conditions was elaborated in Table 1.21-1.26: 
Cs2CO3 proved superior to CsOAc for 2° amine nucleophiles and only substoichiometric amount 
(20 mol %) is required (Table 1.22 & 1.24). A variety of hydrogen acceptors were examined 
showing styrene to be superior, as it was reduced faster than the substrate (Table 1.23). Further, 
decreasing the equivalents of amine nucleophile (1.05 equiv) led to only slightly diminished 
yields (Table 1.22). Slight modification of the reaction conditions was required for other amine 
nucleophiles. For less nucleophilic aniline derivatives, excess nucleophile (3.0 equiv) and 
increased base (0.9 equiv) were required to prevent unproductive reaction pathways (Table 1.25). 
With primary alkyl amine nucleophiles, a stronger base and higher temperature were essential, 
which presumably aid in the conversion of the less electrophilic imine intermediate to the 
hemiaminal intermediate. Additionally, acetone proved to be the better hydrogen acceptor, 
consistent with our allylic alcohol amidation (Table 1.26).32 
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1.3.2 Substrate Scope 
With the optimized conditions in hand, the amine nucleophile scope was investigated 
(Table 1.17): cyclic amines such as piperidine (7), indoline (16), and 2-(piperazin-1-yl) 
pyrimidine (59) and acyclic amines, including dimethyl amine (10) and N-benzyl methyl amine 
(11) all gave excellent yields of desired products. Moderate yields were obtained with aniline 
derivatives (17, 21, 60-61). Electron-deficient (21) and sterically hindered anilines (61) afford 
slightly diminished yields. Primary amines are relatively challenging nucleophiles for this 
reaction and 4 and 62 were obtained in 64% and 39%, respectively. Unsurprisingly, diethyl and 
dibenzyl amines showed no reactivity under optimized conditions, consistent with Table 1.16.  
Table 1.17 Scope of amine nucleophiles.a 
Ph NEt2 +
1.5 mol % [Rh(COD)Cl]2
3.0 mol % (±)-BINAP 
 3.0 mol % NaBArF4
base, hydrogen acceptor

















































































a a a a
a a b b
b b c c
 
a Condition a: 2° amines (1.05 equiv), Cs2CO3 (20 mol %), styrene (1.5 equiv), THF/H2O (1:0.2). b Condition b: 
anilines (3.0 equiv), Cs2CO3 (90 mol %), styrene (1.5 equiv), THF/H2O (1:0.3). c Condition c: 1° alkyl amine (1.0 
equiv), KOH (2.5 equiv), acetone (1.0 equiv), THF/H2O (1:1), 100 °C. 
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The enantioselectivity of this transformation was explored under optimized conditions 
with different amine nucleophiles (Table 1.18). Excellent enantioselectivities (>96:4 er) were 
observed in the asymmetric oxidative amidation of (E)-geranyl diethyl amine with morpholine, 
aniline, and benzyl amine, affording 63-65 in fair to excellent yields. Using either (S)-BINAP or 
the (Z)-allyl diethylamine affords the opposite enantiomer in identically excellent enantio-
selectivity.  
Table 1.18 Enantioselective isomerization/amidation of (E)-geranyl diethyl amine.a 
NEt2 +
1.5 mol % [Rh(COD)Cl]2
3.0 mol % NaBArF4
 3.0 mol % (R)-BINAP
base, hydrogen acceptor
























78%, 3.5:96.5 er b  
a For conditions see Table 1.17. Isolated yield, average of two runs. Absolute configuration is assigned by analogy 
to 79 (vide infra). b With (S)-BINAP. 
 
Focusing our efforts on substrates not previously shown in the Noyori isomerization, the 
scope of prochiral allylamines was next explored (Table 1.19). A variety of substrates were 
transformed to the corresponding β-branched amides with high enantioselectivities in moderate 
to very good yields. Various 3,3-aryl,alkyl allylic diethylamines were investigated (66-72); 
stereocenters bearing both small (Me, Et) and large (iPr) substituents uniformly give excellent 
enantiomeric ratios (66-68). Aryl halides were tolerated under the optimized conditions, although 
some protodebromination product was observed from aryl bromides (71). When β-dialkyl allylic 
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diethylamines (73-76) were exposed to the reaction conditions, chiral amides bearing a dialkyl 
stereocenter were obtained with excellent enantioselectivity, even with minimally differentiated 
substituents (76, nBu vs nPent).  
Additionally, 3,3-diaryl allylic diethylamines also undergo this asymmetric isomerization 
/oxidation reaction. Substrates bearing electron-rich (77) and electron-poor (78) aryl substituents 
afforded good yields and enantiomeric ratios. Heterocycles such as thiophene (79) were tolerated 





1.5 - 3.0 mol % [Rh(COD)Cl]2
 3.0 - 6.0 mol % (R)-BINAP
3.0 - 6.0 mol % NaBArF4
































73% yield, 96:4 er
75












 72% yield, 99:1 er
80








 67% yield, 99:1 er
66













































60 % yield 95:5 er
79




a For conditions see Table 1.17. Isolated yield, average of two runs. b Determined from the dr of transamidation 
product from 76. c Absolute configuration of 79 was determined by X-ray crystallography. 
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under reaction conditions. Further, a chroman-derived β-cyclic substrate (80) afforded the chiral 
amide product with excellent enanotioselectivity, demonstrating an improvement over other 
approaches, e.g. chiral resolution. 
The diastereoselectivity of this reaction was investigated with both enantiopure amine 
nucleophiles and allylic amines (Table 1.20). When chiral α-branched amines were used as 
nucleophiles, 81-84 were formed in high er (>99:1) and dr (>96:4). Further, both the enantiomer 
of ligand, (R)- or (S)-BINAP, and the enantiomer of amine employed dictate which diastereomer 
is formed. This indicates both that the stereocenter α to the amine are unepimerized under the 
reaction conditions, even with the relatively activated chiral benzylic amine (83-84), and that it 
has no effect on the selectivity of the isomerization reaction.  
Next the isomerization of allylic amine with proximal stereocenters was examined (Table 
1.20). Interestingly, the diastereoselecitivity of the isomerization of both chiral allyic amine with 
(±)-BINAP favoured the formation of 85 (56:44 dr) and 88 (14:85 dr), respectively, with the 
closer stereocenter in substrate has a greater effect on the diastereoselectivity of the reaction. 
Excitingly, both substrates undergo the Rh-catalyzed isomerization/oxidation to afford desired 
products with excellent diastereoselectivities (>97.5:2.5) when enantioenriched ligands are 
employed. The isomerization reaction proved to be ligand-controlled, as the mismatched 
















81 a 82 b
44% yield, 96:4 dr
99:1 er













83 a 84 b
38% yield, 99:1 dr
>99:1 er












































64% yield, 98:2 dr
86 b
65% yield, 2:98 dr
87 a
46% yield, 97.5:2.5 dr
88 b
73% yield, 2:98 dr
 
a with (R)-BINAP. b with (S)-BINAP. For standard conditions, see Table 1.17. 
 
1.3.3 Mechanistic Investigations 
As shown in Scheme 1.9, isotope labeling studies were carried out using H218O and D2O 
respectively. The H218O labeling study (Eqn 1, Scheme 1.9) confirms that the oxygen in the 
product originates from the water. Similarly, deuterium incorporation at the α-position of the 
amide was observed (Eqn 2, Scheme 1.9), as it was in the allylic alcohol amidation,32 supporting 


























Scheme 1.9 Isotope labeling studies.  
In conclusion, we have developed a Rh-catalyzed one-step synthesis of chiral β-branched 
amides. This method allows for the installation of a stereocenter and amide functionality in a 
single step under mild conditions. Excellent enantio- and diastereoselectivity was observed for a 
variety of allylic amine substrates and amine nucleophiles. 
 
1.3.4 Experimental Procedures 
General Information 
General Experimental Procedures: All reactions were carried out in flame-dried (or oven-
dried at 140 °C for at least 2 h) glassware under an atmosphere of nitrogen unless otherwise 
indicated. Nitrogen was dried using a drying tube equipped with Drierite™ unless otherwise 
noted. Air- and moisture-sensitive reagents were handled in a nitrogen-filled glovebox (working 
oxygen level ~ 0.1 ppm). Column chromatography was performed with silica gel from Grace 
Davison Discovery Sciences (35-75 µm) with a column mixed as a slurry with the eluent and 
was packed, rinsed, and run under air pressure. Analytical thin-layer chromatography (TLC) was 
performed on precoated glass silica gel plates (by EMD Chemicals Inc.) with F-254 indicator. 
Visualization was either by short wave (254 nm) ultraviolet light, or by staining with potassium 
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permanganate followed by brief heating on a hot plate or by a heat gun. Distillations were 
performed using a 3 cm short-path column under reduced pressure or by using a Hickman still at 
ambient pressure. 
Instrumentation: 1H NMR and 13C NMR were recorded on a Varian Unity 400/500 MHz 
(100/125 MHz respectively for 13C) or a VXR-500 MHz spectrometer. Spectra were referenced 
using either CDCl3 or C6D6 as solvents (unless otherwise noted) with the residual solvent peak as 
the internal standard (1H NMR: δ 7.26 ppm, 13C NMR: δ 77.00 ppm for CDCl3 and 1H NMR: δ 
7.15 ppm, 13C NMR: δ 128.60 ppm for C6D6). Chemical shifts were reported in parts per million 
and multiplicities are as indicated: s (singlet,) d (doublet,) t (triplet,) q (quartet,) p (pentet,) m 
(multiplet,) and br (broad). Coupling constants, J, are reported in Hertz and integration is 
provided, along with assignments, as indicated. Analysis by Gas Chromatography-Mass 
Spectrometry (GC-MS) was performed using a Shimadzu GC-2010 Plus Gas chromatograph 
fitted with a Shimadzu GCMS-QP2010 SE mass spectrometer using electron impact (EI) 
ionization after analytes traveled through a SHRXI–5MS- 30m x 0.25 mm x 0.25 µm column 
using a helium carrier gas.  Data are reported in the form of m/z (intensity relative to base peak = 
100). Gas Chromatography (GC) was performed on a Shimadzu GC-2010 Plus gas 
chromatograph with SHRXI–MS- 15m x 0.25 mm x 0.25 µm column with nitrogen carrier gas 
and a flame ionization detector (FID). Enantiomeric ratios were measured on either WatersTM 
600 Series HPLC with WatersTM 996 PAD or Agilent Technologies 1100 HPLC with diode array 
detector using Chiralpak IC-3, or ID-3 columns. Low-resolution Mass Spectrometry and High 
Resolution Mass Spectrometry were performed in the Department of Chemistry at University of 
Illinois at Urbana-Champaign. The glove box, MBraun LABmaster sp, was maintained under 
nitrogen atmosphere. 
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Materials: Solvents used for extraction and column chromatography were reagent grade and 
used as received. Reaction solvents tetrahydrofuran (Fisher, unstabilized HPLC ACS grade), 
diethyl ether (Fisher, BHT stabilized ACS grade), methylene chloride (Fisher, unstabilized 
HPLC grade), dimethoxyethane (Fisher, certified ACS), toluene (Fisher, optima ACS grade), 
1,4-dioxane (Fisher, certified ACS), acetonitrile (Fisher, HPLC grade), and hexanes (Fisher, 
ACS HPLC grade) were dried on a Pure Process Technology Glass Contour Solvent Purification 
System using activated Stainless Steel columns while following manufacture’s recommendations 
for solvent preparation and dispensation unless otherwise noted. All amines were distilled and 
degassed by the freeze-pump-thaw method, and were stored under an atmosphere of nitrogen in 












Optimization Tables for Reaction Conditions 





1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-BINAP
3.0 mol % Anion source
3.0 equiv styrene
1.5 equiv CsOAc
THF / H2O (v:v=1:1)




61.0 equiv 1.5 equiv
 
Entry Additive % Yield 6 b 
1c none 0 
2 NaClO4 19 
3 AgPF6 40 
4 NaBArF4 71 
 
a General conditions of these screens: cinnamyl diethylamine (0.12 mmol, 1.0 equiv), morpholine (1.5 equiv), 
styrene (3.0 equiv), CsOAc (1.5 equiv), THF (0.1 mL, 1.2 M), DI H2O (0.1 mL). b In situ yield determined by GC 
analysis and comparison to an internal standard. c Rh(COD)2BF4 as catalyst. Entry 1 is the standard condition for 











Table 1.22 Varying the base and amine equivalence in optimizing the Rh-catalyzed 





1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-BINAP
3.0 mol % NaBArF4
3.0 equiv styrene
1.5 equiv base
THF / H2O (v:v=1:1)




61.0 equiv X equiv
 
Entry base X equiv % Yield 6 b 
1 CsOAc 3.0 77 
2 KOH 3.0 13 
3 Cs2CO3 3.0 86 
4 NaHCO3 3.0 69 
5 Et3N 3.0 70 
6 DIPEA 3.0 72 
7 Cs2CO3 1.05 80 
8 Cs2CO3 1.2 84 
9 Cs2CO3 1.5 85 
10 Cs2CO3 2.0 85 
 
a General conditions of these screens: cinnamyl diethylamine (0.12 mmol, 1.0 equiv), morpholine (X equiv), styrene 
(3.0 equiv), base (1.5 equiv), THF (0.1 mL, 1.2 M), DI H2O (0.1 mL). b In situ yield determined by GC analysis and 








Table 1.23 Varying the hydrogen acceptor and equivalence in optimizing the Rh-catalyzed 





1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-BINAP
3.0 mol % NaBArF4
X equiv hydrogen acceptor
1.5 equiv Cs2CO3
THF / H2O (v:v=1:1)








Entry Hydrogen acceptor X equiv % Yield 6 b % Yield 6’ b 
1 Styrene 3.0 82 3 
2 Acetone 3.0 53 10 
3 Cyclohexanone 3.0 56 5 
4 Cyclohexene 3.0 53 11 
5 MMA 3.0 44 3 
6 NMO 3.0 46 5 
7 Styrene 1.0 68 7 
8 Styrene 1.5 79 5 
9 Styrene 2.0 80 3 
10 Styrene 4.0 79 2 
11 Styrene 5.0 80 2 
 
a General conditions of these screens: cinnamyl diethylamine (0.12 mmol, 1.0 equiv), morpholine (1.5 equiv), 
hydrogen acceptor (X equiv), Cs2CO3 (1.5 equiv), THF (0.1 mL, 1.2 M), DI H2O (0.1 mL). b In situ yield 









Table 1.24 Varying the base equivalence and THF/H2O ratio in optimizing the Rh-





1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-BINAP
3.0 mol % NaBArF4
3.0 equiv styrene
X equiv Cs2CO3
THF / H2O (v:v=1:Y) 








Entry THF / H2O (v:v) X equiv % Yield 6 b % Yield 6’ b 
A1 1:1 1.5 79 3 
B1 1:1 1.0 68 3 
C1 1:1 0.5 63 4 
D1 1:1 0 49 7 
A2 1:0.75 1.125 72 2 
B2 1:0.75 0.75 75 3 
C2 1:0.75 0.375 67 3 
D2 1:0.75 0 59 5 
A3 1:0.5 0.75 83 3 
B3 1:0.5 0.5 NA NA 
C3 1:0.5 0.25 72 3 
D3 1:0.5 0 68 3 
A4 1:0.25 0.375 89 2 
B4 1:0.25 0.25 84 3 
C4 1:0.25 0.125 82 4 
D4 1:0.25 0 71 2 
E1 1:0.2  0.5 91 3 
E2 1:0.2 0.3 86 3 
E3 1:0.2 0.2 85 3 
E4 1:0.2 0.1 82 3 
E5 1:0.2 0.05 79 2 
 
a General conditions of these screens: cinnamyl diethylamine (0.12 mmol, 1.0 equiv), morpholine (1.5 equiv), 
styrene (3.0 equiv), THF (0.1 mL, 1.2 M), Cs2CO3 (H2O solution). b In situ yield determined by GC analysis and 





Table 1.25 Optimization of reaction between cinnamyl diethylamine and aniline. a 
Ph NEt2 +
1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-BINAP
3.0 mol % NaBArF4
X mol % Base
Y equiv Hydrogen Acceptor




171.0 equiv Z equiv
NH2
 
Entry Base (X mol %) Hydrogen acceptor (Y) Z THF/H2O (v:v) % Yield b 
1 CsOH•H2O (150) Styrene (3 equiv) 3 1 : 1 47 
2 CsOAc (150) Styrene (3 equiv) 3 1 : 1 51 
3 Cs2CO3 (150) Styrene (3 equiv) 3 1 : 1 64 
4 Cs2CO3 (150) Acetone (3 equiv) 3 1 : 1 44 
5 Cs2CO3 (150) CF3COPh (3 equiv) 3 1 : 1 29 
6 Cs2CO3 (150)  Styrene (3 equiv) 2.5 1 : 1 61 
7 Cs2CO3 (150) Styrene (3 equiv) 2 1 : 1 55 
8 Cs2CO3 (150) Styrene (3 equiv) 1.5 1 : 1 40 
9 Cs2CO3 (150) Styrene (1.5 equiv) 3 1 : 1 63 
10 Cs2CO3 (150) Styrene (1.2 equiv) 3 1 : 1 54 
11 Cs2CO3 (120) Styrene (1.5 equiv) 3 1 : 0.3 60 
12 Cs2CO3 (100) Styrene (1.5 equiv) 3 1 : 0.3 67 
13 Cs2CO3 (90) Styrene (1.5 equiv) 3 1 : 0.3 78 
14 Cs2CO3 (68) Styrene (1.5 equiv) 3 1 : 0.3 65 
15 Cs2CO3 (45) Styrene (1.5 equiv) 3 1 : 0.3 54 
16 Cs2CO3 (90) Styrene (1.5 equiv) 3 1 : 0.6 56 
 
a General conditions of these screens: cinnamyl diethylamine (1.0 equiv, 0.12 mmol), aniline (Z equiv), hydrogen 
acceptor (Y equiv), base (X mol %), THF (0.1 mL, 1.2 M), DI H2O. b In situ yield determined by GC analysis and 





Table 1.26 Optimization of reaction between cinnamyl diethylamine and benzylamine. a 
Ph NEt2 +
1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-BINAP
3.0 mol % NaBArF4
Hydrogen Acceptor, Base




4X equiv Y equiv
NH2
 
Entry Hydrogen acceptor Base Temp X : Y % Yield b 
1 3 equiv Styrene 1.5 equiv Cs2CO3 80 °C 1 : 1.5 < 5 
2 3 equiv Acetone 1.5 equiv KOH 80 °C 1 : 1.5 < 5 
3 3 equiv NMO 1.5 equiv KOH 80 °C 1 : 1.5 18 
4 1.5 equiv NMO 1.5 equiv KOH 80 °C 1 : 1.5 23 
5 1.5 equiv NMO 2.5 equiv KOH 80 °C 1 : 1.5 42 
6 1.5 equiv NMO 2.5 equiv KOH 100 °C 1 : 1.5 57 
7 1.5 equiv NMO 2.5 equiv KOH 100 °C 1 : 1 62 
8 1.5 equiv NMO 2.5 equiv KOH 100 °C 1.25 : 1 70 
9 1.5 equiv Acetone 2.5 equiv KOH 100 °C 1.25 : 1 66 
10 1 equiv Acetone 2.5 equiv KOH 100 °C 1.25 : 1 67 
 
a General conditions of these screens: cinnamyl diethylamine (X equiv, 0.12 mmol if limiting), benzylamine (Y 
equiv, 0.12 mmol if limiting), hydrogen acceptor, base, THF (0.1 mL, 1.2 M), DI H2O (0.1 mL). b In situ yield 










Isotope Labeling Study 










1.5 mol % [Rh(COD)Cl]2
3.0 mol % NaBArF4
 3.0 mol % (±)-BINAP
1.5 equiv styrene
20 mol % Cs2CO3
THF / H218O , 80 °C, 24 h 6-O18
 
Procedure: [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (±)-BINAP (4.5 mg, 0.0072 
mmol, 3.0 mol %), NaBAr4F (6.4 mg, 0.0072 mmol, 3.0 mol %),  and Cs2CO3 (16 mg, 0.048 
mmol, 20 mol %) were added to a 4 mL vial equipped with a stir bar. After purging with with 
nitrogen, to the vial was added sequentially THF (0.2 mL), cinnamyl diethylamine (46 mg, 0.24 
mmol, 1.0 equiv), styrene (42 µL, 0.36 mmol, 1.5 equiv), morpholine (0.25 mol, 1.05 equiv), and 
18O- water (0.04 mL). The resulting solution was allowed to stir for 24 h at 80 °C. The reaction 
vial was cooled to room temperature followed by the addition of diphenylmethane as an internal 
standard for analysis of the crude reaction mixture. The biphasic solution was added EtOAc, 
dried over anhydrous MgSO4, concentrated in vacuo and then purified by silica gel 










   
Figure 1.5 Mass spectrum of 6-O18. 
 

















1.5 mol % [Rh(COD)Cl]2
3.0 mol % NaBArF4
 3.0 mol % (±)-BINAP
1.5 equiv styrene
20 mol % Cs2CO3































































Figure 1.7 1H NMR of 6-d2. 







Pulse Sequence s2pul 
Experiment 1D 
Probe QUAD 
Number of Scans 64 
Receiver Gain 52 
Relaxation Delay 5.0000 
Pulse Width 0.0000 



































Figure 1.8 2D NMR of 6-d2. 
 
Figure 1.9 Mass spectrum of 6-d2. 
 
Calculation: 13C natural abundance is 1.1%. Combined with 6-d2 mass spectrum, we can get  
6-d2 : 6-d1: 6 = 57% : 34% : 9%, which should give 74% D-incorporation, consistent with NMR 
results. 
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E-alkene + R-BINAP: 74% yield, 96:4 er
Z-alkene + S-BINAP: 77% yield, 97:3 er
Z-alkene + R-BINAP: 78% yield, 3.5:96.5 er
E-alkene + S-BINAP: 78% yield, 3.5:96.5 er
63-S
63-R  
General procedure:  [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), R- or S-BINAP (4.5 
mg, 0.0072 mmol, 3.0 mol %),  NaBAr4F (6.4 mg, 0.0072 mmol, 3.0 mol %),  and Cs2CO3 (16 
mg, 0.048 mmol, 20 mol %) were added to a 4 mL vial equipped with a stir bar. After purging 
with with nitrogen, to the vial was added sequentially THF (0.2 mL), E- or Z- geranyl 
diethylamine (50 mg, 0.24 mmol, 1.0 equiv), styrene (42 µL, 0.36 mmol, 1.5 equiv), morpholine 
(22 µL, 0.25 mol, 1.05 equiv), and DI water (0.04 mL). The resulting solution was allowed to stir 
for 24 h at 80 °C. The reaction vial was cooled to room temperature followed by the addition of 
diphenylmethane as an internal standard for analysis of the crude reaction mixture. The biphasic 
solution was added EtOAc, dried over anhydrous MgSO4, concentrated in vacuo and then 
purified by silica gel chromatography (1:1 hexanes/EtOAc) to afford the desired product. 
Enantiomeric ratio was measured by HPLC compared to a racemic sample.  
Table 1.27 Correlation of enantioselectivity and starting material purity. 
Entry E : Z a Yield Product S : R es 
1 97.5 : 2.5 74 % 96 : 4 98 % 
2 94.0 : 6.0 78 % 91 : 9 97 % 
3 87.9 : 12.1 79 % 87 : 13 99 % 
4 43.8 : 56.2 74 % 47.5 : 52.5 93 % 
5 1.6 : 98.4 78 % 3.5 : 96.5 98 % 
a Determined by GC analysis. All with (R)-BINAP. 
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Experimental Procedure, Isolation, and Characterization 
+
1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-or (R)-BINAP
3.0 mol % NaBArF4
20 mol % Cs2CO3
1.5 equiv styrene








General procedure A (for 2° amine): [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (±)-
BINAP or R-BINAP (4.5 mg, 0.0072 mmol, 3.0 mol %),  NaBAr4F (6.4 mg, 0.0072 mmol, 3.0 
mol %),  and Cs2CO3 (16 mg, 0.048 mmol, 20 mol %) were added to a 4 mL vial equipped with 
a stir bar. After purging with nitrogen, to the vial was added sequentially THF (0.2 mL), allylic 
diethylamine (0.24 mmol, 1.0 equiv), styrene (42 µL, 0.36 mmol, 1.5 equiv), secondary amine 
(0.25 mmol, 1.05 equiv), and DI water (0.04 mL). The resulting solution was allowed to stir for 
24 h at 80 °C. The reaction vial was cooled to room temperature followed by the addition of 
diphenylmethane as an internal standard for analysis of the crude reaction mixture. The biphasic 
solution was added EtOAc, dried over anhydrous MgSO4, concentrated in vacuo and then 
purified by silica gel chromatography (hexanes/EtOAc) to afford the desired product. 
 
1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-or (R)-BINAP
3.0 mol % NaBArF4
90 mol % Cs2CO3
1.5 equiv styrene








General procedure B (for 1° aryl amine): [Rh(COD)Cl]2 (4.4 mg, 0.009 mmol, 1.5 mol %), (±)-
BINAP or R-BINAP (11.2 mg, 0.018 mmol, 3.0 mol %), NaBAr4F (16.0 mg, 0.018 mmol, 3.0 
mol %),  and Cs2CO3 (175.9 mg, 0.54 mmol, 0.9 equiv) were added to a 20 mL vial equipped 
with a stir bar. After purging with nitrogen, to the vial was added sequentially THF (0.5 mL), 
allylic diethylamine (0.60 mmol, 1.0 equiv), styrene (103 µL, 0.54 mmol, 1.5 equiv), primary 
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aniline (1.8 mmol, 3.0 equiv), and DI water (0.15 mL). The resulting solution was allowed to stir 
for 24 h at 80 °C. The reaction vial was cooled to room temperature followed by the addition of 
diphenylmethane as an internal standard for analysis of the crude reaction mixture. The biphasic 
solution was diluted in EtOAc, washed with HCl 1N (2 x 20 mL), dried over anhydrous MgSO4, 
concentrated in vacuo and then purified by silica gel chromatography (hexanes/EtOAc) to afford 
the desired product. 
 
1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (±)-or (R)-BINAP
3.0 mol % NaBArF4
2.5 equiv KOH
1.1 equiv acetone








General procedure C (for 1° alkyl amine): [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), 
(±)-BINAP or R-BINAP (4.5 mg, 0.0072 mmol, 3.0 mol %),  and NaBAr4F (6.4 mg, 0.0072 
mmol, 3.0 mol %) were added to a 4 mL vial equipped with a stir bar. After purging with with 
nitrogen, allylic diethylamine (0.36 mmol, 1.25 equiv), primary amine (0.24 mol, 1.0 equiv), 
acetone (19.4 µL, 0.264 mmol, 1.1 equiv), THF (0.2 mL), and 3 M KOH (0.2 mL, 2.5 equiv 
KOH) were added sequentially to the vial. The resulting solution was stirred at 80 °C for 24 h. 
The reaction vial was cooled to room temperature followed by the addition of diphenylmethane 
as an internal standard for analysis of the crude reaction mixture. The biphasic solution was 
diluted with EtOAc, dried over anhydrous MgSO4, concentrated in vacuo, and purified by silica 





1-morpholino-3-phenylpropan-1-one (6, Table 1.17): Prepared 
according to General procedure A in 81 % isolated yield. Rf = 0.15 (1:1 
hexane/EtOAc) 
1H NMR (400 MHz, CDCl3) δ: 7.33 – 7.27 (m, 2H), 7.25 – 7.17 (m, 3H), 3.68 – 3.57 (m, 4H), 
3.55 – 3.48 (m, 2H), 3.40 – 3.31 (m, 2H), 2.98 (t, J = 7.8 Hz, 2H), 2.61 (t, J = 7.8 Hz, 2H) ppm.  
13C NMR (101 MHz, CDCl3) δ: 170.97, 141.14, 128.64, 128.56, 126.37, 66.95, 66.56, 46.06, 
42.03, 34.92, 31.58 ppm.  IR: ν 2927, 2858, 1642, 1432 cm-1. HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C13H17NO2, 220.1338; found, 220.1334.  
 
3-phenyl-1-(piperidin-1-yl)propan-1-one (7, Table 1.17): Prepared 
according to General procedure A in 80% isolated yield. Rf = 0.05 (5:1 
hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.27 (m, 2H), 7.25 – 7.17 (m, 3H), 3.61 – 3.51 (m, 2H), 
3.44 – 3.27 (m, 2H), 2.97 (t, J = 8.0 Hz, 2H), 2.62 (t, J = 8.0 Hz, 2H), 1.64 – 1.58 (m, 2H), 1.55 – 
1.49 (m, 2H), 1.49 – 1.43 (m, 2H) ppm.  13C NMR (101 MHz, CDCl3) δ: 170.52, 141.57, 
128.56, 128.53, 126.18, 46.72, 42.83, 35.31, 31.73, 26.49, 25.65, 24.63 ppm.  IR: ν 2937, 2856, 
1639, 1437 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO, 218.1545; found, 
218.1543. 
 
N, N-dimethyl-3-phenylpropanamide (10, Table 1.17): Prepared 
















1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.26 (m, 2H), 7.25 – 7.17 (m, 3H), 2.97 (t, J = 7.6 Hz, 
2H), 2.95 (s, 3H), 2.93 (s, 3H), 2.61 (t, J = 7.9 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ: 172.29, 
141.62, 128.58, 128.54, 126.20, 37.28, 35.56, 35.45, 31.50 ppm.  IR: ν 2933, 2893, 1645, 1496, 
1398 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C11H26NO, 178.1232; found, 
178.1235. 
 
N-benzyl-N-methyl-3-phenylpropanamide (11, Table 1.17): 
Prepared according to General procedure A in 71% isolated yield. Rf = 
0.2 (6:1 hexane/EtOAc) 
1H NMR (400 MHz, CDCl3, mixture of amide rotamers)2 δ: 7.38 – 7.15 (m, 9H), 7.12 – 7.05 (m, 
1H), 4.60 (s, 1.1H), 4.47 (s, 0.8H), 3.09 – 2.97 (m, 2H), 2.96 (s, 1.1H), 2.85 (s, 1.8H), 2.76 – 
2.61 (m, 2H) ppm.  13C NMR (101 MHz, CDCl3, mixture of amide rotamers)2 δ: 172.72, 172.39, 
141.50, 141.41, 137.47, 136.64, 129.03, 128.69, 128.60, 128.58, 128.16, 127.69, 127.43, 126.35, 
126.24, 53.37, 50.98, 35.54, 35.11, 34.90, 34.15, 34.11, 31.68, 31.50 ppm.  IR: ν 3031, 2933, 
1643, 1495, 1453 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H20NO, 254.1545; 
found, 254.1542. 
 
1-(indolin-1-yl)-3-phenylpropan-1-one (16, Table 1.17): Prepared 
according to General procedure A in 76% isolated yield. Rf = 0.1 (10:1 
hexane/EtOAc). mp =110-112 °C  
1H NMR (500 MHz, CDCl3, mixture of amide rotamers)9 δ: 8.26 (d, J = 8.1 Hz, 1H), 7.34 – 7.26 











0.2H, minor rotamer), 3.97 (t, J = 8.5 Hz, 2H, major rotamer), 3.15 (t, J = 8.5 Hz, 2H), 3.12 – 
3.05 (m, 2H, major rotamer), 2.98 (t, J = 8.0 Hz, 0.2H minor rotamer), 2.74 (dd, J = 8.7, 7.0 Hz, 
2H) ppm.  13C NMR (101 MHz, CDCl3) (major rotamer) δ: 170.48, 143.07, 141.33, 131.16, 
128.66, 128.56, 127.64, 126.30, 124.61, 123.68, 117.10, 48.01, 38.02, 30.85, 28.09 ppm.  IR: ν 




Table 1.17): Prepared according to General procedure A from 
cinnamyl in 63 % isolated yield (acid/base workup followed by 
recrystallization from DCM/pentane). mp =74-76 °C  
1H NMR (500 MHz, CDCl3) δ: 8.31 (d, J = 4.7 Hz, 2H), 7.33 – 7.27 (m, 2H), 7.25 – 7.18 (m, 
3H), 6.53 (t, J = 4.7 Hz, 1H), 3.84 – 3.76 (m, 2H), 3.74 – 3.67 (m, 4H), 3.47 – 3.40 (m, 2H), 3.01 
(t, J = 7.8Hz, 2H), 2.68 (t, J = 7.9 Hz, 2H) ppm.  13C NMR (126 MHz, CDCl3) δ: δ 171.00, 
161.55, 157.87, 141.25, 128.66, 128.59, 126.37, 110.53, 45.44, 43.69, 43.60, 41.54, 35.27, 31.65 
ppm.  IR: ν 3030, 2964, 2865, 1632, 1587, 1548, 1496, 1500, 1435, 1355 cm-1.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C17H21N4O, 297.1715; found, 297.1720. 
 
 N-phenyl-3-phenylpropanamide (17, Table 1.17): Prepared according 
to General procedure B in 73 % isolated yield. Rf = 0.3 (4:1 hexane 













1H NMR (500 MHz, CDCl3) δ 7.44 (m, 3H), 7.28 (m, 4H), 7.22 (m, J = 7.6 Hz, 3H), 7.09 (t, J = 
7.4 Hz, 1H), 3.04 (t, J = 7.7 Hz, 2H), 2.65 (t, J = 7.3 Hz, 2H) ppm.  13C NMR (126 MHz, 
CDCl3) δ 170.68, 140.71, 137.86, 129.03, 128.72, 128.47, 126.46, 124.40, 120.13, 39.47, 31.67 
ppm.  IR: ν 3323, 2924, 2856, 1651, 1599, 1526, 1440 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C15H15NO, 226.1232; found, 226.1231. 
 
N-(4-chlorophenyl)-3-phenylpropanamide (60, Table 1.17): 
Prepared according to General procedure B in 62 % isolated yield. Rf 
= 0.3 (3:1 hexane/EtOAc). mp = 138-139 °C  
1H NMR (500 MHz, CDCl3) δ 7.46 (s, broad, 1H), 7.36 (d, J = 8.5 Hz, 2H), 7.29 (t, J = 7.4 Hz, 
2H), 7.21 (m, 5H), 3.02 (t, J = 7.6 Hz, 2H), 2.64 (t, J = 7.6 Hz, 2H) ppm.  13C NMR (126 MHz, 
CDCl3) δ 170.76, 140.51, 136.38, 129.38, 129.02, 128.77, 128.43, 126.56, 121.39, 39.39, 31.60 
ppm.  IR: ν 3299, 3029, 2931, 1658, 1593, 1522, 1491, 1397, 1091 cm-1.  HRMS (ESI-TOF) 
m/z: [M+H+] calculated for C15H14ClNO, 260.0842; found, 260.0838. 
 
 N-(4-(trifluoromethyl)phenyl)-3-phenylpropanamide (21, Table 
1.17): Prepared according to General procedure B in 53 % isolated 
yield. Rf = 0.3 (4:1 hexane/EtOAc). mp = 142-145 °C  
1H NMR (500 MHz, CDCl3) δ 7.54 (s, 4H), 7.31 (t, J = 7.6 Hz, 2H), 7.23 (d, J = 7.5 Hz, 3H), 
3.06 (t, J = 7.7 Hz, 2H), 2.69 (t, J = 7.5 Hz, 2H) ppm.  13C NMR (126 MHz, CDCl3) δ 170.79, 
140.82, 140.42, 128.86, 128.48, 126.68, 126.35 (q, JCF = 3.8 Hz), 126.29 (q, JCF = 32.9 Hz), 














δ -62.20 ppm.  IR: ν 3327, 3030, 2926, 1672, 1600, 1524, 1408, 1319, 1164, 1065 cm-1.  HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C16H14F3NO, 294.1106; found, 294.1106. 
 
N-(2-methylphenyl)-3-phenylpropanamide (61, Table 1.17): Prepared 
according to General procedure B in 61 % isolated yield. Rf = 0.4 (2:1 
hexane/EtOAc); mp = 119-121 °C  
1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 1H), 7.30 (d, J = 7.5 Hz, 2H), 7.20 (m, 6H, 
integration gives 1 extra proton due to solvent peak), 7.06 (t, J = 7.4 Hz, 1H), 6.97 (s, broad, 
1H), 3.06 (t, J = 7.6 Hz, 2H), 2.69 (t, J = 7.6 Hz, 2H), 2.06 (s, 3H) ppm.  13C NMR (126 MHz, 
CDCl3) δ 170.55, 140.68, 135.59, 130.50, 129.48, 128.75, 128.51, 126.73, 126.50, 125.35, 
123.53, 39.26, 31.81, 17.66 ppm.  IR: ν 3338, 3289, 3030, 1673, 1601, 1524, 1409, 1320, 1162 
cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H17NO, 240.1388; found, 240.1387. 
 
N-benzyl-3-phenylpropanamide (4, Table 1.17): Prepared according 
to General procedure C in 64 % isolated yield. Rf = 0.3 (1.5:1 hexane/ 
EtOAc) mp =77-81 °C  
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.15 (m, 10H), 5.81 (s, broad, 1H), 4.39 (d, J = 5.7 Hz, 
2H), 2.99 (t, J = 7.6 Hz, 2H), 2.51 (t, J = 7.6 Hz, 2H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
172.01, 140.87, 138.25, 128.73, 128.64, 128.50, 127.81, 127.52, 126.34, 43.64, 38.57, 31.82 
ppm.  IR: ν 3284, 3028, 1636, 1539, 1218, 693 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated 















N-(2-morpholinoethyl)-3-phenylpropanamide (62, Table 1.17): 
Prepared according to General procedure C with [Rh(COD)Cl]2 (3 
mol%), BINAP (6 mol%), and NaBArF (6 mol%), run for 48 hours.  
Isolated by acid/base extraction followed by recrystallization in hexane for 39% isolated yield. 
mp =94-95 °C 
1H NMR (400 MHz, CDCl3) δ: 7.29 – 7.17 (m, 5H), 5.89 (s, broad, 1H), 3.65 (t, J = 4.7 Hz, 4H), 
3.30 (q, J = 5.6 Hz, 2H), 2.96 (t, J = 7.6 Hz, 2H), 2.49 (t, J = 7.6 Hz, 2H), 2.40 – 2.35 (m, 6H) 
ppm.  13C NMR (126 MHz, CDCl3) δ 172.14, 140.98, 128.55, 128.44, 126.27, 66.94, 56.98, 
53.30, 38.50, 35.60, 31.84 ppm.  IR: ν 3307, 2932, 1637, 1546, 1115, 698 cm-1.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C15H23N2O2, 263.1760; found, 263.1761. 
 
(S)-3,7-dimethyl-1-morpholinooct-6-en-1-one (63, Table 1.18): Prepared 
according to General procedure A in 74 % isolated yield. Rf = 0.1 (2:1 
hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 5.09 (tsept, J = 7.1, 1.4 Hz, 1H), 3.71 – 3.57 
(m, 6H), 3.50 – 3.43 (m, 2H), 2.31 (dd, J = 14.5, 5.8 Hz, 1H), 2.12 (dd, J = 14.5, 8.3 Hz, 1H), 
2.07 – 1.91 (m, 3H), 1.67 (d, J = 1.4 Hz, 3H), 1.60 (s (br), 3H), 1.44 – 1.34 (m, 1H), 1.24 – 1.17 
(m, 1H), 0.96 (d, J = 6.6 Hz, 3H).  13C NMR (101 MHz, CDCl3) δ: 171.40, 131.67, 124.48, 
67.16, 66.86, 46.40, 42.02, 40.45, 37.20, 30.17, 25.85, 25.61, 19.92, 17.86 ppm.  IR: ν 2966, 
2927, 2859, 1644, 1434 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H26NO2, 
















(S)-3,7-dimethyl-N-phenyloct-6-enamide (64, Table 1.18): Prepared 
according to General procedure B in 61 % isolated yield. Rf = 0.4 (4:1 
hexane/EtOAc). mp = 46-48 °C 
1H NMR (500 MHz, CDCl3) δ: 7.52 (d, J = 8.0 Hz, 2H), 7.43 (s, 1H), 
7.30 (t, J = 7.9 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 5.09 (t, J = 6.8 Hz, 1H), 2.37 (dd, J = 13.2, 5.3 
Hz, 1H), 2.07 (m, 4H), 1.68 (s, 3H), 1.60 (s, 3H), 1.42 (ddt, J = 12.3, 9.6, 5.9 Hz, 1H), 1.26 (m, 
1H), 1.00 (d, J = 6.2 Hz, 3H) ppm.  13C NMR (101 MHz, CDCl3) δ: 171.12, 138.08, 131.72, 
129.06, 124.37, 124.29, 120.00, 45.63, 37.00, 30.70, 29.82, 25.84, 25.61, 19.69, 17.80 ppm.  IR: 
ν 3291, 2963, 2915, 2849, 1652, 1599, 1534, 1444, 1374 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C16H23NO, 246.1858; found, 246.1855. 
 
(S)-N-benzyl-3,7-dimethyloct-6-enamide (65, Table 1.18): Prepared 
according to General procedure C in 47% isolated yield. Rf = 0.3 (3:1 
hexane/EtOAc) mp =54-58 °C 
1H NMR (400 MHz, CDCl3) δ:  7.37 – 7.25 (m, 5H), 5.72 (s, borad, 
1H), 5.08 (tt, J = 7.2, 1.5 Hz), 4.45 (dd, J = 5.7, 2.9 Hz, 2H), 2.26 – 2.20 (m, 1H), 2.07 – 1.94 (m, 
4H), 1.67 (s, 3H), 1.59 (s, 3H), 1.42 – 1.34 (m, 1H), 1.26 – 1.16 (m, 1H), 0.95 (d, J = 6.2 Hz, 3H) 
ppm.  13C NMR (126 MHz, CDCl3) δ: 172.51, 138.58, 131.58, 128.76, 127.92, 127.54, 124.43, 
44.59, 43.65, 37.02, 30.60, 25.81, 25.56, 19.68, 17.76 ppm.  IR: ν 3285, 2913, 1631, 1544, 731, 













(R)-1-morpholino-3-phenylbutan-1-one (66, Table 1.19): Prepared 
according to General procedure A with 6 mol % [Rh], 80 °C, 36 hours 
in 75 % isolated yield. Rf = 0.1 (2:1 hexane/EtOAc) 
1H NMR (400 MHz, CDCl3) δ: 7.34 – 7.27 (m, 2H), 7.25 – 7.18 (m, 3H), 3.72 – 3.57 (m, 2H), 
3.57 – 3.42 (m, 3H), 3.39 – 3.28 (m, 2H), 3.27 – 3.17 (m, 2H), 2.62 (dd, J = 14.5, 7.0 Hz, 1H), 
2.50 (dd, J = 14.5, 7.4 Hz, 1H), 1.35 (d, J = 7.0 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
170.54, 146.15, 128.67, 127.04, 126.62, 66.96, 66.55, 46.33, 42.02, 41.54, 37.05, 21.76 ppm.  
IR: ν 2967, 2961, 1640, 1429 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H20NO2, 
234.1494; found, 234.1492. 
 
(R)-1-morpholino-3-phenylpentan-1-one (67, Table 1.19): Prepared 
according to General procedure A with 6 mol % [Rh], 80 °C, 36 hours 
in 70 % isolated yield. Rf = 0.2 (1:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.33 – 7.27 (m, 2H), 7.23 – 7.16 (m, 3H), 3.70 – 3.56 (m, 2H), 
3.53 – 3.37 (m, 3H), 3.35 – 3.26 (m, 1H), 3.24 – 3.10 (m, 2H), 3.08 – 3.02 (m, 1H), 2.60 (dd, J = 
14.4, 7.8 Hz, 1H), 2.54 (dd, J = 14.4, 6.5 Hz, 1H), 1.80 (ddq, J = 14.3, 5.1, 7.3 Hz, 1H), 1.66 
(ddq, J = 14.3, 9.8, 7.3 Hz, 1H), 0.80 (t, J = 7.3 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
170.71, 144.30, 128.61, 127.80, 126.65, 66.95, 66.54, 46.39, 44.75, 42.02, 40.11, 29.00, 12.29 
ppm.  IR: ν 2964, 2927, 2858, 1638, 1454, 1425 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] 













(S)-4-methyl-1-morpholino-3-phenylpentan-1-one (68, Table 1.19): 
Prepared according to General procedure A with 6 mol % [Rh], 100 °C, 
36 hours in 71 % isolated yield. Rf = 0.2 (1:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.23 (m, 2H), 7.22 – 7.13 (m, 3H), 3.65 – 3.52 (m, 2H), 
3.51 – 3.44 (m, 1H), 3.41 – 3.25 (m, 3H), 3.24 – 3.17 (m, 1H), 3.13 – 3.03 (m, 1H), 2.91 (td, J = 
8.6, 5.6 Hz, 1H), 2.67(dd, J = 14.3, 5.5 Hz, 1H), 2.64(dd, J = 14.3, 8.9 Hz, 1H), 1.94 (dsep, J = 
8.4, 6.7 Hz, 1H), 1.01 (d, J = 6.6 Hz, 3H), 0.75 (d, J = 6.7 Hz, 3H) ppm.  13C NMR (126 MHz, 
CDCl3) δ: 171.02, 143.54, 128.45, 128.34, 126.52, 66.93, 66.56, 50.03, 46.42, 42.02, 36.95, 
32.82, 21.20, 20.79 ppm.  IR: ν 2965, 2930, 2872, 1636, 1453, 1428 cm-1.  HRMS (ESI-TOF) 
m/z: [M+H+] calculated for C16H24NO2, 262.1807; found, 262.1813. 
 
(R)-1-morpholino-3-phenylheptan-1-one (69, Table 1.19): Prepared 
according to General procedure A with 3 mol % [Rh], 80 ˚C, and 33 
hours in 77 % isolated yield. Rf = 0.1 (2.5:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.27 (m, 2H), 7.23 – 7.16 (m, 3H), 3.69 – 3.55 (m, 2H), 
3.51 – 3.37 (m, 3H), 3.33 – 3.25 (m, 1H), 3.22 – 3.08 (m, 3H), 2.60 (dd, J = 14.4, 7.9 Hz, 1H), 
2.52 (dd, J = 14.4, 6.5 Hz, 1H), 1.74 (ddt, J = 13.0, 10.3, 5.4 Hz, 1H), 1.65 (dtd, J = 13.1, 9.8, 5.0 
Hz, 1H), 1.36 – 1.04 (m, 4H), 0.82 (t, J = 7.2 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
170.68, 144.61, 128.61, 127.73, 126.61, 66.94, 66.53, 46.38, 42.99, 42.01, 40.44, 35.80, 29.84, 
22.76, 14.11 ppm.  IR: ν 2936, 2930, 2859, 1640, 1455, 1427 cm-1.  HRMS (ESI-TOF) m/z: 













(R)-1-morpholino-3-(4-chlorophenyl)butan-1-one (70, Table 1. 
19): Prepared according to General procedure A with 3 mol % [Rh], 
80 ˚C, and 48 hours in 72 % isolated yield. Rf = 0.2 (1:2 hexane 
/EtOAc). 
1H NMR (500 MHz, CDCl3) δ: 7.26 (d, J = 8.1 Hz, 2H), 7.16 (d, J = 8.1 Hz, 2H), 3.57 (m, 5H), 
3.33 (m, 4H), 2.57 (dd, J = 14.9, 7.1 Hz, 1H), 2.50 (dd, J = 15.0, 7.2 Hz, 1H), 1.31 (d, J = 7.0 
Hz, 3H) ppm. 13C NMR (126 MHz, CDCl3) δ: 170.19, 144.71, 132.14, 128.71, 128.39, 66.97, 
66.57, 46.24, 42.04, 41.30, 36.23, 21.86 ppm.  IR: ν 2964, 2926, 2857, 1638, 1493, 1434, 1273, 
1223, 1113 cm-1. HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H18ClNO2, 268.1104; found, 
268.1101. 
 
(R)-3-(4-bromophenyl)-N-phenylheptanamide (71, Table 1.19): 
Prepared according to General procedure B with 6 mol % [Rh], 80 
˚C, 36 hours in 40 % isolated yield. Rf = 0.2 (8:1 hexane/EtOAc) 
mp=86-89 °C 
1H NMR (500 MHz, CDCl3) δ: 7.43 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.31 – 7.26 
(m, 2H), 7.15 – 7.01 (m, 3H), 6.82 (brs, 1H), 3.25 – 3.09 (m, 1H), 2.64 (dd, J = 14.3, 6.3 Hz, 
1H), 2.50 (dd, J = 14.3, 8.4 Hz, 1H), 1.73 (ddt, J = 14.5, 10.4, 10.4, 5.3, 1H), 1.61 (dtd, J = 14.5, 
9.8, 5.0 Hz, 2H), 1.37 – 1.04 (m, 4H), 0.83 (t, J = 7.1 Hz, 3H) ppm.  13C NMR (126 MHz, 
CDCl3) δ: 169.66, 143.38, 137.63, 131.87, 129.39, 129.09, 124.53, 120.06, 109.90, 45.70, 42.32, 
35.78, 29.67, 22.69, 14.09 ppm.  IR: ν 3249, 2960, 2929, 2860, 1657, 1597, 1550, 1489, 1445 















(R)-3-(4-methoxyphenyl)-N-phenylbutanamide (72, Table 1.19): 
Prepared according to General procedure B with 3 mol % [Rh], 80 
°C, 48 hours in 67 % isolated yield. Rf = 0.5 (2:1 hexane/EtOAc). 
mp = 127-128 °C 
1H NMR (500 MHz, CDCl3) δ: 7.37 (d, J = 8.0 Hz, 2H), 7.26 (t, J = 8.4 Hz, 3H, a broad singlet 
overlap with the triplet, total integration is 3), 7.17 (d, J = 8.2 Hz, 2H), 7.07 (t, J = 7.4 Hz, 1H), 
6.85 (d, J = 8.2 Hz, 2H), 3.78 (s, 3H), 3.33 (h, J = 7.1 Hz, 1H), 2.57 (h, J = 7.2 Hz, 2H), 1.33 (d, 
J = 7.0 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 170.30, 158.28, 137.85, 137.80, 128.98, 
127.84, 124.33, 120.10, 114.17, 55.38, 47.03, 36.34, 22.02 ppm.  IR: ν 3299, 3000, 2957, 2837, 
1651, 1599, 1512, 1442, 1366, 1306, 1183 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C17H19NO2, 270.1494; found, 270.1489. 
 
(R)-3-cyclohexyl-1-morpholinobutan-1-one(73, Table 1.19): Prepared 
according to General procedure A with 5 mol % [Rh], 80 °C, 36 hours 
in 79 % isolated yield. Rf = 0.1 (2:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 3.70 – 3.58 (m, 6H), 3.50 – 3.43 (m, 2H), 2.37 (dd, J = 14.5, 4.7 
Hz, 1H), 2.08 (dd, J = 14.5, 9.4 Hz, 1H), 1.88 (dqt, J = 9.2, 6.8, 4.6 Hz, 1H), 1.78 – 1.70 (m, 2H), 
1.69 – 1.58 (m, 3H), 1.31 – 1.15 (m, 3H), 1.12 (tt, J = 12.7, 3.3 Hz, 1H), 1.07 – 0.94 (m, 2H), 
0.90 (d, J = 6.8 Hz, 3H) ppm.  13C NMR (101 MHz, CDCl3) δ: 171.93, 67.15, 66.85, 46.41, 
42.97, 42.06, 37.55, 35.49, 30.54, 29.07, 26.86, 26.80, 26.75, 16.59 ppm.  IR: ν 2923, 2852, 















(R)-3-cyclopropyl-N-phenylbutanamide (74, Table 1.19): Prepared 
according to General procedure B with 3 mol % [Rh], 100 ˚C, 24 hours in 
58 % isolated yield. Rf = 0.4 (3:1 hexane/EtOAc). mp = 68-70 °C 
1H NMR (500 MHz, CDCl3) δ: 7.63 (s, 1H), 7.51 (d, J = 8.0 Hz, 2H), 7.28 (t, J = 7.8 Hz, 2H), 
7.07 (t, J = 7.4 Hz, 1H), 2.45 (dd, J = 13.8, 6.4 Hz, 1H), 2.26 (dd, J = 13.8, 7.8 Hz, 1H), 1.30 
(m, 1H), 1.05 (d, J = 6.7 Hz, 3H), 0.56 (dp, J = 13.4, 4.9, 4.3 Hz, 1H), 0.40 (dd, J = 8.1, 4.3 Hz, 
2H), 0.17 (dd, J = 9.4, 4.7 Hz, 1H), 0.08 (dd, J = 9.2, 4.6 Hz, 1H). 13C NMR (126 MHz, CDCl3) 
δ: 171.18, 138.12, 129.02, 124.27, 120.12, 45.77, 36.71, 20.02, 17.91, 4.31, 3.71 ppm.  IR: ν 
3296, 3076, 2959, 2924, 1655, 1599, 1443, 1164 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C13H17NO, 204.1388; found, 204.1387. 
 
(S)-3-(2-(benzyloxy)ethyl)-1-(piperidin-1-yl)heptan-1-one (75, 
Table 1.19): Prepared according to General procedure A with 6 mol 
% [Rh], 80 °C, 36 hours in 65 % isolated yield. Rf = 0.2 (3:1 hexane/ 
EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.36 – 7.30 (m, 3H), 7.30 – 7.25 (m, 2H), 4.48 (s, 2H), 3.60 – 
3.48 (m, 4H), 3.41 – 3.31 (m, 2H), 2.32 (dd, J = 14.7, 6.9 Hz, 1H), 2.25 (dd, J = 14.7, 7.0 Hz, 
1H), 2.03 (hept, J = 6.4 Hz, 1H), 1.69 (tt, J = 12.8, 6.4 Hz, 1H), 1.63 – 1.57 (m, 3H), 1.56 – 1.46 
(m, 4H), 1.39 – 1.19 (m, 6H), 0.88 (t, J = 6.7 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
170.98, 138.78, 128.45, 127.75, 127.59, 73.02, 68.80, 46.97, 42.79, 38.46, 34.14, 33.94, 32.60, 
29.03, 26.73, 25.80, 24.76, 23.12, 14.26 ppm.  IR: ν 2933, 2857, 1640, 1436 cm-1.  HRMS (ESI-














(S)-3-butyl-1-morpholinooctan-1-one (76, Table 1.19): Prepared 
according to General procedure A with 3 mol % [Rh], 100°C, 36 hours 
in 73 % isolated yield. Rf = 0.2 (2:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ: 3.68 – 3.64 (m, 4H), 3.64 – 3.60 (m, 2H), 3.47 (t, J = 4.8 Hz, 
2H), 2.22 (d, J = 6.9 Hz, 2H), 1.92 – 1.79 (m, 1H), 1.36 – 1.19 (m, 14H), 0.93 – 0.81 (m, 6H). 
13C NMR (126 MHz, CDCl3) δ: δ 171.79, 67.17, 66.87, 46.41, 42.07, 37.97, 35.10, 34.02, 33.76, 
32.32, 28.99, 26.45, 23.16, 22.81, 14.27, 14.24.  IR: 2958, 2928, 2858, 1647, 1459, 1428 cm-1. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H32NO2, 270.2433; found, 270.2433. 
 
(S)-3-(4-methoxyphenyl)-1-morpholino-3-phenylpropan-1-
one (77, Table 1.19): Prepared according to General procedure 
A with 6 mol% [Rh], 100 °C, 48 hours in 70 % isolated yield. Rf 
= 0.2 (1:2 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ:  7.29 – 7.25 (m, 2H), 7.23 – 7.12 (m, 2H), 6.84 – 6.81 (m, 2H), 
4.60 (t, J = 7.6 Hz, 1H), 3.76 (s, 3H), 3.58 – 3.50 (m, 4H), 3.38 – 3.29 (m, 4H), 3.01 (d, J = 7.6 
Hz, 2H) ppm.  13C NMR (126 MHz, CDCl3) δ 170.14, 158.25, 144.39, 136.14, 128.87, 128.63, 
127.86, 126.56, 114.00, 66.90, 66.50, 55.34, 46.76, 46.32, 42.11, 38.84 ppm.  IR: ν 2952, 2918, 
2851, 1627, 1513, 1242, 1114, 701 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
















propan-1-one (78, Table 1.19): Prepared according to General 
procedure A with 6 mol% [Rh], 100 °C, 48 hours in 60 % isolated 
yield. Rf = 0.2 (1:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.54 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.33 – 7.28 
(m, 2H), 7.24 – 7.18 (m, 3H), 4.74 (t, J = 7.4 Hz, 1H), 3.76 – 3.42 (m, 5H), 3.41 – 3.32 (m, 3H), 
3.06 (d, J = 7.4 Hz, 2H) ppm.  13C NMR (126 MHz, CDCl3) δ: 169.46, 148.17, 143.27, 128.92, 
128.90 (q, JCF = 32.5 Hz) 128.27, 127.95, 127.05, 125.64 (q, JCF = 3.8 Hz), 124.28 (q, JCF = 271.9 
Hz), 66.95, 66.54, 47.16, 46.25, 42.22, 38.55 ppm.  19F NMR (470 MHz, CDCl3) δ: -62.48 ppm.  
IR: ν 2919, 2855, 1732, 1635, 1324, 1108 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C20H24NO3, 326.1756; found, 326.1752. 
 
(S)-1-morpholino-3-phenyl-3-(thiophen-2-yl)propan-1-one(79, Table 
1.19): Prepared according to General procedure A with 6 mol % [Rh], 
100°C, 36 hours in 71 % isolated yield. Rf = 0.15 (2:1 hexane/EtOAc) 
mp=102-104 °C 
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.29 (m, 4H), 7.25 – 7.20 (m, 1H), 7.15 (dd, J = 5.1, 1.2 
Hz, 1H), 6.92 (dd, J = 5.1, 3.5 Hz, 1H), 6.84 (dt, J = 3.5, 1.0 Hz, 1H, allylic coupling with 3° H), 
4.90 (t, J = 7.4 Hz, 1H), 3.64 – 3.43 (m, 5H), 3.42 – 3.35 (m, 1H), 3.35 – 3.26 (m, 2H), 3.09 (dd, 
J = 14.7, 7.1 Hz, 1H), 3.03 (dd, J = 14.7, 7.7 Hz, 1H) ppm.  13C NMR (126 MHz, CDCl3) δ: 
169.43, 148.10, 143.67, 128.78, 127.84, 127.15, 126.82, 124.49, 124.03, 66.93, 66.57, 46.34, 
43.36, 42.21, 40.29 ppm.  IR: 2921, 2859, 2855, 1630, 1437 cm-1.  HRMS (ESI-TOF) m/z: 














(S)-2-(chroman-4-yl)-1-morpholinoethan-1-one (80, Table 1.19): 
Prepared according to General procedure A with 6 mol % [Rh], 100°C, 36 
hours in 63 % isolated yield. Rf = 0.1 (1:1 hexane/EtOAc)  
1H NMR (500 MHz, CDCl3) δ: 7.13 – 7.09 (m, 2H), 6.86 (td, J = 7.4, 1.2 
Hz, 1H), 6.81 (dd, J = 8.7, 1.4 Hz, 1H), 4.23 (ddd, J = 11.3, 5.4, 3.8 Hz, 1H), 4.16 (ddd, J = 11.1, 
9.7, 2.8 Hz, 1H), 3.77 – 3.58 (m, 5H), 3.58 – 3.32 (m, 4H), 2.76 (dd, J = 15.5, 5.1 Hz, 1H), 2.54 
(dd, J = 15.5, 9.3 Hz, 1H), 2.23 (dddd, J = 13.7, 9.6, 5.7, 3.8 Hz, 1H), 1.85 (dtd, J = 14.0, 5.1, 2.8 
Hz, 1H) ppm.  13C NMR (126 MHz, CDCl3) δ: 170.01, 154.74, 129.10, 127.98, 125.13, 120.50, 
117.20, 67.01, 66.61, 63.34, 46.18, 42.15, 39.82, 30.44, 27.66 ppm.  IR: 2966, 2927 2860, 1638, 
1489 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H20NO3, 262.1443; found, 
262.1440. 
 
(R)-3-phenyl-N-((R)-1-phenylethyl)butanamide (81, Table 1.20): 
Two step sequence: The isomerization was allowed to run at 60 °C 
with 3 mol % [Rh] and 200 uL THF (1.2M) for 6 hrs followed by the 
addtion of 2 equiv (R)-1-phenylethan-1-amine, 3.0 qeuiv acetone, 2.0 equiv KOH and 100 uL 
H2O. Then the reaction was allowed to stir at 80 °C for 24 hrs. The crude was purified by column 
chromatograph to provide prooduct in 44% isolated yield (eluent: 3:1 hexane/EtOAc). Rf = 0.1 
(4:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.37 – 7.15 (m, 8H), 7.05 – 6.94 (m, 2H), 5.57 – 5.40 (m, 1H), 
5.04 (p, J = 7.1 Hz, 1H), 3.30 (h, J = 7.1 Hz, 1H), 2.55 – 2.33 (m, 2H), 1.39 (d, J = 6.9 Hz, 3H), 
1.32 (d, J = 7.0 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 170.71, 145.83, 143.00, 128.76, 












3067, 3062, 2967, 2929, 2897, 1635, 1547, 1450 cm-1.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C18H22NO, 268.1701; found, 268.1697. 
 
(S)-3-phenyl-N-((R)-1-phenylethyl)butanamide (82, Table 1.20): 
Same prep as 81 with 46% isolated yield (eluent: 3:1 hexane/ 
EtOAc). Rf = 0.1 (4:1 hexane/EtOAc) 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.27 (m, 4H), 7.25 – 7.20 (m, 4H), 7.19 – 7.16 (m, 2H), 
5.39 – 5.30 (br, 1H), 5.01 (p, J = 7.1 Hz, 1H), 3.29 (h, J = 7.2 Hz, 1H), 2.46 – 2.38 (m, 2H), 1.30 
(d, J = 6.9, Hz, 3H), 1.24 (d, J = 6.9 Hz, 3H) ppm.  13C NMR (126 MHz, CDCl3) δ: 170.73, 
145.92, 143.22, 128.79, 128.74, 127.43, 127.02, 126.64, 126.26, 48.63, 46.27, 37.47, 21.98, 
21.52 ppm.  IR: ν 3277, 3070, 3054, 2964, 2930, 2869, 1633, 1551, 1448 cm-1.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C18H22NO, 268.1701; found, 268. 1703. 
 
(R)-1-((S)-2-((benzyloxy)methyl)pyrrolidin-1-yl)-3-phenylbutan-
1-one (83, Table 1.20): Prepared according to General Procedure A 
Allylic amine was allowed to stir with 6 mol% [Rh]/(R)-BINAP/ 
NaBArF4 in THF at 60°C for 4 h. Amine nucleophile was then added to the reaction vial along 
with Cs2CO3, styrene (3 equiv), H2O, and the reaction stirred for another 36 h at 80°C. The 
product was isolate in 44% yield. Rf = 0.2 (30% EtOAc/Hexane). 
1H NMR (500 MHz, CDCl3 mixture of rotamers) δ 7.36 – 7.23 (m, 8H), 7.22 – 7.16 (m, 2H), 
4.53 (dd, J = 12.0, 15.3 Hz, 2H), 4.42 (s, 1H), 4.26 (tt, J = 6.6, 2.9 Hz, 1H), 3.64 (dd, J = 9.3, 3.3 











3H), 2.02 – 1.68 (m, 6H), 1.33 (d, J = 6.9 Hz, 3H), 1.29 (d, J = 7.0 Hz, 1H), 1.26 (s, 1H) ppm. 
13C NMR (125 MHz, CDCl3 mixture of rotamers) δ 170.87, 170.75, 146.72, 146.64, 138.75, 
137.98, 128.60, 128.53, 128.46, 127.94, 127.67, 127.60, 127.13, 127.04, 126.36, 126.25, 73.33, 
73.30, 71.11, 70.32, 57.21, 56.58, 47.61, 45.72, 43.90, 43.10, 36.47, 29.84, 28.94, 27.66, 24.26, 
21.93, 21.48, 21.39 ppm.  IR: ν 2957, 2918, 2851, 1630, 1560, 1454, 1411, 1376 cm-1.  HRMS 
(EDI-TOF) m/z: [M+H+] calculated for C22H27NO2, 338.2120; found, 338.2119. 
 
(S)-1-((S)-2-((benzyloxy)methyl)pyrrolidin-1-yl)-3-phenylbutan-
1-one (84, Table 1.20): Prepared according to the same procedures 
as 83. The product was isolate in 42% yield. Rf = 0.2 (30% EtOAc/ 
Hexane). 
1H NMR (500 MHz, CDCl3 mixture of rotamers) δ: 7.41 – 7.27 (m, 6H), 7.25 – 7.22 (m, 2H), 
7.21 – 7.12 (m, 2H), 4.49 (d, J = 13.0 Hz, 1.3H), 4.42 (d, J = 12.0 Hz, 0.7H), 4.34 – 4.27 (m, 
0.6H), 3.73 – 3.66 (m, 0.4H), 3.59 (dd, J = 9.4, 3.3 Hz, 0.6H), 3.45 – 3.29 (m, 3.4H), 3.28 – 3.20 
(m, 1.0H), 2.61 – 2.49 (m, 1.4H), 2.46 (dd, J = 14.7, 8.0 Hz, 0.6H), 2.03 – 1.68 (m, 4H), 1.34 (d, 
J = 7.0 Hz, 1.8H), 1.28 (d, J = 7.0 Hz, 1.2H).  13C NMR (125 MHz, CDCl3, mixture of rotamers) 
δ: 171.21, 170.73, 146.55, 146.28, 138.72, 137.96, 128.62, 128.50, 128.47, 128.43, 127.98, 
127.77, 127.62, 127.58, 127.05, 127.02, 126.35, 73.45, 73.25, 71.52, 70.03, 56.99, 56.50, 47.54, 
45.48, 43.82, 43.50, 37.09, 36.61, 28.62, 27.58, 24.22, 21.97, 21.70, 21.31 ppm.  IR: ν 2957, 








hexan-1-one (85, Table 1.20): Prepared according to General 
Procedure A with 6 mol% [Rh]/(R)-BINAP/NaBArF4 in 64% isolated 
yield. Rf = 0.2 (30% EtOAc/Hexane). 
1H NMR (500 MHz, CDCl3) δ 3.93 – 3.85 (m, 1H), 3.73 – 3.56 (m, 6H), 3.46 (t, J = 4.9 Hz, 
2H), 2.33 – 2.28 (m, 1H), 2.20 – 2.07 (m, 2H), 1.57 (s, 1H), 1.51 (ddd, J = 13.2, 8.9, 4.1 Hz, 1H), 
1.29 – 1.17 (m, 2H), 1.13 (dd, J = 6.0, 0.8 Hz, 3H), 0.96 (d, J = 6.2 Hz, 3H), 0.88 (d, J = 0.8 Hz, 
9H), 0.06 (s, 3H), 0.05 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 171.02, 67.06, 66.79, 66.24, 
47.08, 46.36, 41.88, 41.45, 27.03, 25.89, 24.58, 19.66, 18.06, -4.05, -4.74 ppm. IR: ν 2958, 
2928, 2894, 2856, 1645, 1462, 1429, 1252 cm-1.  HRMS (EDI-TOF) m/z: [M+H+] calculated for 
C17H36NO3Si, 330.2464; found, 330.2460. 
 
 (3R,5R)-5-((tert-butyldimethylsilyl)oxy)-3-methyl-1-morpholino-
hexan-1-one (86, Table 1.20): Prepared according to General 
Procedure A with 6 mol% [Rh]/(S)-BINAP/NaBArF4 in 65% isolated 
yield. Rf = 0.2 (30% EtOAc/Hexane). 
1H NMR (500 MHz, CDCl3) δ: 3.91 (q, J = 6.2 Hz, 1H), 3.72 – 3.58 (m, 6H), 3.51 – 3.43 (m, 
2H), 2.44 – 2.30 (m, 1H), 2.20 – 1.99 (m, 2H), 1.40 (hept, J = 7.0, 6.6 Hz, 2H), 1.29 – 1.22 (m, 
1H), 1.14 (d, J = 6.0 Hz, 3H), 0.96 (d, J = 6.2 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 6H) ppm.  13C NMR 
(125 MHz, CDCl3) δ: 171.16, 67.18, 67.11, 66.86, 47.15, 46.37, 42.04, 40.62, 27.47, 26.06, 










(3R,4S)-3-methyl-1-morpholino-4-phenylpentan-1-one (87, Table 1. 
20): Prepared according to General procedure A with 6 mol % [Rh]/(R)-
BINAP, 100°C, 36 hours in 46 % isolated yield. Rf = 0.1 (3:1 
hexane/EtOAc). 
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.22 (m, 2H), 7.20 – 7.13 (m, 3H), 3.70 – 3.38 (m, 6H), 
3.28 – 3.10 (m, 2H), 2.53 (p, J = 7.2 Hz, 1H), 2.20 (dd, J = 14.4, 3.5 Hz, 1H), 2.17 – 2.09 (m, 
1H), 1.93 (dd, J = 14.3, 9.3 Hz, 1H), 1.24 (d, J = 7.1 Hz, 3H), 0.99 (d, J = 6.5 Hz, 3H) ppm.  13C 
NMR (125 MHz, CDCl3) δ: 171.41, 146.37, 128.47, 127.70, 126.30, 67.06, 66.73, 46.12, 45.43, 
41.97, 38.50, 36.97, 18.57, 17.53 ppm.  IR: ν 2966, 2956, 2863, 1640, 1453, 1429 cm-1.  HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C16H24NO2, 262.1807; found, 262.1805. 
 
(3S,4S)-3-methyl-1-morpholino-4-phenylpentan-1-one (88, Table 1. 
20): Prepared according to General procedure A with 6 mol % [Rh]/(S)-
BINAP, 100°C, 36 hours in 73 % isolated yield. Rf = 0.1 (3:1 hexane/ 
EtOAc). 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.27 (m, 2H), 7.21 – 7.14 (m, 3H), 3.70 – 3.54 (m, 6H), 
3.29 – 3.17 (m, 2H), 2.76 (p, J = 6.9 Hz, 1H), 2.35 (dd, J = 14.5, 4.5 Hz, 1H), 2.29 – 2.16 (m, 
1H), 2.00 (dd, J = 14.5, 9.2 Hz, 1H), 1.27 (d, J = 7.1 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H) ppm.  13C 
NMR (125 MHz, CDCl3) δ: 171.50, 145.18, 128.27, 128.07, 126.27, 67.10, 66.76, 46.16, 44.49, 
42.05, 37.06, 36.71, 17.72, 17.50 ppm.  IR: ν 2968, 2927, 2862, 1641, 1453, 1429 cm-1.  HRMS 
















1.4 Diastereoselective Synthesis of Trisubstituted Allylic Amine Substrates 














-10 °C, 15 min
1.65 equiv
H2O
-10 °C, 20 min
1.0 equiv




Procedure: To a dry 100 mL schlenk flask was charged with a stir bar and 0.292 g Cp2ZrCl2 (1 
mmol, 20 mmol %), purged with nitrogen followed by the addition of 25 mL DCM. Cooled to -
10 °C, 7.5 mL 2 M AlMe3/hexanes solution (15 mmol, 3.0 equiv) was added slowly. The 
reaction was allowed to stir at -10 °C for 15 min followed by the slow addition of 168 µL H2O 
(8.2 mmol, 1.65 equiv). The resµting mixture was stirred vigorously at -10 °C for 20 min then 
added the alkyne (5 mmol, 1.0 equiv). The reaction flask was then was then warmed up to rt and 
stir overnight. A solution of the iminium chloride salt (10 mmol, 2 equiv) in 5 mL dry DCM was 
added slowly to the flask at 0 °C, then reaction was warmed up to rt and stir for another 3 hrs . 
The reaction is quenched by careful addition of 2 M NaOH solution at 0 °C, then filtered through 
ceilite and washed with warm DCM. The resulting mixture was then extract by DCM three time 
and combined organic layers were dried by Na2SO4, concentrated in vacuo, and distilled under 
vacuum to afford desired allylic diethylamines.  
 
N-ethyl-N-methyleneethanaminium chloride, prepared according to the 
literature.33 
1H NMR (500 MHz, CDCl3) δ: 8.71 (s, 2H), 3.97 (q, J = 7.3 Hz, 4H), 1.48 (t, J = 7.3 Hz, 6H) 





(E)-N, N-diethyl-3-phenylbut-2-en-1-amine, prepared according to 
previously described method.  
1H NMR (500 MHz, CDCl3) δ: 7.44 – 7.39 (m, 2H), 7.35 – 7.29 (m, 2H), 
7.25 – 7.21 (m, 1H), 5.92 (tq, J = 6.7, 1.3 Hz, 1H), 3.28 (d, J = 6.6 Hz, 2H), 2.59 (q, J = 7.2 Hz, 
4H), 2.07 (d, J = 1.1 Hz, 3H), 1.08 (t, J = 7.2 Hz, 6H) ppm.  13C NMR (125 MHz, CDCl3) δ: 
143.64, 136.65, 128.31, 126.91, 125.89, 125.77, 51.50, 47.16, 16.22, 12.05 ppm.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C14H22N, 204.1752; found, 204.1757.  
 
(E)-3-(4-chlorophenyl)-N, N-diethylbut-2-en-1-amine, prepared 
according to previously described method. 
1H NMR (500 MHz, CDCl3) δ: 7.31 (d, J = 8.7 Hz, 2H), 7.26 (d, J = 
8.8 Hz, 2H), 5.89 (tq, J = 6.8, 5.5, 1.3 Hz, 1H), 3.26 (d, J = 6.6 Hz, 2H), 2.58 (q, J = 7.2 Hz, 4H), 
2.03 (s, broad, 3H), 1.07 (t, J = 7.1 Hz, 6H) ppm.  13C NMR (125 MHz, CDCl3) δ: 141.93, 
135.73, 132.65, 128.37, 127.02, 126.25, 51.44, 47.13, 16.13, 11.90 ppm.  HRMS (ESI-TOF) 
m/z: [M+H+] calculated for C14H20ClN, 238.1363; found, 238.1364.  
 
(E)-N, N-diethyl-3-(4-methoxyphenyl)but-2-en-1-amine, prepared 
according to previously described method. 
1H NMR (500 MHz, CDCl3) δ: 7.35 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 
8.8 Hz, 2H), 5.84 (tq, J = 6.8, 1.4 Hz, 1H), 3.79 (s, 3H), 3.26 (d, J = 6.7 Hz, 2H), 2.58 (q, J = 7.1 











158.71 , 136.09 , 136.05 , 126.72 , 124.02 , 113.60 , 55.32 , 51.43 , 47.05 , 16.16 , 11.94 ppm. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H23NO, 234.1858; found, 234.1853.  
 
(E)-3-cyclohexyl-N, N-diethylbut-2-en-1-amine, prepared according to 
previously described method. 
1H NMR (500 MHz, CDCl3) δ 5.24 (t, J = 6.8 Hz, 1H), 3.06 (d, J = 6.7 Hz, 2H), 2.50 (q, J = 7.1 
Hz, 4H), 1.91 – 1.62 (m, 6H), 1.61 (d, J = 1.4 Hz, 3H), 1.34 – 1.08 (m, 5H), 1.03 (t, J = 7.1 Hz, 
6H) ppm.  13C NMR (125 MHz, CDCl3) δ: 143.14, 119.76, 50.67, 47.64, 46.86, 32.07, 26.91, 
26.56, 15.02, 11.99 ppm.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H29N, 210.2222; 
found, 210.2225.  
 
(E)-3-(5-bromo-2-fluorophenyl)-N,N-diethylbut-2-en-1-amine, prepared 
according to previously described procedure in 60% yield. 
1H NMR (500 MHz, CDCl3) δ: 7.36 (dd, J = 6.8, 2.6 Hz, 1H), 7.30 (ddd, J = 
8.7, 4.3, 2.6 Hz, 1H), 6.90 (dd, J = 10.2, 8.7 Hz, 1H), 5.73 (t, J = 6.6 Hz, 1H), 3.25 (d, J = 6.6 Hz, 
2H), 2.58 (q, J = 7.2 Hz, 4H), 2.01 (s, 3H), 1.07 (t, J = 7.1 Hz, 6H).  13C NMR (125 MHz, 
CDCl3) δ: 159.06 (d, J = 247.5 Hz), 134.53 (d, J = 15.7 Hz), 132.48 (d, J = 4.6 Hz), 132.32 , 
131.08 (d, J = 8.4 Hz), 130.28 , 117.57 (d, J = 24.6 Hz), 116.46 (d, J = 3.4 Hz), 50.92 , 47.20 , 










(E)-3-cyclopropyl-N,N-diethylbut-2-en-1-amine, prepared according to 
previously described procedure in 78% yield. 
1H NMR (500 MHz, CDCl3) δ: 5.29 (t, J = 6.8 Hz, 3H), 3.05 (d, J = 6.8 Hz, 2H), 2.49 (q, J = 7.2 
Hz, 4H), 1.54 (s, 3H), 1.42 – 1.33 (m, 1H), 1.02 (t, J = 7.2 Hz, 6H), 0.57 – 0.51 (m, 2H), 0.46 – 
0.42 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 138.44, 120.19, 50.66, 46.81, 19.01, 14.54, 
11.91, 4.61. 
 
1H NMR (500 MHz, CDCl3) δ 5.30 (ddt, J = 7.1, 5.8, 1.4 Hz, 1H), 
3.95 (dt, J = 6.8, 5.9 Hz, 1H), 3.08 (d, J = 6.7 Hz, 2H), 2.54 (q, J = 7.1 
Hz, 4H), 2.24 (dd, J = 13.4, 5.8 Hz, 1H), 2.08 (dd, J = 13.1, 6.8 Hz, 1H), 1.67 (s, 3H), 1.12 (d, J 
= 6.0 Hz, 3H), 1.05 (t, J = 7.2 Hz, 6H), 0.90 (s, 8H), 0.06 (s, 3H), 0.05 (s, 3H) ppm.  13C NMR 
(125 MHz, CDCl3) δ 135.12, 124.68, 67.64, 50.67, 50.42, 46.86, 26.02, 23.57, 18.31, 17.16, 
11.95, -4.40, -4.63 ppm.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H37NOSi, 300.2723; 
found, 300.2731.  
 
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.27 (m, 1H), 7.22 – 7.19 (m, 
2H), 7.18 – 7.16 (m, 1H), 5.51 (tt, J = 6.7, 1.3 Hz, 1H), 3.40 (q, J = 7.1 
Hz, 1H), 3.12 (dt, J = 6.7, 0.9 Hz, 2H), 2.55 (q, J = 7.2, 4H), 1.49 (d, J = 
1.1 Hz, 1H), 1.37 (d, J = 7.1 Hz, 3H), 1.05 (t, J = 7.1 Hz, 6H) ppm. 13C NMR (125 MHz, CDCl3) 
δ: 145.49, 141.14, 128.33, 127.61, 126.08, 121.91, 50.87, 48.08, 47.02, 19.78, 15.36, 12.00 ppm. 















0.6 equiv 1.0 equiv -45° C, 30 min
1.1 equiv
R1C CH








Procedure: A dry 50mL schlenk flask was charged with stir bar and 0.80g CuI (4.2 mmol, 0.6 
equiv), purged with nitrogen then cooled down to -45 °C (dry ice/MeCN). 8 mL dry Et2O was 
added followed by the slow addition of 4.38 mL n-BuLi (1.6 M in hexanes, 7.0 mmol, 1.0 
equiv). The purple/blue mixture was allowed to stir for 30 min at -45 °C, followed by the 
addition of alkyne (7.6 mmol, 1.1 equiv) over 15 minutes. The reaction flask was then warmed 
up to -25 °C (dry ice/CCl4). After 30 minutes stirring at -25 °C, the reaction was cooled to -45 °C 
again followed by the addition of 8 mL dry THF and aminating reagent PhSCH2NEt2 (6.0 mmol, 
0.9 equiv) and the mixture was allowed to warm to room temperature, stirred for 3-4 hours then 
hydrolyzed, at ice bath, with 30 mL sat. NH4Cl sol. and 10 mL NH4OH sol. After filtration and 
extraction with ether, the organic layers are combined and filtered again, followed by acid/base 
extraction to give the product and column chromatography to afford desired product.  
 
N-ethyl-N-((phenylthio)methyl)ethanamine, prepared according to the 
literature.34 
 1H NMR (500 MHz, CDCl3) δ: 7.50 – 7.44 (m, 2H), 7.30 – 7.23 (m, 2H), 7.23 – 7.17 (m, 1H), 
4.60 (s, 2H), 2.63 (q, J = 7.2 Hz, 4H), 1.01 (t, J = 7.2 Hz, 6H) ppm.  13C NMR (125 MHz, 
CDCl3) δ: 137.85, 132.64, 129.00, 126.61, 63.62, 46.64, 12.93 ppm. 
 
(E)-N, N-diethyl-3-phenylhept-2-en-1-amine, prepared according to 






1H NMR (500 MHz, CDCl3) δ: 7.41 – 7.34 (m, 2H), 7.33 – 7.28 (m, 2H), 7.25 – 7.20 (m, 1H), 
5.78 (t, J = 6.6 Hz, 1H), 3.27 (d, J = 6.6 Hz, 2H), 2.58 (q, J = 7.1 Hz, 4H), 2.54 – 2.48 (m, 2H), 
1.38 – 1.27 (m, 4H), 1.07 (t, J = 7.1 Hz, 6H), 0.87 (t, J = 6.9 Hz 3H) ppm.  13C NMR (125 MHz, 
CDCl3) δ: 143.08, 142.27, 128.30, 126.83, 126.44, 126.26, 51.28, 47.13, 31.09, 29.93, 22.88, 
14.11, 12.10 ppm.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H28NO, 246.2222; found, 
246.2224.  
 
(E)-3-(4-bromophenyl)-N, N-diethylhept-2-en-1-amine, prepared 
according to previously described method.  
1H NMR (500 MHz, CDCl3) δ 7.45 – 7.37 (m, 2H), 7.24 – 7.20 (m, 
2H), 5.76 (t, J = 6.6 Hz, 1H), 3.24 (d, J = 6.5 Hz, 2H), 2.56 (q, J = 7.1 Hz, 4H), 2.50 – 2.43 (m, 
2H), 1.35 – 1.23 (m, 4H), 1.06 (t, J = 7.1 Hz, 6H), 0.87 (t, J = 7.0 Hz, 6H) ppm.  13C NMR (125 
MHz, CDCl3) δ 141.94, 141.24, 131.37, 128.10, 127.03, 120.67, 51.28, 47.14, 30.93, 29.76, 
22.78, 14.08, 12.03 ppm.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H27NBr, 324.1327; 
found, 324.1319.  
 
(E)-3-butyl-N, N-diethyloct-2-en-1-amine, prepared according to 
previously described method.  
1H NMR (400 MHz, CDCl3) δ: 5.21 (t, J = 6.7 Hz, 1H), 3.06 (d, J = 6.7 Hz, 2H), 2.50 (q, J = 7.2 
Hz, 4H), 2.07 – 1.92 (m, 4H), 1.44 – 1.35 (m, 2H), 1.34 – 1.18 (m, 8H), 1.03 (t, J = 7.2 Hz, 6H), 








31.80, 30.92, 30.29, 27.86, 23.03, 22.73, 14.24, 14.20, 11.97 ppm.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C16H34N, 240.2691; found, 240.2695.  
 
(E)-3-(2-(benzyloxy)ethyl)-N,N-diethylhept-2-en-1-amine, prepared 
according to previously described method.  
1H NMR (500 MHz, CDCl3) δ; 7.36 – 7.31 (m, 3H), 7.30 – 7.26 (m, 1H), 5.28 (t, J = 7.0 Hz, 
1H), 4.51 (s, 2H), 3.56 (t, J = 7.2 Hz, 2H), 3.07 (d, J = 6.6 Hz, 2H), 2.50 (q, J = 7.1 Hz, 4H), 2.35 
(t, J = 7.2 Hz, 3H), 2.05 (t, J = 7.5 Hz, 2H), 1.44 – 1.18 (m, 4H), 1.02 (t, J = 7.2 Hz, 6H), 0.90 (t, 
J = 7.0 Hz, 3H) ppm.  13C NMR (125 MHz, CDCl3) δ: 139.06, 138.69, 128.47, 127.75, 127.61, 
123.88, 72.99, 69.68, 50.50, 46.86, 37.07, 30.82, 30.72, 22.95, 14.17, 11.99 ppm.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C20H34NO, 304.2640; found, 304.2641.  
 






1.0 equiv 1.3 equiv
2.0 equiv KOH
THF/MeOH, rt, overnight
1.0 mol % Pd(OAc)2
2.0 mol % PPh3Ar
 
Procedure: To a 50 ml round bottom flask was charged with a stir bar and 11 mg Pd(OAc)2 
(0.050 mmol, 1.0 mol %), 26 mg PPh3 (0.10 mmol, 2.0 mol %), 0.560 g KOH (10 mmol, 2.0 
equiv), starting material vinyl bromide (1.34g, 5 mmol, 1.0 equiv), aryl boronic acid (6.5 mmol, 
1.3 equiv) and 5 mL THF and 5 mL MeOH. The reaction was stirred at rt overnight followed by 
dilution with EtOAc, and washed by 1 N NaOH solution and brine. The organic layer was then 






according to previously described procedure in 70% yield. 
1H NMR (500 MHz, CDCl3) δ:  7.40 – 7.34 (m, 2H), 7.33 – 7.28 (m, 1H), 7.20 – 7.12 (m, 4H), 
7.11 – 7.05 (m, 2H), 6.19 (t, J = 6.7 Hz, 1H), 3.15 (d, J = 6.7 Hz, 2H), 2.52 (q, J = 7.1 Hz, 4H), 
2.32 (s, 3H), 0.96 (t, J = 7.1 Hz, 6H).  13C NMR (125 MHz, CDCl3) δ: 143.23, 140.11, 139.65, 
137.01, 129.97, 128.96, 128.21, 127.27, 127.15, 126.55, 51.86, 47.13, 21.20, 11.96. 
 
(E)-N,N-diethyl-3-(4-methoxyphenyl)-3-phenylprop-2-en-1-amine: 
prepared according to previously described procedure in 64% yield. 
1H NMR (400 MHz, CDCl3) δ 7.40 – 7.31 (m, 3H), 7.20 – 7.13 (m, 
3H), 6.82 – 6.79 (m, 2H), 6.18 (t, J = 6.9 Hz, 1H), 3.79 (s, 3H), 3.25 (d, J = 6.9 Hz, 2H), 2.63 (q, 
J = 7.1 Hz, 4H), 1.01 (t, J = 7.2 Hz, 6H) ppm.  13C NMR (125 MHz, CDCl3) δ 159.08, 143.41, 
139.98, 134.91, 129.90, 128.50, 128.25, 127.24, 124.60, 113.63, 55.38, 51.67, 46.99, 11.66 ppm. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H26NO, 296.2014; found, 296.2009.  
 
(E)-N,N-diethyl-3-phenyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-
1-amine: prepared according to previously described procedure in 
72% yield. 
1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 8.2 Hz, 2H), 7.42 – 7.32 
(m, 5H), 7.16 – 7.13 (m, 2H), 6.31 (t, J = 6.7 Hz, 1H), 3.18 (d, J = 6.7 Hz, 2H), 2.53 (q, J = 7.1 
Hz, 4H), 0.98 (q, J = 7.1 Hz, 6H).  13C NMR (125 MHz, CDCl3) δ 145.80, 142.32, 139.03, 











(q, J = 271.8 Hz), 51.88, 47.21, 11.87 ppm.  19F NMR (470 MHz, CDCl3) δ -62.51 ppm.  HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C20H23NF3, 334.1783; found, 334.1775.  
 
(E)-N,N-diethyl-3-phenyl-3-(thiophen-2-yl)prop-2-en-1-amine(5o): 
prepared according to Method SE. 
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.32 (m, 3H), 7.26 – 7.22 (m, 2H), 
7.15 (dd, J = 5.1, 1.2 Hz, 1H), 6.89 (dd, J = 5.1, 3.6 Hz, 1H), 6.59 (dd, J = 3.7, 1.2 Hz, 1H), 6.27 
(t, J = 6.8 Hz, 1H), 3.07 (d, J = 6.8 Hz, 2H), 2.50 (q, J = 7.1 Hz, 4H), 0.95 (t, J = 7.1 Hz, 6H) 
ppm. 
13C NMR (125 MHz, CDCl3) δ 146.95, 138.95, 137.84, 129.65, 128.43, 127.77, 127.41, 125.65, 
125.54, 124.47, 51.57, 47.07, 11.85 ppm. 
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Chapter 2: Rhodium-Catalyzed Asymmetric Synthesis of  
Gamma-Branched Amines† 
2.1 Introduction 
Aliphatic amines with adjacent stereocenters are prevalent in natural products and 
pharmaceuticals and are often key contributors to their potent biological activity.1 In particular, 
enantiopure γ-branched amines represent an important subclass of bioactive amines, including 
many pharmaceutical agents (Scheme 2.1). Despite the generality of this structure, the direct 
synthesis of chiral, γ-branched amines remains underdeveloped compared to the well-established 
methods for constructing α- and β-branched amines2–5, as well as distal stereocenters to other 
function groups such as ketones,6 aldehydes,7–10 and amides11.  
 
 
Scheme 2.1 Biologically active molecules containing chiral γ-branched amine moiety. 
                                                
† Portions of this chapter are reprinted with permission from Wu, Z.; Laffoon, S. D.;	Hull, K. L. 
















































Scheme 2.2 Catalytic synthesis of chiral γ-branched amine moiety. 
Known catalytic approaches to install this subunit often require multistep synthetic 
sequences via chiral, β-branched carbonyl intermediates, which can hinder the rapid generation 
of compound libraries for high throughput screening in medicinal chemistry. For example, 
transition metal-catalyzed asymmetric hydrogenation of α,β-unsaturated acids or esters12–14 
affords the enantiopure β-branched carbonyl intermediates, followed by a reductive amination to 
install the desired chiral γ-branched amines (Eqn 1, Scheme 2.2). However, varying substituents 
at the newly introduced stereocenters, such as aryl vs. alkyl, acyclic vs. cyclic, or carbon atom 
vs. heteroatom, often requires different metal/ligand scaffolds to achieve high enantio-
selectivity.12–14 The redox neutral isomerization of allylic amines15,16 or alcohols17–19 provides a 
solution to this problem; however, current methods suffer from very limited substrate scope.9–13 
To the best of our knowledge, there is only one reported method for the direct synthesis of chiral 
γ-branched amines (Eqn 2, Scheme 2.2). Buchwald et al. have shown that 3,3-disubstituted 
allylic esters can undergo an enantioselective hydrocupration followed by β-alkoxide elimination 
and subsequent anti-Markovnikov hydroamination of the intermediate terminal olefin to afford γ-
branched amines in one step.20 Although this method demonstrates high enantioselectivity under 



















































requires additional synthetic operations and limits the substrate scope to secondary alkyl 
amines.20 
 
Scheme 2.3 Proposed reaction pathway. 
Our group has recently published a one-step synthesis of chiral, β-branched amides via 
Rh-catalyzed enantioselective isomerization of allylic amines, followed by enamine exchange, 
and subsequent oxidation.21 The slow oxidation of the more sterically hindered diethyl enamine 
(i, when R=ethyl, Scheme 2.3) compared to facile oxidation of enamine (ii) leads to exclusive 
formation of the desired amide product (iii). Based on this report, we proposed that chiral 
enamine intermediate (ii) could instead be reduced to afford the valuable enantiopure γ-branched 
amine (v). 
We report herein a nucleophilic amination of allylic amines with exogenous amine 
nucleophiles to generate chiral enamine intermediates followed by transfer hydrogenation to 
afford enantiopure γ-branched amines (Scheme 2.4).  
 























































Table 2.1 Selected optimization of reductive amination of allylic amines.a 
 
Entry 89 R, R’ T (°C) X Hydrogen Donor % Yield 90
b % Yield 91b 
1 89a Et, Et 40 1.2 iPrOH < 1 c 5 
2 89a Et, Et 40 1.2 MeOH < 1 c 2 
3 89a Et, Et 40 1.2 HCO2NH4 12 20 
4 89a Et, Et 40 1.2 HCOOH 88 (96.2:3.8 er) 10 
5 89a Et, Et 60 2.0 HCOOH 87 8 
6 89a Et, Et 60 3.0 HCOOH 88 5 
7 89b Me, Me 80 1.2 HCOOH 53 (96.4:3.6 er) 43 
8 89c iPr, iPr 80 1.2 HCOOH 80 (77.6:22.4 er) < 1 
9 89d Cy, H 80 1.2 HCOOH 44 28 
a General reaction conditions: geranyl amine (89) (0.12 mmol, 1.0 equiv, E/Z = 97.5:2.5), morpholine (X equiv), 
hydrogen donor (3.0 equiv), THF (1.2 M). The absolute configurations of 90 and 91 were assigned by analogy. b) In 
situ yield determined by GC or NMR analysis. c) Enamine of 91 was observed as the major product. 
 
2.2 Reaction Design and Optimization 
To establish a method for the selective conversion of allylic amines to enantiopure γ-
branched amines, we began our investigation by examining a variety of hydrogen donors in the 
reductive amination of geranyl diethylamine with morpholine under slightly modified conditions 
from our previous report.21 Compared to the oxidative process, the reduction is more challenging 
as the hydrogenated starting material (Scheme 2.3, iv) was often observed as the major 
byproduct in the amidation reaction.21 Therefore, an appropriate selection of a hydrogen donor 









i) 1.5 mol % [Rh(COD)Cl]2
3.0 mol % (R)-BINAP
3.0 mol % NaBArF4
THF, T °C, 22 h
ii) hydrogen donor













intermediate (ii) was the key challenge in our investigation. No conversion of 89a was observed 
in the presence of H2 donors, presumably due to protonation of the basic allylic nitrogen atom or 
coordination to the cationic catalyst, thereby impeding the initiation of the 1,3-hydride shift.4 
Sequential addition of the hydrogen donor after the isomerization/enamine exchange step led to 
higher conversion of starting material, with HCO2H showing superior reactivity and selectivity 
(Table 2.1, entries 1-4). Increasing the equivalency of amine nucleophile improved the ratio of 
90/91, but did not increase the yield of the desired product 90 (Table 2.1, entries 4-6). Different 
allylic amine precursors (89b-d) were then tested to compare both chemo- and enantioselectivity 
(Table 2.1, entries 7-9). Elevated temperature was required to achieve high conversion for these 
substrates. Less sterically hindered dimethylamino substrate 89b afforded poor chemoselectivity 
and high enantioselectivity; however, bulkier allylic diisopropylamine 89c showed greater 
chemoselectivity but poor enantioselectivity. Secondary amine precursor 89d was less reactive 
and selective under these conditions.  
 
2.3 Substrate Scope 
With these optimized conditions in hand, the amine nucleophile scope was investigated 
(Table 2.2). Secondary cyclic amines such as morpholine (90), Boc-protected piperazine (92), 
tetrahydroisoquinoline (93) and 2-(piperazin-1-yl) pyrimidine (94) all gave similarly excellent 
yields and enantiometric ratios. Without the addition of amine, 95 could be obtained in high 
yield and er. Surprisingly, more sterically hindered acyclic dialkyl amines 96 and 97 (compared 
to diethylamine) were effective nucleophiles in this reaction, indicating that the volatility of the 
resulting diethyl amine byproduct is likely playing a larger role than steric hindrance in 
determining the chemoselectivity (vide infra). Enantiopure α-branched amine afforded the 
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Table 2.2 Scope of amine nucleophiles for reductive amination of allylamine.a 
 
a General reaction conditions: 89a (0.24 mmol, 1.0 equiv, E/Z = 97.5:2.5, 40 °C for 1st step) or 89e (0.24 mmol, 1.0 
equiv, E/Z > 99:1, 60 °C for 1st step), nucleophile (1.2 equiv), hydrogen donor (3.0 equiv), THF (1.2 M). b For 90-
98, HCO2H used as H2 donor at 60 °C for 2nd step; For 99-105, NaBH4 (1.5 equiv) used as reductant at 0°C to rt for 
2nd step. c For 93 and 94, nucleophiles were added together with HCO2H. d No nucleophile added. e (S)-BINAP used.  




i) 1.5 mol % [Rh(COD)Cl]2
3.0 mol % (R)-BINAP 
 3.0 mol % NaBArF4











ii) 3.0 euqiv HCO2H
0 or 60°C, 2 h
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desired products 97 and 98 with high er’s (>97:3) and dr’s (>20:1), demonstrating that the 
isomerization is not affected by the chirality of the nucleophile, but is instead controlled by the 
ligand. Importantly, no racemization of the chiral amine occurred under the reaction conditions. 
Under slightly modified conditions, primary aryl and alkyl amines were coupled with 
allylic diethyl amine electrophiles to afford the chiral secondary amines, respectively. In these 
cases, NaBH4 proved to be a superior reductant than HCO2H. Both electron rich (100) and poor 
(101) anilines afforded the desired chiral amines with identically excellent enantiomeric ratios. 
In the presence of primary alkyl amines (with the exception of tBuNH2 104), the isomerization of 
allylic diethyl amine was completely prohibited; therefore, a sequential addition of nucleophile 
was required to reach high yields. Primary alkyl amines, α to 1°(102), 2°(103), and 3° (104) 
carbons, all afforded desired products with moderate to good yields and excellent 
enantioselectivity. A nucleophile containing a tethered tertiary nitrogen atom (105) was well 
tolerated.  
A survey of 3,3-disubstituted allylic amine electrophiles revealed that a wide variety of 
tertiary stereocenters can be installed under these reductive amination conditions (Table 2.3). 
Several 3,3-aryl,alkyl allylic diethylamines (106-108) were tested and all afforded products with 
good yields and enantioselectivities. An ortho substituent on the aryl ring (108) has no effect on 
the enantioselectivity of the isomerization, and the standard reaction conditions were amenable 
to aryl bromides, with no proteodebromination byproducts observed. The use of β,β-dialkyl 
allylic diethylamine (109-111) was successful, enabling the highly enantioselective synthesis of 
γ-dialkyl amines, even with minimally differentiated substituents (109, nPent vs nBu). When 
more challenging 3,3-diaryl allylic diethylamines (112-114) were subjected to the reaction 
conditions, amine products bearing γ-diaryl stereocenters, a common moiety in pharmaceutical 
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agents, can be formed with excellent enantioselectivity.22–25 Substrates bearing electron-rich 
(113) and electron-poor (114) aryl substituents afforded good yields and excellent enantiomeric 
ratios. This method can be used to set stereocenters containing sterically and electronically 
similar phenyl and para-tolyl groups with excellent selectivity (112, 96.5:3.5 er). Chiral γ-cyclic 
amines containing five-, six-, and seven-membered rings (115-117) could be obtained as well 
Table 2.3 Scope of allylamines.a 
 
a General reaction conditions: allylic diethylamine (0.24 mmol, 1.0 equiv, E/Z > 99:1 unless otherwise noted), 
nucleophile (1.2 equiv), HCO2H (3.0 equiv), THF (1.2 M). b Substrate E/Z = 96.7:3.3. c Substrate Z/E > 99:1. d 1,4-
dioxane used. e Substrate Z/E=95.6:4.4. f Toluene used. The absolute configuration of product is determined by the 





i) 1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (R)-BINAP
3.0 mol % NaBArF4















































ii) 3.0 equiv HCO2H
60-100°C, 2-12 h



















































with high enantioselectivity under identical conditions.26,27 
Due to the superior reactivity and broad substrate tolerance of this catalyst, we sought to 
further develop this method for the construction of highly valuable stereocenters containing CF3, 
CF2H, and SiR3 substituents (Table 2.3). In order to effect suitable conversion, modification of 
the reaction solvent and increased temperatures were required. This may be attributed to the 
difficult isomerization of the more hindered allylic amines. Under these new conditions, difficult 
to synthesize enantiopure γ-trifluromethylated (118-120) and difluoromethylated (121) amines 
can be accessed with moderate to good yields and excellent enantioselectivities.28,29 It is worth 
noting that the (Z)-CF3 allylic amine was slightly more reactive under these conditions compared 
to the (E)-isomer (118), as higher conversion was observed for 119. Phenyl dimethylsilyl 
substituted allylic diethylamines (122) afforded good yields and enantioselectivities under these 
conditions as well. It is noteworthy that the chiral silyl group can be installed, as this can be 
converted to a range of functionalities.30 
 
2.4 Synthetic Application 
This methodology was applied in the enantioselective syntheses of biologically active 
Terikalant and Tolterodine as illustrated in Scheme 2.5. Substrate 123 and nucleophile 124 were 
prepared according to literature procedures. The presence of 124 proved to inhibit the 
isomerization of allylic amine 123. Therefore, the addition of nucleophile along with formic acid 
after the isomerization step was found effective, giving 75% yield as well as excellent er 
(96.7:3.3) for Terikalant (Scheme 2.5a), a significant improvement over the current synthesis 
utilizing chiral resolution.31 A highly enantioselective synthesis of (R)-Tolterodine was then 
demonstrated in Scheme 2.5b.32–34 The (E)-vinyl bromide 125, prepared from trans-cinnamyl 
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chloride,35 was coupled with aryl boronic acid 126 to afford the diastereopure (E)-allylic amine 
127 in 91% yield. A sequential addition of catalyst, hydrogen donor, and strong acid afforded the 
desired (R)-Tolterodine in 88% overall yield and 96.0:4.0 er. Although diisopropylamine was not 
a sufficient nucleophile to perform the enamine exchange with the diethyl enamine, the 
isomerization of allylic diisopropylamine 127 also proceeds in a highly enantioselective fashion. 
It is worth noting that the reaction was carried out on the 1.0 mmol scale with half the catalyst 
loading compared to the aminations performed on the smaller scale. Compared to state-of-the-art 
Tolterodine synthesis, which requires the ortho-hydroxyl substituent to direct the asymmetric 
hydrogenation,34 our method allows for a modular and rapid synthesis of Tolterodine derivatives, 
including those without the ortho-hydroxyl functionality (112-114). 
 




i) 1.5 mol % [Rh(COD)Cl]2
3.0 mol % (R)-BINAP
3.0 mol % NaBArF4
THF, 80  °C, 15 hrs
HCO2H
(3.0 equiv)








1.0 mol % Pd(OAc)2
2.0 mol % PPh3
2.0 equiv KOH




i) 0.75 mol % [Rh(COD)Cl]2
1.5 mol % (S)-BINAP
1.5 mol % NaBArF4
dioxane, 100°C, 10 hrs
ii) HCO2H
(3.0 equiv)

























2.5 Mechanistic Investigations 
To gain insight into the overall selectivity of this tandem process, a series of control 
reactions were carried out under optimized conditions (Scheme 2.6, a-d). The selectivity of the 
enamine exchange step was first investigated. In general, less sterically hindered amine  
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3 mol % [Rh]
40 °C, 6 h
1.2 equiv HNR2 
3.0 equiv HCO2H
















Scheme 2.6 Continued.  
nucleophiles (compared to diethylamine) led to higher selectivity of desired product enamine 128 
over the diethylenamine 129a (Scheme 2.6a). For sterically similar dibutyl and dibenzyl amines, 
128 was found to be the major product, presumably due to a combination of the relative amine 
volatilities, stoichiometry of the reaction, and enamine stability. When equimolar amounts of 
nucleophile and substrate were subjected to the reaction conditions, similar product distributions 
were observed regardless of the permutation of allylic amine versus nucleophile (Scheme 2.6b). 
This implies that the exchanging product distribution is controlled by a thermodynamic 
equilibrium under standard reaction conditions. When the nucleophiles and hydrogen donor were 
added simultaneously into the reaction after the isomerization step (Scheme 2.6c), the observed 
selectivities are similar to those shown in Scheme 2.6a, indicating that the exchange step is faster 
than the reduction. Finally, various secondary amine nucleophiles were studied under standard 
conditions (Scheme 2.6d). Higher selectivities were observed compared to those in Scheme 2.6a, 
implying that the reduction of desired enamine intermediates is faster than the diethylenamine 
129a. Therefore, the chemoselectivity of this two-step one-pot reaction comes from both steps, 
favoring the desired product. 
(d)
3 mol % [Rh]











































Scheme 2.7 Proposed catalytic cycles.  
A proposed mechanism is shown in Scheme 2.7: the basic nitrogen atom of the allylic 
amine substrate coordinates to the cationic rhodium to form A, followed by β-hydride 
elimination and re-insertion of in situ generated conjugated iminium B to afford the chiral 
enamine C. A thermally controlled enamine exchange leads to D, which then undergoes 
subsequent transfer hydrogenation upon addition of formic acid. A rhodium-mediated transfer 
hydrogenation mechanism is proposed, as lower conversion was observed in the absence of 
metal catalyst when investigating the reduction of pre-made enamine. An in situ formed rhodium 
formate species F can undergo decarboxylation to generate Rh hydride species G.36,37 Subsequent 
iminium E inserts into Rh–H G to give the desired chiral γ-branched amine and regenerate 
rhodium formate F. 
We have developed conditions for a highly enantioselective, modular synthesis of chiral 
γ-branched amines. This method enables a rapid assembly of various stereocenters as well as 
amine functionalities via a tandem isomerization–enamine exchange–transfer hydrogenation 
process. Stereocenters bearing diaryl, cyclic, fluoroalkyl and silyl substituents are established 







































2.6 Experimental Procedures  
General Information  
General Experimental Information: All reactions were carried out in flame-dried (or oven-
dried at 140 °C for at least 2 h) glassware under an atmosphere of nitrogen unless otherwise 
indicated. Nitrogen was dried using a drying tube equipped with Drierite™ unless otherwise 
noted. Air- and moisture-sensitive reagents were handled in a nitrogen-filled glovebox (working 
oxygen level ~ 0.1 ppm). Column chromatography was performed with 1) basic aluminium 
oxide from ACROS Organics (50-200 µm, 60 A), Brockmann I grade, activated upon addition of 
certain amount of water according to the substrates, dry loading of activated aluminium oxide 
was applied followed by flush with eluent to get rid of air bubbles; 2) silica gel from Grace 
Davison Discovery Sciences (35-75 µm) with a column mixed as a slurry with the eluent and 
was packed, rinsed, and run under air pressure. Analytical thin-layer chromatography (TLC) was 
performed on precoated glass silica gel plates (by EMD Chemicals Inc.) with F-254 indicator. 
Visualization was either by short wave (254 nm) ultraviolet light, or by staining with potassium 
permanganate followed by brief heating on a hot plate or by a heat gun. Distillations were 
performed using a 3 cm short-path column under reduced pressure or by using a Hickman still at 
ambient pressure. 
Instrumentation: 1H NMR and 13C NMR were recorded on a Varian Unity 400/500 MHz 
(100/125 MHz respectively for 13C) or a VXR-500 MHz spectrometer. Spectra were referenced 
using either CDCl3 or C6D6 as solvents (unless otherwise noted) with the residual solvent peak as 
the internal standard (1H NMR: δ 7.26 ppm, 13C NMR: δ 77.00 ppm for CDCl3 and 1H NMR: δ 
7.15 ppm, 13C NMR: δ 128.60 ppm for C6D6). Chemical shifts were reported in parts per million 
and multiplicities are as indicated: s (singlet,) d (doublet,) t (triplet,) q (quartet,) p (pentet,) m 
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(multiplet,) and br (broad). Coupling constants, J, are reported in Hertz and integration is 
provided, along with assignments, as indicated. Analysis by Gas Chromatography-Mass 
Spectrometry (GC-MS) was performed using a Shimadzu GC-2010 Plus Gas chromatograph 
fitted with a Shimadzu GCMS-QP2010 SE mass spectrometer using electron impact (EI) 
ionization after analytes traveled through a SHRXI–5MS- 30m x 0.25 mm x 0.25 µm column 
using a helium carrier gas.  Data are reported in the form of m/z (intensity relative to base peak = 
100). Gas Chromatography (GC) was performed on a Shimadzu GC-2010 Plus gas 
chromatograph with SHRXI–MS- 15m x 0.25 mm x 0.25 µm column with nitrogen carrier gas 
and a flame ionization detector (FID). Enantiomeric ratios were measured on Shimadzu 
Prominence HLPC system with SPD-M20A UV/VIS Photodiode array detector using Chiralpak 
IA-3, IB-3, IC-3, ID-3 or Chiralcel OJ-H columns. Low-resolution Mass Spectrometry and High 
Resolution Mass Spectrometry were performed in the Department of Chemistry at University of 
Illinois at Urbana-Champaign. The glove box, MBraun LABmaster sp, was maintained under 
nitrogen atmosphere.  
Materials: Solvents used for extraction and column chromatography were reagent grade and 
used as received. Reaction solvents tetrahydrofuran (Fisher, unstabilized HPLC ACS grade), 
diethyl ether (Fisher, BHT stabilized ACS grade), methylene chloride (Fisher, unstabilized 
HPLC grade), dimethoxyethane (Fisher, certified ACS), toluene (Fisher, optima ACS grade), 
1,4-dioxane (Fisher, certified ACS), acetonitrile (Fisher, HPLC grade), and hexanes (Fisher, 
ACS HPLC grade) were dried on a Pure Process Technology Glass Contour Solvent Purification 
System using activated Stainless Steel columns while following manufacture’s recommendations 
for solvent preparation and dispensation unless otherwise noted. All amines were distilled and 
degassed by the freeze-pump-thaw method, and were stored under an atmosphere of nitrogen in 
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glove box before use. All starting allylic diethylamine materials were distilled before use (often 
gave better reactivity after distillation). 
 
Experimental Procedure, Isolation, and Characterization 
 
General procedure A (for 2° amines): [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), (R)-
BINAP (4.5 mg, 0.0072 mmol, 3.0 mol %), NaBAr4F (6.4 mg, 0.0072 mmol, 3.0 mol %), and 
THF (0.2 mL) were added to a 4 mL vial equipped with a stir bar in the glove box under nitrogen 
atmosphere. To the vial was added sequentially allylic diethylamine (0.24 mmol, 1.0 equiv), and 
secondary amine (0.29 mmol, 1.2 equiv). The resulting solution was allowed to stir for 22 h at 40 
°C (unless otherwise noted). After 22 h, formic acid (0.36 mmol, 3.0 equiv) was added into 
reaction vial via syringe and the reaction was allowed to stir for another 2 h at 60 °C (unless 
otherwise noted). The reaction crude was quenched by the addition of DCM, concentrated in 
vacuo and then purified by basic alumina chromatography to afford the desired product. 
 
 
General procedure B (for aryl amines): [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), 
(R)-BINAP (4.5 mg, 0.0072 mmol, 3.0 mol %), NaBAr4F (6.4 mg, 0.0072 mmol, 3.0 mol %), and 





1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (R)-BINAP
3.0 mol % NaBArF4









1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (R)-BINAP
3.0 mol % NaBArF4
THF, 40 °C, 22 h R1 NH
Ar
R2 R2NaBH4
0 °C to rt, 2 hAr
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atmosphere. To the vial was added sequentially allylic diethylamine (0.24 mmol, 1.0 equiv), and 
aryl amine (0.29 mmol, 1.2 equiv). The resulting solution was allowed to stir for 22 h at 40 °C 
(unless otherwise noted). After 22 h, the reaction vial was cooled to 0 °C followed by the 
addition of NaBH4 (0.18 mmol, 1.5 equiv) and 1.0 ml MeOH. The resulting mixture was allowed 
to stir at 0 °C for 1 h then warmed up to rt for another 1 h. The crude reaction was quenched by 
the addition of DCM, concentrated in vacuo and then re-dissolved in DCM, washed with sat. 
NaHCO3 solution. The organic layer was dried over MgSO4, concentrated in vacuo, and purified 
by silica gel chromatography to afford the desired product.  
 
 
General procedure C (for 1° alkyl amines): [Rh(COD)Cl]2 (2.0 mg, 0.0036 mmol, 1.5 mol %), 
(R)-BINAP (4.5 mg, 0.0072 mmol, 3.0 mol %), NaBAr4F (6.4 mg, 0.0072 mmol, 3.0 mol %), 
THF (0.2 mL), and allylic diethylamine (0.24 mmol, 1.0 equiv) were added to a 4 mL vial 
equipped with a stir bar in the glove box under nitrogen atmosphere. The resulting solution was 
allowed to stir for 6 h at 40 °C (unless otherwise noted), followed by the addition of primary 
alkyl amine (0.29 mmol, 1.2 equiv) then continued stirring at 60 °C for another 12 h. After 12 h, 
the reaction vial was cooled to 0 °C followed by the addition of NaBH4 (0.18 mmol, 1.5 equiv) 
and 1.0 ml MeOH. The resulting mixture was allowed to stir at 0 °C for 1 h then warmed up to rt 
for another 1 h. The reaction crude was then quenched by the addition of DCM, concentrated in 
vacuo and then re-dissolved in DCM, washed with sat. NaHCO3 solution. The organic layer was 
dried over MgSO4, concentrated in vacuo, and purified by basic alumina chromatography to 
afford the desired product. 
R1 NEt2
NH2
1.5 mol % [Rh(COD)Cl]2
 3.0 mol % (R)-BINAP
3.0 mol % NaBArF4
THF, 40 °C, 6 h R1 NH
alkyl
R2 R2NaBH4
0 °C to rt, 2 h
alkyl
60 °C, 12 h
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(S)-4-(3,7-dimethyloct-6-en-1-yl)morpholine (90, Table 2.2): Prepared 
according to General procedure A in 80% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% 
MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 5.09 (t, J = 7.1 Hz, 1H), 3.71 (t, J = 4.7 Hz, 4H), 2.49 – 2.39 (m, 
4H), 2.40 – 2.26 (m, 2H), 2.08 – 1.87 (m, 2H), 1.68 (s, 3H), 1.60 (s, 3H), 1.52 (ddt, J = 12.5, 
10.3, 5.5 Hz, 1H), 1.48 – 1.40 (m, 1H), 1.37 – 1.27 (m, 2H), 1.17 (m, 1H), 0.89 (d, J = 6.6 Hz, 
3H).  13C NMR (125 MHz, CDCl3) δ: 131.33, 124.93, 67.19, 57.41, 54.07, 37.37, 33.72, 31.19, 
25.86, 25.62, 19.86, 17.80.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H28NO, 226.2171; 
found, 226.2175.  
 
tert-butyl (S)-4-(3,7-dimethyloct-6-en-1-yl)piperazine-1-carboxylate 
(92, Table 2.2): Prepared according to General procedure A in 75% 
isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH as eluent.  
1H NMR (500 MHz, CDCl3) δ: 5.08 (t, J = 7.0 Hz, 1H), 3.43 (m, 4H), 2.46 – 2.22 (m, 6H), 2.09 
– 1.85 (m, 2H), 1.68 (s, 3H), 1.59 (s, 3H), 1.55 – 1.49 (m, 2H), 1.45 (s, 9H), 1.31 (m, 2H), 1.22 – 
1.10 (m, 1H), 0.88 (d, J = 6.5 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 154.91, 131.34, 124.91, 
79.68, 56.98, 53.31, 37.35, 33.94, 31.20, 28.58, 25.86, 25.61, 19.84, 17.80.  HRMS (ESI-TOF) 





For 93 and 94, nucleophiles were observed to slow down the isomerization of allylic amine, 




Table 2.2): Prepared according to modified General procedure A in 
66% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 50 : 1 
hexanes/ EtOAc with 0.5% MeOH to 30 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient 
eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.16 – 7.07 (m, 3H), 7.05 – 6.97 (m, 1H), 5.11 (t, J = 6.9 Hz, 
1H), 3.63 (s, 2H), 2.91 (t, J = 6.0 Hz, 2H), 2.73 (td, J = 6.0, 3.1 Hz, 2H), 2.52 (dt, J = 9.5, 5.5 Hz, 
2H), 2.10 – 1.88 (m, 2H), 1.69 (s, 3H), 1.67 – 1.63 (m, 1H), 1.61 (s, 3H), 1.55 – 1.48 (m, 1H), 
1.46 – 1.32 (m, 2H), 1.24 – 1.15 (m, 1H), 0.93 (d, J = 6.6 Hz, 3H). 13C NMR (125 MHz, CDCl3) 
δ: 135.09, 134.53, 131.30, 128.76, 126.73, 126.17, 125.66, 125.00, 56.73, 56.49, 51.25, 37.44, 
34.39, 31.27, 29.30, 25.88, 25.66, 19.91, 17.82.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C19H30N, 272.2378; found, 272.2377.  
 
1.5 mol % [Rh(COD)Cl]2
3.0 mol % (R)-BINAP 
 3.0 mol % NaBArF4



















Table 2.2): Prepared according to modified General procedure A in 
83% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30:1 
hexanes/ EtOAc with 0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient 
eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.30 (d, J = 4.7 Hz, 2H), 6.47 (t, J = 4.7 Hz, 1H), 5.09 (t, J = 7.0 
Hz, 1H), 3.92 – 3.76 (br, 4H), 2.54 – 2.45 (br, 4H), 2.44 – 2.30 (m, 2H), 2.09 – 1.87 (m, 2H), 
1.68 (s, 3H), 1.60 (s, 3H), 1.58 – 1.53 (m, 1H), 1.51 – 1.43 (m, 1H), 1.39 – 1.29 (m, 2H), 1.22 – 
1.13 (m, 1H), 0.90 (d, J = 6.6 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 161.83, 157.83, 131.34, 
124.93, 190.91 57.10, 53.41, 43.84, 37.37, 34.01, 31.27, 25.87, 25.63, 19.87, 17.81. HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C18H31N4, 303.2549; found, 303.2549.  
 
(S)-N,N-diethyl-3,7-dimethyloct-6-en-1-amine (95, Table 2.2): Prepared 
according to General procedure A without any nucleophilic amine added in 
83% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 5.09 (t, J = 7.1 Hz, 1H), 2.51 (q, J = 7.1, 4H), 2.46 – 2.36 (m, 
2H), 1.97 (qq, J = 14.5, 7.1 Hz, 2H), 1.67 (d, J = 1.6 Hz, 3H), 1.59 (s, 3H), 1.53 – 1.38 (m, 2H), 
1.36 – 1.21 (m, 2H), 1.16 (m, 1H), 1.01 (t, J = 7.1 Hz, 6H), 0.88 (d, J = 6.5 Hz, 3H).  13C NMR 






17.77, 11.84.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H30N, 212.2378; found, 
212.2385.  
 
(S)-N,N-dibenzyl-3,7-dimethyloct-6-en-1-amine (96, Table 2.2): Prep-
ared according to General procedure A in 70% isolated yield.  
Column Chromatography Condition: silica gel, 20 : 1 hexanes/ EtOAc as 
eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.39 – 7.34 (m, 4H), 7.33 – 7.28 (m, 4H), 7.24 – 7.18 (m, 2H), 
5.06 (tq, J = 7.1, 1.4 Hz, 1H), 3.58 (d, J = 13.7 Hz, 2H), 3.50 (d, J = 13.7 Hz, 2H), 2.43 (t, J = 7.3 
Hz, 2H), 2.04 – 1.83 (m, 2H), 1.67 (brs, 3H), 1.57 (brs, 4H, overlap), 1.52 – 1.42 (m, 1H), 1.37 – 
1.27 (m, 1H), 1.27 – 1.17 (m, 1H), 1.13 – 1.00 (m, 1H), 0.76 (d, J = 6.5 Hz, 3H).  13C NMR (125 
MHz, CDCl3) δ: 140.17, 131.13, 128.93, 128.24, 126.83, 125.08, 58.42, 51.44, 37.26, 34.15, 
30.52, 25.87, 25.61, 19.75, 17.79.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H34N, 
336.2691; found, 336.2695.  
 
(R)-N-methyl-3-phenyl-N-((S)-1-phenylethyl)butan-1-amine(97, Table 
2.2): Prepared according to General procedure A with (R)-BNIAP as 
ligand in 64% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/ EtOAc with 
0.5% MeOH to 30 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δδ 7.31 – 7.23 (m, 5H), 7.23 – 7.19 (m, 2H), 7.19 – 7.12 (m, 3H), 








(ddd, J = 12.5, 9.3, 5.3 Hz, 1H), 2.13 (s, 3H), 1.79 (dddd, J = 13.3, 9.4, 8.0, 5.3 Hz, 1H), 1.71 
(ddt, J = 13.4, 9.3, 6.2 Hz, 1H), 1.30 (d, J = 6.8 Hz, 3H), 1.20 (d, J = 6.9 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ: 147.74, 144.08, 128.42, 128.16, 127.82, 127.08, 126.77, 125.94, 63.22, 52.72, 
38.47, 37.96, 35.76, 22.66, 18.24.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H26N, 
268.2065; found, 268.2073.  
 
(S)-N-methyl-3-phenyl-N-((S)-1-phenylethyl)butan-1-amine(98, Table 
2.2): Prepared according to General procedure A with (S)-BNIAP as 
ligand in 60% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/ EtOAc with 
0.5% MeOH to 30 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.26 (m, 3H), 7.25 – 7.18 (m, 4H), 7.17 – 7.11 (m, 3H), 
3.49 (q, J = 6.7 Hz, 1H), 2.70 (h, J = 7.0 Hz, 1H), 2.36 – 2.20 (m, 2H), 2.12 (s, 3H), 1.81 – 1.67 
(m, 2H), 1.26 (d, J = 6.8 Hz, 3H), 1.17 (d, J = 7.0 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 
147.77, 144.23, 128.41, 128.19, 127.80, 127.07, 126.79, 125.93, 63.34, 52.58, 38.60, 37.79, 
35.65, 22.48, 18.55.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H26N, 268.2065; found, 
268.2066.  
 
(S)-N-(3,7-dimethyloct-6-en-1-yl)aniline (99, Table 2.2): Prepared 
according to General procedure B in 81% isolated yield.  









1H NMR (500 MHz, CDCl3) δ: 7.22 – 7.11 (m, 2H), 6.75 – 6.66 (m, 1H), 6.64 – 6.58 (m, 2H), 
5.11 (t, J = 7.0 Hz, 1H), 3.60 (brs, 1H), 3.26 – 3.00 (m, 2H), 2.12 – 1.91 (m, 2H), 1.70 (s, 3H), 
1.68 – 1.63 (m, 1H), 1.61 (s, 3H), 1.59 – 1.54 (m, 1H), 1.49 – 1.34 (m, 2H), 1.28 – 1.17 (m, 1H), 
0.95 (d, J = 6.6 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 148.64, 131.49, 129.36, 124.79, 
117.27, 112.87, 42.12, 37.24, 36.84, 30.58, 25.88, 25.62, 19.75, 17.83.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C16H26N, 232.2065; found, 232.2064.  
 
(S)-N-(3,7-dimethyloct-6-en-1-yl)benzo[d][1,3]dioxol-5-amine (100, 
Table 2.2): Prepared according to General procedure B in 74% isolated 
yield.  
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ 
EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 6.65 (d, J = 8.2 Hz, 1H), 6.24 (d, J = 2.3 Hz, 1H), 6.04 (dd, J = 
8.3, 2.3 Hz, 1H), 5.85 (s, 2H), 5.12 (t, J = 7.0 Hz, 1H), 3.35 (brs, 1H), 3.15 – 2.91 (m, 2H), 2.13 
– 1.88 (m, 2H), 1.69 (s, 3H), 1.66 – 1.62 (m, 1H), 1.61 (s, 3H), 1.57 – 1.50 (m, 1H), 1.46 – 1.31 
(m, 2H), 1.28 – 1.14 (m, 1H), 0.94 (d, J = 6.5 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 148.46, 
144.52, 139.55, 131.49, 124.78, 108.75, 104.44, 100.65, 96.00, 43.15, 37.24, 36.85, 30.58, 25.88, 
25.61, 19.75, 17.83.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H26NO2, 276.1964; 







Table 2.2): Prepared according to General procedure B in 61% 
isolated yield (as a mixture of 12:1 desired product and hydrogenated 
product). 
Column Chromatography Condition: silica gel, 99 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.32 (d, J = 8.6 Hz, 2H), 6.51 (d, J = 8.4 Hz, 2H), 5.05 – 4.99 
(m, 1H), 3.87 (brs, 1H), 3.21 – 2.84 (m, 2H), 2.06 – 1.80 (m, 2H), 1.62 (d, J = 1.3 Hz, 3H), 1.60 
– 1.55 (m, 1H), 1.53 (d, J = 1.4 Hz, 3H), 1.51 – 1.45 (m, 1H), 1.44 – 1.35 (m, 1H), 1.34 – 1.25 
(m, 1H), 1.17 – 1.10 (m, 1H), 0.88 (d, J = 6.6 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 151.04, 
131.72, 126.82 (q, J = 3.8 Hz), 125.28 (q, J = 270.2 Hz), 124.75, 118.72 (q, J = 32.7 Hz), 111.92, 
41.76, 37.26, 36.63, 30.59, 25.98, 25.69, 19.80, 17.93.  19F NMR (471 MHz, CDCl3) δ: -61.30. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H25NF3, 300.1939; found, 300.1947.  
 
(S)-N-benzyl-3,7-dimethyloct-6-en-1-amine (102, Table 2.2): Prepared 
according to General procedure C in 70% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 20 : 1 
hexanes/ EtOAc with 0.5% MeOH to 10 : 1 hexanes/ EtOAc with 1.0% 
MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.30 (m, 4H), 7.26 – 7.21 (m, 1H), 5.09 (dddd, J = 7.1, 
5.7, 2.9, 1.4 Hz, 1H), 3.79 (s, 2H), 2.72 – 2.58 (m, 2H), 2.06 – 1.88 (m, 2H), 1.68 (d, J = 1.3 Hz, 
3H), 1.59 (s, 3H), 1.56 – 1.44 (m, 2H), 1.39 – 1.28 (m, 2H), 1.21 – 1.10 (m, 1H), 0.88 (d, J = 6.5 








54.35, 47.60, 37.43, 37.38, 30.77, 25.87, 25.64, 19.78, 17.80.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C17H28N, 246.2222; found, 246.2228.  
 
(R)-N-((R)-1-cyclohexylethyl)-3-phenylbutan-1-amine (103, Table 
2.2): Prepared according to General procedure C in 61% isolated 
yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 
0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.32 – 7.27 (m, 2H), 7.22 – 7.15 (m, 3H), 2.77 (h, J = 7.1 Hz, 
1H), 2.63 – 2.53 (m, 1H), 2.42 – 2.29 (m, 2H), 1.80 – 1.68 (m, 4H), 1.67 – 1.57 (m, 3H), 1.25 (d, 
J = 6.9 Hz, 4H, overlap), 1.20 – 1.04 (m, 4H), 0.99 – 0.92 (m, 1H), 0.91 (d, J = 6.4 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ: 147.49, 128.49, 127.07, 126.06, 57.93, 46.03, 43.12, 39.00, 38.35, 
30.07, 28.09, 26.92, 26.80, 26.66, 22.74, 16.87. HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C18H30N, 260.2378; found, 260.2381.  
 
(R)-N-(tert-butyl)-3-phenylbutan-1-amine (104, Table 2.2): Prepared 
according to General procedure B in 58% isolated yield.  
Column Chromatography Condition: silical gel, 30 : 1 hexanes/ EtOAc 
to 10 : 1 hexanes/ EtOAc as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.39 – 7.30 (m, 3H), 7.26 – 7.19 (m, 2H), 2.84 (h, J = 7.0 Hz, 






(125 MHz, CDCl3) δ: 147.38, 128.47, 127.07, 126.06, 50.34, 40.91, 39.60, 38.34, 29.16, 22.80. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H24N, 206.1909; found, 206.1913.  
 
(S)-3,7-dimethyl-N-(2-morpholinoethyl)oct-6-en-1-amine (105, 
Table 2.2): Prepared according to General procedure C in 66% 
isolated yield.  
Purification: No column chromatography needed. Reaction crude was concentrated to remove 
solvent then re-dissolve in Et2O followed by acid/base extraction to afford the desired product. 
1H NMR (500 MHz, CDCl3) δ: δ 5.09 (ddt, J = 8.9, 7.2, 1.6 Hz, 1H), 3.93 – 3.48 (m, 4H), 2.71 
(t, J = 6.2 Hz, 2H), 2.62 (dddd, J = 20.9, 11.4, 10.4, 5.7 Hz, 2H), 2.49 (t, J = 6.1 Hz, 2H), 2.45 – 
2.40 (m, 4H), 1.96 (m, 2H), 1.81 (brs, 1H), 1.67 (d, J = 1.6 Hz, 3H), 1.59 (s, 3H), 1.57 – 1.44 (m, 
2H), 1.40 – 1.28 (m, 2H), 1.18 – 1.11 (m, 1H), 0.88 (d, J = 6.4 Hz, 3H).  13C NMR (125 MHz, 
CDCl3) δ: 131.32, 124.92, 67.18, 58.42, 53.91, 48.14, 46.35, 37.36, 37.32, 30.80, 25.86, 25.64, 
19.74, 17.79.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H33 N2O, 269.2593; found, 
269.2593. 
 
(R)-4-(3-phenylbutyl)morpholine (106, Table 2.3): Prepared according 
to General procedure A in 77% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 







1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.27 (m, 2H), 7.22 – 7.15 (m, 3H), 3.69 (t, J = 4.7 Hz, 
4H), 2.75 (h, J = 7.1 Hz, 1H), 2.47 – 2.33 (m, 4H), 2.27 (ddd, J = 12.1, 8.5, 6.5 Hz, 1H), 2.19 
(ddd, J = 12.1, 8.6, 6.6 Hz, 1H), 1.83 – 1.73 (m, 2H), 1.26 (d, J = 6.9 Hz, 3H).  13C NMR (125 
MHz, CDCl3) δ: 147.30, 128.51, 127.08, 126.13, 67.18, 57.45, 53.94, 38.24, 35.18, 22.64. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H22NO, 220.1701; found, 220.1706. 
 
(R)-4-(3-phenylheptyl)morpholine (107, Table 2.3): Prepared accord-
ing to General procedure A in 86% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient 
eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.25 (m, 2H), 7.21 – 7.16 (m, 1H), 7.15 – 7.10 (m, 2H), 
3.68 (t, J = 4.7 Hz, 4H), 2.53 (tt, J = 9.7, 5.4 Hz, 1H), 2.43 – 2.29 (m, 4H), 2.21 (ddd, J = 12.1, 
10.2, 5.8 Hz, 1H), 2.10 (ddd, J = 12.1, 10.2, 4.9 Hz, 1H), 1.85 (ddt, J = 13.1, 10.5, 5.4 Hz, 1H), 
1.76 – 1.68 (m, 1H), 1.67 – 1.50 (m, 2H), 1.38 – 1.00 (m, 4H), 0.82 (t, J = 7.2 Hz, 3H).  13C 
NMR (125 MHz, CDCl3) δ: 145.76, 128.41, 127.73, 126.08, 67.17, 57.46, 53.94, 44.27, 36.96, 
33.75, 29.89, 22.88, 14.15.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H28NO, 262.2171; 
found, 262.2177. 
 
(R)-4-(3-(5-bromo-2-fluorophenyl)butyl)morpholine (108, Table 2.3): 





Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 50 : 1 hexanes/ EtOAc with 
0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 (dd, J = 6.5, 2.5 Hz, 1H), 7.29 – 7.22 (m, 1H), 6.88 (dd, J = 
9.9, 8.6 Hz, 1H), 3.68 (t, J = 4.7 Hz, 4H), 3.08 (h, J = 7.0 Hz, 1H), 2.44 – 2.34 (m, 4H), 2.29 
(ddd, J = 12.3, 9.2, 6.0 Hz, 1H), 2.22 (ddd, J = 12.2, 9.3, 5.9 Hz, 1H), 1.86 – 1.68 (m, 2H), 1.25 
(d, J = 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ: 159.90 (d, J = 245.2 Hz), 136.23 (d, J = 16.3 
Hz), 131.19 (d, J = 5.4 Hz), 130.34 (d, J = 8.4 Hz), 117.31 (d, J = 24.8 Hz), 116.79 (d, J = 3.2 
Hz), 67.11, 57.06, 53.87, 33.80, 31.15, 31.14, 20.93. HRMS (ESI-TOF) m/z: [M+H+] calculated 
for C14H20NOBrF, 316.0712; found, 316.0716. 
 
(S)-3-butyl-N-methyl-N-((S)-1-phenylethyl) octan-1-amine (109, 
Table 2.3): Prepared according to General procedure A in 61% 
isolated yield. [α]D23 = -21.09 (c = 1.05) 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/ EtOAc with 
0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.29 (m, 4H), 7.24 – 7.20 (m, 1H), 3.55 (q, J = 6.7 Hz, 
1H), 2.40 (ddd, J = 12.5, 9.8, 6.0 Hz, 1H), 2.29 – 2.20 (m, 1H), 2.18 (s, 3H), 1.45 – 1.38 (m, 2H), 
1.36 (d, J = 6.8 Hz, 3H), 1.32 – 1.22 (m, 6H), 1.22 – 1.10 (m, 9H), 0.87 (t, J = 7.1 Hz, 6H).  13C 
NMR (125 MHz, CDCl3) δ: 144.35, 128.19, 127.82, 126.81, 63.55, 52.39, 38.79, 35.89, 33.82, 
33.60, 32.47, 31.03, 28.96, 26.41, 23.25, 22.85, 18.91, 14.29, 14.28. HRMS (ESI-TOF) m/z: 




(R)-N,N-dibenzyl-3-cyclopropylbutan-1-amine (110, Table 2.3): 
Prepared according to General procedure A in 69% isolated yield.  
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ EtOAc 
as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.37 (d, J = 7.1 Hz, 4H), 7.31 (dd, J = 8.4, 6.7 Hz, 4H), 7.25 – 
7.19 (m, 2H), 3.62 (d, J = 13.6 Hz, 2H), 3.51 (d, J = 13.6 Hz, 2H), 2.54 (ddd, J = 12.8, 9.0, 6.4 
Hz, 1H), 2.46 (ddd, J = 12.7, 9.1, 5.1 Hz, 1H), 1.74 (ddt, J = 12.7, 9.2, 6.0 Hz, 1H), 1.54 – 1.39 
(m, 1H), 0.84 (d, J = 6.6 Hz, 3H), 0.79 – 0.64 (m, 1H), 0.50 – 0.38 (m, 1H), 0.36 – 0.28 (m, 2H), 
0.02 – -0.05 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 140.14, 128.98, 128.23, 126.83, 58.36, 
51.49, 36.71, 34.59, 19.89, 18.35, 4.49, 3.23.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C21H28N, 294.2222; found, 294.2220. 
 
(R)-4-(3-(2-(benzyloxy)ethyl)heptyl)morpholine (111, Table 2.3): 
Prepared according to General procedure A in 66% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 15 : 1 
hexanes/ EtOAc with 0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.35 – 7.31 (m, 4H), 7.30 – 7.26 (m, 1H), 4.49 (s, 2H), 3.70 (t, J 
= 4.7 Hz, 4H), 3.49 (t, J = 6.9 Hz, 2H), 2.47 – 2.38 (m, 4H), 2.35 – 2.28 (m, 2H), 1.60 (qd, J = 
6.8, 1.4 Hz, 2H), 1.53 – 1.49 (m, 1H), 1.48 – 1.42 (m, 2H), 1.29 – 1.23 (m, 8H), 0.88 (t, J = 6.8 
Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 138.75, 128.48, 127.76, 127.64, 73.07, 68.70, 67.15, 
57.10, 54.06, 33.93, 33.66, 33.34, 30.59, 28.84, 23.17, 14.25.  HRMS (ESI-TOF) m/z: [M+H+] 





(S)-4-(3-phenyl-3-(p-tolyl)propyl)morpholine (112, Table 2.3): 
Prepared according to General procedure A in 66% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 
hexanes/ EtOAc with 0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient 
eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.26 (m, 3H), 7.25 – 7.24 (m, 1H), 7.21 – 7.14 (m, 3H), 
7.12 – 7.08 (m, 2H), 3.98 (t, J = 7.4 Hz, 1H), 3.77 – 3.68 (m, 4H), 2.46 – 2.37 (m, 4H), 2.32 (s, 
3H), 2.30 – 2.27 (m, 2H), 2.27 – 2.20 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 145.19, 141.90, 
135.81, 129.29, 128.57, 127.90, 127.81, 126.23, 67.19, 57.46, 53.94, 48.74, 32.61, 21.12. HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C20H26NO, 296.2014; found, 296.2006. 
 
(S)-4-(3-(4-methoxyphenyl)-3-phenylpropyl) morpholine (113, 
Table 2.3): Prepared according to General procedure A in 81% 
isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 8 g H2O, 10 : 1 hexanes/ EtOAc with 
1.0% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.29 – 7.26 (m, 1H), 7.25 – 7.21 (m, 3H), 7.20 – 7.13 (m, 3H), 
6.89 – 6.76 (m, 2H), 3.95 (t, J = 7.6 Hz, 1H), 3.77 (s, 3H), 3.71 (t, J = 4.7 Hz, 5H), 2.49 – 2.36 
(m, 4H), 2.31 – 2.24 (m, 2H), 2.24 – 2.15 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 158.06, 
145.32, 137.04, 128.85, 128.57, 127.85, 126.22, 113.96, 67.18, 57.45, 55.35, 53.94, 48.27, 32.74. 








(114, Table 2.3): Prepared according to General procedure A in 78% 
isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 
0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.53 (d, J = 7.9 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.33 – 7.27 
(m, 2H), 7.25 – 7.18 (m, 3H), 4.17 – 4.03 (m, 1H), 3.71 (t, J = 4.7 Hz, 4H), 2.50 – 2.34 (m, 4H), 
2.32 – 2.16 (m, 4H).  13C NMR (125 MHz, CDCl3) δ: 149.05, 143.86, 128.80, 128.65 (q, J = 
32.4 Hz), 128.31, 127.94, 126.74, 125.56 (q, J = 3.8 Hz), 124.36 (q, J = 271.8 Hz), 67.16, 57.02, 
53.90, 48.81, 32.34, 29.85.  19F NMR (471 MHz, CDCl3) δ: -62.75.  HRMS (ESI-TOF) m/z: 
[M+H+] calculated for C20H23 NOF3, 350.1732; found, 350.1729. 
 
(R)-N,N-dibenzyl-2-(2,3-dihydro-1H-inden-1-yl)ethan-1-amine (115, 
Table 2.3): Prepared according to General procedure A in 69% isolated 
yield.  
Column Chromatography Condition: silica gel, 99 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.42 – 7.36 (m, 4H), 7.32 (t, J = 7.5 Hz, 4H), 7.24 (t, J = 7.4 Hz, 
2H), 7.21 – 7.17 (m, 1H), 7.15 – 7.08 (m, 2H), 7.07 – 7.03 (m, 1H), 3.69 (d, J = 13.5 Hz, 2H), 
3.52 (d, J = 13.6 Hz, 2H), 3.16 (ddd, J = 12.0, 9.9, 6.0 Hz, 1H), 2.84 (ddd, J = 15.8, 8.6, 4.5 Hz, 
1H), 2.75 (dt, J = 15.9, 8.1 Hz, 1H), 2.61 (dd, J = 12.9, 7.6 Hz, 1H), 2.55 (ddt, J = 13.0, 8.4, 4.4 
Hz, 1H), 2.16 – 2.07 (m, 1H), 2.03 (dtt, J = 12.4, 7.9, 4.1 Hz, 1H), 1.61 – 1.55 (m, 1H), 1.47 (dq, 





126.97, 126.32, 126.14, 124.50, 123.59, 58.58, 51.70, 42.74, 32.64, 32.22, 31.52. HRMS (ESI-
TOF) m/z: [M+H+] calculated for C25H28N, 342.2222; found, 342.2221. 
 
(S)-N,N-dibenzyl-2-(chroman-4-yl)ethan-1-amine (116, Table 2.3): 
Prepared according to General procedure A from in 77% isolated yield.  
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ EtOAc as 
eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.39 (d, J = 7.1 Hz, 4H), 7.33 (dd, J = 8.4, 6.7 Hz, 4H), 7.28 – 
7.23 (m, 2H), 7.11 – 7.03 (m, 1H), 7.02 – 6.94 (m, 1H), 6.83 – 6.74 (m, 2H), 4.05 (dd, J = 6.5, 
4.3 Hz, 2H), 3.74 (d, J = 13.5 Hz, 2H), 3.48 (d, J = 13.5 Hz, 2H), 2.94 (dq, J = 9.9, 5.0 Hz, 1H), 
2.61 (dt, J = 12.9, 7.6 Hz, 1H), 2.51 (ddd, J = 12.7, 7.3, 4.7 Hz, 1H), 2.06 (dtd, J = 14.0, 7.7, 4.1 
Hz, 1H), 1.84 – 1.70 (m, 1H), 1.62 (dddd, J = 14.2, 10.0, 7.0, 4.6 Hz, 1H), 1.51 – 1.40 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ: 154.64, 139.89, 129.12, 129.08, 128.38, 127.24, 127.07, 126.96, 
120.24, 116.83, 63.54, 58.75, 50.54, 34.08, 31.06, 26.58.  HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C25H28NO, 358.2171; found, 358.2171. 
 
(S)-4-(2-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl)ethyl)morpholine 
(117, Table 2.2): Prepared according to General procedure A in 75% isolated 
yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 30 : 1 






1H NMR (500 MHz, Benzene-d6) δ: 7.13 (dd, J = 7.5, 1.8 Hz, 1H), 7.10 (td, J = 7.2, 1.8 Hz, 1H), 
7.06 (td, J = 7.1, 1.8 Hz, 1H), 7.03 (dd, J = 7.4, 1.8 Hz, 1H), 3.61 (t, J = 4.8 Hz, 4H), 2.90 (qd, J 
= 7.1, 2.3 Hz, 1H), 2.82 – 2.73 (m, 1H), 2.71 – 2.64 (m, 1H), 2.19 – 2.11 (m, 6H), 1.91 (dq, J = 
13.8, 7.4 Hz, 1H), 1.79 – 1.44 (m, 7H).  13C NMR (125 MHz, CDCl3) δ: 145.14, 142.59, 130.03, 
128.03, 126.06, 126.04, 67.15, 57.99, 54.02, 43.20, 36.26, 33.40, 29.85, 29.72, 28.22. HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C17H26NO, 260.2014; found, 260.2017. 
 
(S)-N,N-dibenzyl-4,4,4-trifluoro-3-phenylbutan-1-amine (5m, Table 
2.3): Prepared according to General procedure A from (E)-N,N-diethyl-
4,4,4-trifluoro-3-phenylbut-2-en-1-amine in 63% isolated yield.  
Column Chromatography Condition: silica gel, 50 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.27 (m, 9H), 7.25 – 7.18 (m, 4H), 7.01 (dd, J = 7.5, 1.8 
Hz, 2H), 3.67 (d, J = 13.5 Hz, 2H), 3.43 – 3.34 (m, 1H), 3.32 (d, J = 13.5 Hz, 2H), 2.37 (ddd, J = 
12.1, 8.6, 6.1 Hz, 1H), 2.33 – 2.27 (m, 1H), 2.27 – 2.19 (m, 1H), 2.02 – 1.88 (m, 1H).  13C NMR 
(125 MHz, CDCl3) δ: 139.41, 134.82 (q, J = 1.9 Hz), 129.15, 129.13, 128.60, 128.39, 127.97, 
127.31 (q, J= 279.5 Hz), 127.09, 58.46, 50.19, 47.49 (q, J = 26.6 Hz), 26.95 (q, J = 1.7 Hz).  19F 
NMR (471 MHz, CDCl3) δ: -69.58 (d, J = 9.8 Hz). HRMS (ESI-TOF) m/z: [M+H+] calculated 
for C24H25NF3, 384.1939; found, 384.1927. 
 
(R)-N,N-dibenzyl-4,4,4-trifluoro-3-phenylbutan-1-amine (5n, Table 
2.2): Prepared according to General procedure A from (Z)-N,N-diethyl-





Column Chromatography Condition: silica gel, 50 : 1 hexanes/ EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.35 – 7.24 (m, 9H), 7.24 – 7.17 (m, 4H), 7.08 – 6.95 (m, 2H), 
3.67 (d, J = 13.4 Hz, 2H), 3.44 – 3.34 (m, 1H), 3.32 (d, J = 13.5 Hz, 2H), 2.43 – 2.33 (m, 1H), 
2.32 – 2.20 (m, 2H), 1.94 (dtd, J = 15.2, 6.8, 3.3 Hz, 1H).  13C NMR (125 MHz, CDCl3) δ: 
139.41, 134.82 (q, J = 1.8 Hz), 129.15, 129.13, 128.60, 128.39, 127.97, 127.31 (q, J= 279.0 Hz), 
127.09, 58.47, 50.19, 47.49 (q, J = 26.6 Hz), 26.96 (q, J = 1.8 Hz).  19F NMR (471 MHz, CDCl3) 
δ: -69.58 (d, J = 9.8 Hz).  HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H25NF3, 384.1939; 
found, 384.1952. 
 
(R)-N,N,3-tribenzyl-4,4,4-trifluorobutan-1-amine (120, Table 2.3): 
Prepared according to General procedure A from in 59% isolated yield. 
Column Chromatography Condition: silica gel, 50 : 1 hexanes/ 
EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.30 (dd, J = 8.1, 6.8 Hz, 4H), 7.26 – 7.15 (m, 9H), 7.04 – 6.99 
(m, 2H), 3.54 – 3.46 (m, 2H), 3.38 (d, J = 13.6 Hz, 2H), 2.94 – 2.81 (m, 1H), 2.54 – 2.45 (m, 
2H), 2.45 – 2.34 (m, 2H), 1.82 (dtd, J = 14.5, 7.3, 4.9 Hz, 1H), 1.60 (ddt, J = 13.6, 7.7, 5.6 Hz, 
1H).  13C NMR (125 MHz, CDCl3) δ: 139.40, 138.26, 129.28, 129.02, 128.58, 128.44 (q, J = 
280.4 Hz), 128.33, 127.05, 126.61, 58.14, 50.53, 42.39 (q, J = 24.8 Hz), 34.40 (q, J = 2.9 Hz), 
24.96 (q, J = 1.8 Hz).  19F NMR (471 MHz, CDCl3) δ: -70.26 (d, J = 8.3 Hz).  HRMS (ESI-




(R)-N,N,3-tribenzyl-4,4-difluorobutan-1-amine (121, Table 2.3): 
Prepared according to General procedure A in 70% isolated yield. 
Column Chromatography Condition: silica gel, 30 : 1 hexanes/ 
EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.28 (m, 7H), 7.26 – 7.22 (m, 4H), 7.21 – 7.16 (m, 1H), 
7.08 – 7.02 (m, 2H), 5.54 (td, J = 56.7, 2.9 Hz, 1H), 3.57 – 3.48 (m, 2H), 3.44 (d, J = 13.4 Hz, 
2H), 2.67 (dd, J = 13.9, 6.9 Hz, 1H), 2.49 – 2.47 (m, 1H), 2.45 (t, J = 6.8 Hz, 2H), 2.33 – 2.11 
(m, 1H), 1.83 – 1.67 (m, 1H), 1.53 – 1.46 (m, 1H).  13C NMR (125 MHz, CDCl3) δ: 139.60, 
139.00, 129.28, 129.11, 128.60, 128.37, 127.09, 126.42, 117.96 (t, J = 241.7 Hz), 58.37, 50.35, 
41.73 (t, J = 19.1 Hz), 33.89 (dd, J = 6.2, 3.6 Hz), 24.20 (t, J = 3.9 Hz).  19F NMR (471 MHz, 
CDCl3) δ: -124.91 (ddd, J = 277.9, 56.8, 15.6 Hz), -126.24 (ddd, J = 277.8, 56.7, 17.6 Hz). 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C25H28NF2, 380.2190; found, 380.2182. 
 
(R)-4-(3-(dimethyl(phenyl)silyl)-3-phenylpropyl)morpholine (122, 
Table 2.3): Prepared according to General procedure A from (Z)-3-
(dimethyl(phenyl)silyl)-N,N-diethyl-3-phenylprop-2-en-1-amine  in 75% 
isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/ EtOAc with 
0.5% MeOH to 15 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.42 – 7.36 (m, 2H), 7.39 – 7.28 (m, 3H), 7.23 – 7.15 (m, 2H), 
7.12 – 7.05 (m, 1H), 6.98 – 6.91 (m, 2H), 3.65 (t, J = 4.7 Hz, 4H), 2.32 – 2.23 (m, 5H), 2.20 





0.25 (s, 3H), 0.16 (s, 3H).  13C NMR (125 MHz, CDCl3) δ: 142.71, 137.57, 134.24, 129.19, 
128.20, 128.00, 127.75, 124.75, 67.11, 58.83, 53.86, 34.51, 26.45, -3.73, -5.29.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C21H30NOBSi, 340.2097; found, 340.2091. 
 
(S)-1-(2-(chroman-4-yl)ethyl)-4-(3,4-dimethoxyphenyl) 
piperidine (Terikanlant, Scheme 2.5): Prepared according to 
General procedure A in 75% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 12 : 1 hexanes/ EtOAc with 
0.5% MeOH to 6 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.20 (d, J = 7.6 Hz, 1H), 7.13 (ddd, J = 8.7, 7.4, 1.7 Hz, 1H), 
6.90 (td, J = 7.4, 1.3 Hz, 1H), 6.87 – 6.80 (m, 4H), 4.31 – 4.19 (m, 2H), 3.91 (s, 3H), 3.90 (s, 
3H), 3.23 – 3.06 (m, 2H), 2.94 (dq, J = 10.2, 5.3 Hz, 1H), 2.55 (t, J = 7.7 Hz, 2H), 2.49 (dt, J = 
11.7, 4.2 Hz, 1H), 2.21 – 2.03 (m, 4H), 1.95 – 1.75 (m, 6H).  13C NMR (125 MHz, CDCl3) δ: 
154.61, 148.92, 147.42, 139.23, 129.22, 127.47, 126.34, 120.27, 118.66, 116.95, 111.25, 110.24, 
63.62, 56.71, 56.03, 55.91, 54.85, 54.43, 42.50, 33.91, 33.89, 33.85, 32.19, 27.24. HRMS (ESI-
TOF) m/z: [M+H+] calculated for C24H32NO3, 382.2382; found, 382.2375.  
 
Enantioselective Synthesis of (R)-Tolterodine 
 
Vinyl bromide 6 was prepared from trans-cinnamyl chloride according to literature.35 
1.0 mol % Pd(OAc)2
2.0 mol % PPh3
2.0 equiv KOH













Suzuki coupling: To a oven-dried 100 ml round bottom flask was charged with a stir bar, purged 
with N2 three times then added 11 mg Pd(OAc)2 (0.050 mmol, 1.0 mol %), 26 mg PPh3 (0.10 
mmol, 2.0 mol %), 0.560 g KOH (10 mmol, 2.0 equiv), starting material vinyl bromide (1.48g, 5 
mmol, 1.0 equiv) ,0.996 g (2-methoxy-5-methylphenyl)boronic acid 126 (6.5 mmol, 1.3 equiv) 
and 20 mL THF and 20 mL MeOH. The reaction was stirred at rt overnight followed by dilution 
with EtOAc, and washed by 1 N NaOH solution and brine. Acid-base extraction: the organic 
layer was concentrated in vacuo, re-dissolved in Et2O, and extracted with 3 N HCl solution three 
times. The resulting acidic aqueous layer was then basified by the addition of 5N NaOH solution 
until the pH > 11, followed by the extraction with DCM. The combined organic layers was then 
dried over MgSO4, concentrated in vacuo, purified by Al2O3 column chromatography: 200 g 
Al2O3 + 8 g H2O, 50 : 1 hexanes/ EtOAc with 0.5% MeOH as eluent to afford allylic amine 127 
in 91% isolated yield. For 1n: 1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.26 (m, 2H), 7.24 – 7.19 
(m, 1H), 7.18 – 7.14 (m, 2H), 7.06 – 7.00 (m, 2H), 6.72 (d, J = 8.0 Hz, 1H), 5.89 (t, J = 6.4 Hz, 
1H), 3.51 (s, 3H), 3.28 (d, J = 6.4 Hz, 2H), 3.06 (p, J = 6.5 Hz, 2H), 2.29 (t, J = 0.8 Hz, 3H), 0.96 
(d, J = 6.6 Hz, 12H). 13C NMR (125 MHz, CDCl3) δ: 155.24, 141.08, 138.59, 134.18, 133.49, 
131.64, 129.79, 129.20, 128.69, 127.55, 126.42, 111.95, 55.99, 48.96, 43.99, 20.96, 20.62. The 

















Tolterodine synthesis: [Rh(COD)Cl]2 (4.0 mg, 0.75 mol %), (S)-BINAP (9.6 mg, 1.5 mol %), 
NaBAr4F (12.8 mg, 1.5 mol %), and 1,4-dioxane (0.8 mL) were added to a 20 mL vial equipped 
with a stir bar in the glove box under nitrogen atmosphere. To the vial was added allylic 
diisopropylamine (127, 1.0 mmol, 1.0 equiv). The resulting solution was allowed to stir for 10 h 
at 100 °C. After 10 h, formic acid (3.0 mmol, 3.0 equiv) was added into reaction vial via syringe 
and the reaction was allowed to stir for another 5 h at 100 °C. The reaction crude was then 
diluted in DCM, filtered through basic alumina, and concentrated in vacuo (to get rid of 1,4-
dioxane solvent). The residue was then transferred into another 20 mL vial, followed by the 
addition of HBr solution (2.2 mL, 13.2 equiv) and HOAc (2.0 mL), and allowed to stir at 115 °C 
for 4 h. After 4 h, the reaction crude was then diluted in water, extracted with EtOAc three times. 
Combined organic layers were washed with 1 N NaOH solution three times. The pH of last basic 
wash was verified to be >10. The organic layer was washed with brine, dried over MgSO4, 
concentrated in vacuo and then purified by basic alumina chromatography to afford the desired 
product (R)-Tolterodine in 88% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 5 g H2O, 15 : 1 hexanes/ EtOAc with 
0.5% MeOH to 8 : 1 hexanes/ EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 10.33 (brs, 1H), 7.33 (d, J = 4.3 Hz, 4H), 7.23 (h, J = 4.3 Hz, 
1H), 6.85 (dd, J = 8.2, 2.1 Hz, 1H), 6.80 (d, J = 8.1 Hz, 1H), 6.53 (d, J = 2.5 Hz, 1H), 4.49 (dd, J 
= 11.3, 4.0 Hz, 1H), 3.23 (p, J = 6.7 Hz, 2H), 2.73 (dt, J = 12.7, 3.6 Hz, 1H), 2.50 – 2.25 (m, 2H), 
i) 0.75 mol % [Rh(COD)Cl]2
1.5 mol % (S)-BINAP
1.5 mol % NaBArF4




















2.12 (s, 3H), 2.10 – 2.03 (m, 1H), 1.13 (d, J = 6.7 Hz, 6H), 1.08 (d, J = 6.6 Hz, 6H).  13C NMR 
(125 MHz, CDCl3) δ: 153.34, 144.88, 132.55, 129.53, 128.78, 128.66, 128.42, 127.88, 126.28, 
118.32, 48.03, 42.21, 39.46, 33.37, 20.91, 20.10, 19.69. HRMS (ESI-TOF) m/z: [M+H+] 
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Chapter 3: Hydroaminomethylation of Alkenes by Photoredox Catalysis 
3.1 Introduction 
With annual production on a million-ton scale, aliphatic amines serve as important 
building blocks for the production of agrochemicals, pharmaceuticals, dyes, and functional 
materials.1 Developing efficient, atom-economical, and selective synthetic routes to aliphatic 
amines from feedstock is of great significance and interest for the synthetic community. 
Hydroaminomethylation, the addition of a hydrogen atom and an aminomethyl group across an 
alkene, is a powerful tool for the synthesis of linear aliphatic amines, especially 3,3-
diarypropylamines (pheniramines), which constitute the basic core in many biologically active 
molecules (Scheme 3.1).2,3 
 
Scheme 3.1 Biologically active pheniramines. 
Traditionally, hydroaminomethylation of alkenes is achieved through a domino process 
of hydroformylation and reductive amination by noble metal catalysts in the presence of the 
syngas and amines (Eqn 1, Scheme 3.2). Both Beller and Zhang have developed effective ligand 
scaffolds for the hydroaminomethylation of alkyl alkenes,4 1,1-diaryl alkenes,2,5 and styrenes.6,7 
Despite this great progress, current methods require the usage of pressurized syngas and 






























Scheme 3.2 Literature precedents for hydroaminomethylation. 
substrates.3–7 More recently, Hartwig8,9 and Hou10,11 have identified tantalum and scandium 
catalysts activating 2° and 3° amines to form the corresponding metal η2-imine complexes, 
followed by the addition across alkene to form either branched8-11 or linear10,11 amine products 
(Eqn 2, Scheme 3.2). However, elevated temperature is often required to promote the reactivity, 
leading to poor functional group tolerance for these reactions. These examples represent state-of-
the-art two-electron hydroaminomethylation of alkenes.  
In the past decade, visible light photoredox catalysis has emerged as a powerful tool for 
synthetic organic chemistry.12–14 The precise control of single electron transfer in this system 
makes it extremely appealing for the generation and utilization of the α-amino radicals, since 
these species are more oxidizable compared to the precursor amines and can be rapidly converted 
into iminium ions in the presence of stoichiometric amount of oxidants.15 Several precursors, 
such as α-silyl16,17 and α-boryl17,18 amines, α-amino acids19,20 and tertiary amines21,22 have been 
demonstrated to generate α-amino radicals in the presence of suitable photo-catalysts and visible 
















































unsaturated bonds has been limited to electron deficient alkenes, mostly Michael 
acceptors17,19,21,22 and polarized aldehydes or imines23–25 (Eqn 3, Scheme 3.2). 
To overcome the limitation of current hydroaminomethylation methods, we proposed that 
the α-amino radical generated from α-silyl amine and photo-excited catalyst (PCIII*) would 
undergo radical addition into the alkene to form the more stabilized benzylic radical (Scheme 
3.3). This resulting benzylic radical can be reduced by the photocatalyst (PCII), which upon 
protonation affords the desired γ-branched amine. Considering the mild conditions for 
photoredox catalysis (often at room temperature) and highly regioselective radical addition, this 
proposed reaction would be advantageous in terms of functional group tolerance and 
regioselectivities compared to the two-electron hydroamino-methylation. However, the 
challenges are 1) the unfavorable addition of nucleophilic α-amino radicals into electron-rich 
aryl alkenes, as current radical hydroaminomethylation literatures are only limited to Michael 
acceptors;17,19,21,22 2) the reaction requires rapid reduction of the resulting benzylic radical to 
prevent unproductive radical dimerization, and to turn over the catalyst.  
 








































3.2 Reaction Optimization 
The key for this proposed radical hydroaminomethylation is to find the appropriate 
combination of photocatalyst and proton source to allow both the initial oxidation and benzylic 
radical reduction/protonation to occur. We began our investigation using 1,1-diphenylethylene 
and α-silyl N-methylpiperidine as model substrates with a variety of photocatalysts (PC 1-4) in 
the presence of stoichiometric amount of proton sources (See Table 3.5). These initial results 
indicate that MeOH was superior to H2O, IPA, and HOAc. These photocatalysts were then tested 
under optimized conditions (reaction time, concentration, α-TMS N-methylpiperidine and 
catalyst loading) using methanol as the proton donor (Table 3.1).  
 In this proposed reductive quenching photoredox cycle (Scheme 3.3), we envisioned that 
more oxidizing photocatalyst would initiate the reaction by single electron transfer from α-TMS 
N-methylpiperidine (E1/2 red = +0.71 V vs SCE)16 to the photo-excited catalyst (PCIII*) to generate 
the radical cation. Consistent with this proposal, PC 1, 3, and 4 afforded higher conversion than 
PC 2 (IrIII*/IrII = + 0.31 V vs SCE), with PC 3 and 4 being the optimal (Entries 1-4, Table 3.1). 
Control experiments show that both photocatalyst and light are essential for this transformation 
(Entries 5-6, Table 3.1). Due to the stronger reduction potential (IrII/IrIII) for PC3 compared to 








Table 3.1 Selected optimization for hydroaminomethylation of 1,1-diphenylethelene.a  
 
Entry Photocatalyst Yield b 
1  PC 1 39 
2 PC 2 6 
3 PC 3 90 
4 PC 4 92 
5 none 0 
6d PC 3 0 
 
 
a Standard conditions are alkene (0.1 mmol, 1.0 equiv), amine (1.1 equiv), photocatalyst (0.5 mol %), proton source 
(2.0 equiv), DMF (1.0 mL, 0.1 M), rt, blue LED light. b In situ yield determined by GC analysis. c All potentials are 
given versus the saturated calomel electrode (SCE), see reference 12. d Reaction run in dark.  
 
3.3 Substrate Scope 
With the optimized conditions in hand, the amine scope for this transformation was first 
investigated. As shown in Table 3.2, α-TMS amines derived from 2° cyclic amines such as 
piperidine (131), N-Boc piperazine (132), 1-methyl-1,4-diazepane (133), 2-(piperazin-1-yl) 
pyrimidine (134), proline benzyl ester (135), as well as acylic dibenzylamine (136) all afforded 







0.5 mol % PC
2.0 equiv H+





































PC 1: [Ru(bpy)3](PF6)2 PC 2: fac-Ir(ppy)3 PC 3: [Ir(ppy)2(dtbbpy)]PF6 PC 4: [Ir(dF(CF3)ppy)2(dtbbpy)]PF6
RuII*/RuI = + 0.77 V
RuI/RuII = - 1.33 V
IrIII*/IrII = + 0.31 V
IrII/IrIII = - 2.19 V
IrIII*/IrII = + 0.66 V
IrII/IrIII = - 1.51 V
IrIII*/IrII = + 1.21 V
IrII/IrIII = - 1.37 V
c c c c
 163 



































135, 88%, 3h 137, 85%, 3h136, 95%, 3h 138, 80%, 10h
Ar + TMS N
R2
R1
0.5 mol % PC 3
1.0 equiv 1.1 equiv
2.0 equiv MeOH






R3 R3 = R4 = p-F     
R3 = R4 = p-MeO
R3 = H, R4 = p-CF3     































148, 57%, 24h 149, 31%, 24h
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150, 47%, 4h c
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(±)-154, 54%, 24 h (±)-155, 80%, 4 h (±)-156, 72%, 24 h
 164 
Table 3.2 Continued.  
 
a Standard conditions are alkene (0.2 mmol, 1.0 equiv), amine (1.1 equiv), photocatalyst PC 3 (0.5 mol %), DMF 
(1.0 mL, 0.1 M), rt, blue LED light. b 2.0 equiv amine used. c 1.0 equiv amine and 2.0 equiv alkene used.  
 
including Boc-protected amine, basic tertiary amine, pyrimidine and α-amino ester. Secondary α-
TMS amines (137, 138), more challenging substrate as a result of their higher reduction potential 
compared to tertiary ones, also proved to be effective under standard condition to give the 2° 
amine product in yields of 85% and 80% with the N-H bond untouched.  
For the alkene scope, different electronic properties on 1,1-diaryl alkenes were tested. 
Electron-rich alkenes such as 4,4’-dimethoxylphenyl alkene require longer reaction time (24 
hours) to reach completion (140) with diminished yield (69%); however, hydroaminomethylation 
of electron-poor 4,4’-difluorophenyl alkene (139) only took 2 hours for full conversion with 84% 
isolated yield. Various styrene derivatives were then examined. Arenes bearing electron-
withdrawing groups such as fluoro and bromo (143), trifluoromethyl (144), ketone (145), as well 
as electron-donating methyl (147) and methoxy (148, 149) groups all afforded amine products 
with moderate to excellent yields (31-84%). Heterocycles, such as thiazole (150) and pyridine 
(ortho, meta, and para, 151-153) were well tolerated under standard conditions for the synthesis 
of either secondary or tertiary amine products. Moreover, aryl, alkyl-disubstituted alkenes were 





















Finally, aryl alkenes derived from natural products, such as tryptamine (157) and mycophenolic 
acid (158), were reactive under standard conditions to form the desired products with many 
functional groups like 2° amide, indole, ester, lactone, and internal alkene unaffected. 
Table 3.3 Substrate scope for hydroaminomethylation using tertiary amine.a  
 
a Standard conditions are alkene (0.2 mmol, 1.0 equiv), amine (2.0 equiv), photocatalyst PC 4 (0.5 mol %), DMF 
(0.5 mL, 0.1 M), rt, blue LED light. b Me3N•HCl (3.0 equiv) and DBU (3.0 equiv) were used.  
 
When strong oxidizing catalyst PC 4 was applied, tertiary amines can be directly 
oxidized, then fragment to form the α-amino radical at the most accessible α position.15 Under 
slightly modified conditions, tertiary aliphatic amines such as diisopropylmethyl amine (159), 
diisopropylethyl amine (Hünig’s base, (±)-160), trimethyl amine (161), dicyclohexylmethyl 
amine ((±)-163), as well as aromatic dimethyl (162) and cyclic (164) anilines, all afford the 
desired products with good yields. Notably biologically active diisopromine (159), pheniramine 
((±)-165), and tolpropamine ((±)-166) were synthesized using this method with great efficiency. 
The direct application of commercially available tertiary amines in this transformation 




0.5 mol % PC 4
1.0 equiv 2.0 equiv












































α-TMS diisopropyl or dimethyl amines and the ones with α-substitution, are very challenging. 
Instead, the corresponding tertiary amine precursors are often easily accessible.  
 
3.4 Synthetic Application 
This visible light-mediated hydroaminomethylation was then applied in the synthesis of 
bioactive compounds containing γ-diaryl amine motifs, a well-known first-generation family of 
H1 antihistaminic agent.2 Starting from readily available α-TMS amine, synthesized from 
nucleophilic substitution of (chloromethyl)trimethylsilane with free amine, several γ-diphenyl 
amines were obtained in excellent yield (>80%) in gram-scale with only 0.1 mol % catalyst 
loading, demonstrating the great synthetic potential of this method. It is worth noting that 
Phenpyramine, challenging substrate in Beller’s rhodium-catalyzed hydroaminomethylation 
(35% yield),2 was synthesized in 87% yield at room temperature.  
Table 3.4 Scale-up synthesis of pheniramines.a  
 
a Standard conditions are alkene (1.0 equiv), amine (1.05 equiv), photocatalyst PC 3 (0.1 mol %), DMF (0.1 M), rt, 























1.0 equiv 1.05 equiv
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0.1 mol % PC 3
2.0 equiv MeOH













3.5 Experimental Procedures  
General procedure for substrate synthesis 
Unless prepared according to the following procedure, alkene substrates were distilled after 
received from commercial sources. 
 
Procedure: To a dry 100 mL three-neck flask was charged with a stir bar and 5.4 g Ph3PCH3Br 
(15 mmol, 2.5 equiv) purged with nitrogen followed by the addition of 30 mL dry THF. Cooled 
to 0 °C, 1.68 g tBuOK (15 mmol, 2.5 equiv) was added under nitrogen flow in one portion. The 
reaction was allowed to stir at 0 °C for 30 min followed by the slow addition of the aldehyde or 
ketone (6.0 mmol, 1.0 equiv). The reaction flask was then warmed up to rt and stir overnight. 
The reaction was quenched by water and extracted with EtOAc three time, then the combined 
organic layers were washed with brine, dried by MgSO4, concentrated in vacuo, and purified by 
flash column chromatography on silica gel to afford the desire alkenes.  
 
4,4'-(ethene-1,1-diyl)bis(fluorobenzene): prepared according to previously 
described procedure in 79% yield. 
Column Chromatography Condition: 30 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 7.37 – 7.28 (m, 4H), 7.05 (t, J = 8.7 Hz, 4H), 5.41 (s, 2H).  13C 
NMR (125 MHz, CDCl3) δ: 162.71 (d, J = 247.0 Hz), 148.20, 137.51 (d, J = 3.3 Hz), 129.95 (d, 
J = 8.0 Hz), 115.27 (d, J = 21.4 Hz), 114.28.  19F NMR (471 MHz, CDCl3) δ: -114.40 – -114.53 









4,4'-(ethene-1,1-diyl)bis(methoxybenzene): prepared according to 
previously described procedure in 92% yield. 
Column Chromatography Condition: 4 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 7.40 – 7.16 (m, 4H), 6.96 – 6.66 (m, 4H), 
5.30 (d, J = 1.3 Hz, 2H), 3.83 (d, J = 1.2 Hz, 6H).  13C NMR (125 MHz, CDCl3) δ: 159.44, 
149.12, 134.46, 129.57, 113.63, 111.81, 55.45.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C16H17O2, 241.1229; found, 241.1222.  
 
1-methoxy-4-(1-phenylvinyl)benzene: prepared according to previously 
described procedure in 76% yield. 
Column Chromatography Condition: 10 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 7.37 – 7.31 (m, 5H), 7.30 – 7.26 (m, 2H), 6.91 – 6.84 (m, 2H), 
5.40 (d, J = 1.3 Hz, 1H), 5.36 (d, J = 1.3 Hz, 1H), 3.83 (s, 3H).  13C NMR (125 MHz, CDCl3) δ: 
159.40, 149.58, 141.91, 134.07, 129.52, 128.44, 128.25, 127.78, 113.61, 113.13, 55.44.  HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C15H15O, 211.1123; found, 211.1123.  
 
1-methoxy-3-vinylbenzene: prepared according to previously described 
procedure in 61% yield after distillation. 
Column Chromatography Condition: 8 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 7.25 (t, J = 7.9 Hz, 1H), 7.02 (dt, J = 7.6, 1.2 Hz, 1H), 6.96 (dd, J 
= 2.6, 1.5 Hz, 1H), 6.82 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 6.70 (dd, J = 17.6, 10.8 Hz, 1H), 5.75 





CDCl3) δ: 159.95, 139.18, 136.92, 129.63, 119.05, 114.26, 113.58, 111.67, 55.37.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C9H11O, 135.0810; found, 135.0807.  
 
1-methoxy-2-vinylbenzene: prepared according to previously described 
procedure in 84% yield. 
Column Chromatography Condition: 8 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 7.48 (dd, J = 7.6, 1.7 Hz, 1H), 7.25 (ddd, J = 8.3, 7.3, 1.7 Hz, 
1H), 7.07 (dd, J = 17.8, 11.1 Hz, 1H), 6.99 – 6.92 (m, 1H), 6.88 (dd, J = 8.3, 1.1 Hz, 1H), 5.75 
(dd, J = 17.8, 1.5 Hz, 1H), 5.28 (dd, J = 11.2, 1.5 Hz, 1H), 3.86 (s, 3H).  13C NMR (125 MHz, 
CDCl3) δ: 156.87, 131.82, 128.97, 126.92, 126.67, 120.75, 114.58, 110.98, 55.61.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C9H11O, 135.0810; found, 135.0814.  
 
2-(1-phenylvinyl)pyridine: prepared according to previously described 
procedure in 64% yield. 
Column Chromatography Condition: 4 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 8.65 (ddd, J = 4.9, 2.0, 1.0 Hz, 1H), 7.63 (td, J = 7.7, 1.8 Hz, 
1H), 7.40 – 7.31 (m, 5H), 7.30 – 7.24 (m, 2H), 7.21 (ddd, J = 7.4, 4.8, 1.2 Hz, 1H), 6.09 – 5.94 
(m, 1H), 5.72 – 5.54 (m, 1H).  13C NMR (125 MHz, CDCl3) δ: 158.69, 149.54, 149.34, 140.53, 
136.40, 128.57, 128.43, 127.96, 122.97, 122.56, 117.84. HRMS (ESI-TOF) m/z: [M+H+] 





1-methyl-4-(1-phenylvinyl)benzene: prepared according to previously described 
procedure in 77% yield. 
Column Chromatography Condition: 99 : 1 hexane/EtOAc 
1H NMR (500 MHz, CDCl3) δ: 7.38 – 7.28 (m, 5H), 7.24 (d, J = 7.9 Hz, 2H), 7.15 (d, J = 7.9 
Hz, 2H), 5.44 (d, J = 1.1 Hz, 1H), 5.41 (d, J = 1.3 Hz, 1H), 2.37 (s, 3H).  13C NMR (125 MHz, 
CDCl3) δ: 150.06, 141.84, 138.76, 137.65, 129.00, 128.43, 128.29, 128.25, 127.77, 113.76, 
21.32.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H14, 194.1096; found, 194.1093.  
 
 
Procedure: A dry 100 mL schlenk flask was charged with a stir bar, then purged with nitrogen 
followed by the addition of 50 mL dry THF and 1.4 mL HN(iPr)2 (10 mmol, 1.0 equiv). Cooled 
to -78 °C, n-BuLi solution (10 mmol, 1.0 equiv) was added slowly into the flask. The reaction 
was then warmed up to room temperature and allowed to stir for 10 min. 3.57 g PPh3MeBr (10 
mmol, 1.0 equiv) was then added into the reaction in one portion under N2 flow at   0 °C and the 
resulting crude was stirred at 0 °C for another 1 hour. After 1 hour, the reaction was cooled to -
78 °C followed by the slow addition of 0.94 mL nicotinaldehyde (10 mmol, 1.0 equiv), and 
warmed up to room temperature and allowed to stir overnight. The reaction was quenched by the 
addition of 50 mL water and extracted with Et2O three time, then the combined organic layers 
were dried by MgSO4, concentrated in vacuo, and purified by flash column chromatography on 
silica gel (1:1 hexanes/Et2O as eluent) to afford the desire alkene. (Caution: product is volatile, 









3-vinylpyridine: prepared according to previously described procedure in 75% 
yield (with some Et2O and hexane residues) 
Column Chromatography Condition: 1:1 hexane / Et2O 
1H NMR (500 MHz, CDCl3) δ: 8.61 (d, J = 2.3 Hz, 1H), 8.48 (dd, J = 4.8, 1.6 Hz, 1H), 7.72 (dt, 
J = 7.9, 2.0 Hz, 1H), 7.27 – 7.20 (m, 1H), 6.70 (dd, J = 17.7, 11.0 Hz, 1H), 5.82 (dd, J = 17.6, 0.7 
Hz, 1H), 5.37 (dd, J = 11.0, 0.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ: 149.03, 148.43, 
133.61, 133.15, 132.74, 123.52, 116.32.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C7H8N, 
106.0657; found, 106.0658.  
 
 
Procedure: A 100 mL round-bottom-flask was charged with a stir bar, 1.48 g 4-vinylbenzoic 
acid (10 mmol, 1.0 equiv), 1.78 g carbonyldiimidazole (11 mmol, 1.1 equiv) and 10 mL DCM. 
The mixture was then stirred at room temperature for 15 min until no gas formation.  1.68 g 
tryptamine (10.5 mmol, 1.05 equiv) was added into reaction in one portion. After 12 hours, the 
reaction crude was diluted in DCM and washed with 1 M HCl solution three times and 1M 
NaOH solution once. The organic layer was dried by MgSO4, concentrated in vacuo, and re-
crystalized in DCM to afford the white solid as pure product.  
N-(2-(1H-indol-3-yl)ethyl)-4-vinylbenzamide: prepared according to 














1H NMR (500 MHz, CDCl3) δ: 8.12 (brs, 1H), 7.76 – 7.58 (m, 3H), 7.48 – 7.34 (m, 3H), 7.23 
(ddd, J = 8.2, 7.0, 1.1 Hz, 1H), 7.14 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 7.07 (d, J = 2.3 Hz, 1H), 6.72 
(dd, J = 17.6, 10.9 Hz, 1H), 6.21 (brs, 1H), 5.81 (dd, J = 17.6, 0.8 Hz, 1H), 5.41 – 5.22 (m, 1H), 
3.81 (q, J = 6.4 Hz, 2H), 3.11 (t, J = 6.6 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ: 167.21, 
140.62, 136.60, 136.07, 133.84, 127.46, 127.28, 126.38, 122.39, 122.27, 119.67, 118.87, 115.96, 
113.12, 111.46, 40.45, 25.44. HRMS (ESI-TOF) m/z: [M+H+] calculated for C19H19N2O, 
291.1497; found, 291.1491.  
 
 
Esterification: A 100 mL round-bottom-flask was charged with a stir bar, 6.41 g mycophenolic 
acid (20 mmol, 1.0 equiv), 0.76 g TsOH•H2O (4 mmol, 20 mol %) and 40 mL MeOH. The 
mixture was then stirred at room temperature overnight.  The reaction crude was concentrated in 
vacuo to remove MeOH, then diluted in EtOAc and washed with sat. NaHCO3 solution three 
times. The organic layer was dried by MgSO4, concentrated in vacuo to afford the white solid as 
pure product in 94% yield.  
CDI Coupling: Same procedure as previously described.  
1H NMR (500 MHz, CDCl3) δ: 8.16 (d, J = 8.4 Hz, 2H), 7.53 (d, 
J = 8.4 Hz, 2H), 6.79 (dd, J = 17.6, 10.9 Hz, 1H), 5.91 (d, J = 
17.6 Hz, 1H), 5.42 (d, J = 10.9 Hz, 1H), 5.17 (s, 2H), 5.16 – 5.12 
























6.5 Hz, 2H), 1.60 (s, 3H).  13C NMR (125 MHz, CDCl3) δ: 173.82, 168.14, 164.37, 162.74, 
146.34, 146.31, 142.90, 136.15, 134.74, 130.88, 129.58, 128.04, 126.44, 123.17, 122.33, 117.06, 
114.01, 68.42, 61.39, 51.62, 34.52, 32.76, 23.87, 16.35, 11.95. 
 
Unless prepared according to the following procedure, α-silyl amine substrates were used 
directly from commercial sources. 
 
Procedure: A dry 100 mL round-bottom-flask was charged with a stir bar, 
(chloromethyl)trimethylsilane (20 mmol, 1.0 equiv), piperidine (40 mmol, 2.0 equiv), and 30 mL 
DMF. The flask was then heated up to 90 °C under N2 atmosphere overnight. The reaction was 
quenched by the addition of 30 mL H2O, and extracted with Et2O five times. The combined 
organic layers were washed with H2O twice and brine once, then dried by MgSO4, concentrated 
in vacuo, and purified by fractional distillation to afford the colorless liquid in 70 % yield.  
1-((trimethylsilyl)methyl)piperidine: prepared according to previously 
described procedure. 
1H NMR (500 MHz, CDCl3) δ: 2.31 (brs, 4H), 1.88 (s, 2H), 1.55 (p, J = 5.6 Hz, 4H), 1.43 – 1.29 
(m, 2H), 0.05 (s, 9H). 13C NMR (125 MHz, CDCl3) δ: 58.61, 51.88, 26.38, 23.95, -0.85. HRMS 











Procedure: A dry 50 mL round-bottom-flask was charged with a stir bar, 
(chloromethyl)trimethylsilane (13 mmol, 1.3 equiv), amine (10 mmol, 1.0 equiv), NaI(0.1 mmol, 
1 mol %), Et3N (20 mmol, 2.0 equiv) and 10 mL DMF. The flask was then heated up to 90 °C 
under N2 atmosphere overnight. The reaction was quenched by the addition of 30 mL H2O, and 
extracted with EtOAc three times. The combined organic layers were washed with H2O twice 
and brine once, then dried by MgSO4, concentrated in vacuo, and purified by basic alumina 
chromatography to afford the desired product.  
 
 tert-butyl 4-((trimethylsilyl)methyl)piperazine-1-carboxylate: Prepared 
according to previously described procedure in 84% isolated yield.  
Column Chromatography Condition: 300 g Al2O3 + 14 g H2O, 30 : 1 hexanes/EtOAc with 
0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent.  
1H NMR (500 MHz, CDCl3) δ: 3.48 – 3.32 (m, 4H), 2.32 (t, J = 5.4 Hz, 4H), 1.90 (s, 2H), 1.45 
(s, 9H), 0.05 (s, 9H).  13C NMR (125 MHz, CDCl3) δ: 154.89, 79.51, 56.77, 50.97, 43.90, 28.56, 
-1.10. HRMS (ESI-TOF) m/z: [M+H+] calculated for C13H29N2O2Si, 273.1998; found, 273.2006.  
 
1-methyl-4-((trimethylsilyl)methyl)-1,4-diazepane: Prepared according 
to previously described procedure, purified by fractional distillation to 








1.3 equiv 1.0 equiv
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1H NMR (500 MHz, CDCl3) δ: δ 2.71 – 2.65 (m, 4H), 2.64 – 2.54 (m, 4H), 2.34 (s, 3H), 2.06 (s, 
2H), 1.77 (dq, J = 7.0, 5.8 Hz, 2H), 0.04 (s, 9H). 13C NMR (125 MHz, CDCl3) δ: 58.84, 58.36, 
57.83, 57.12, 51.26, 47.18, 27.40, -1.10. HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C10H25N2Si, 201.1787; found, 201.1787.  
 
2-(4-((trimethylsilyl)methyl)piperazin-1-yl)pyrimidine: Prepared 
according to previously described procedure in 71% isolated yield.  
Column Chromatography Condition: 200 g Al2O3 + 12 g H2O, 30 : 1 
hexanes/EtOAc with 0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.29 (d, J = 4.7 Hz, 2H), 6.45 (t, J = 4.7 Hz, 1H), 4.12 – 3.54 (m, 
4H), 2.77 – 2.28 (m, 4H), 1.94 (s, 2H), 0.08 (s, 9H).  13C NMR (125 MHz, CDCl3) δ: 161.73, 
157.83, 109.76, 56.88, 51.07, 43.97, -1.00.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C12H23N4Si, 251.1692; found, 251.1688.  
 
Benzyl ((trimethylsilyl)methyl)-L-prolinate: Prepared according to 
previously described procedure in 46% isolated yield.  
Column Chromatography Condition: silica, 10 : 1 to 6 : 1 hexanes/EtOAc as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.38 – 7.29 (m, 5H), 5.20 (d, J = 12.3 Hz, 1H), 5.11 (d, J = 12.3 
Hz, 1H), 3.10 (ddd, J = 7.8, 6.3, 3.7 Hz, 2H), 2.33 (q, J = 8.0 Hz, 1H), 2.31 (d, J = 13.9 Hz, 1H), 
2.15 – 2.03 (m, 1H), 1.98 – 1.86 (m, 2H), 1.82 (d, J = 14.0 Hz, 1H) 1.81 – 1.74 (m, 1H), 0.03 (s, 




56.10, 46.00, 29.01, 23.65, -1.29.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C16H26NO2Si, 
292.1733; found, 292.1726.  
 
N,N-dibenzyl-1-(trimethylsilyl)methanamine: Prepared according to 
previously described procedure with 2.0 equiv of (chloromethyl)trimethylsilane 
in 57% isolated yield.  
Column Chromatography Condition: silica, 99 : 1 hexanes/EtOAc as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.42 – 7.36 (m, 4H), 7.31 (dd, J = 8.3, 6.8 Hz, 4H), 7.25 – 7.20 
(m, 2H), 3.47 (s, 4H), 1.94 (s, 2H), 0.04 (s, 9H). 13C NMR (125 MHz, CDCl3) δ: 140.45, 128.82, 
128.26, 126.83, 62.06, 46.00, -1.10. HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H26NSi, 
284.1835; found, 284.1824.  
 
N-((trimethylsilyl)methyl)cyclohexanamine: Prepared according to 
previously described procedure, purified by fractional distillation to afford 
product in 60% yield.  
1H NMR (500 MHz, CDCl3) δ: 2.26 (tt, J = 10.5, 3.7 Hz, 1H), 2.06 (s, 2H), 1.94 – 1.82 (m, 2H), 
1.72 (dt, J = 12.8, 3.6 Hz, 2H), 1.60 (ddt, J = 12.2, 5.0, 2.7 Hz, 1H), 1.33 – 1.08 (m, 3H), 1.08 – 
0.96 (m, 2H), 0.57 (brs, 1H), 0.03 (s, 9H).  13C NMR (125 MHz, CDCl3) δ: 60.87, 37.16, 33.29, 






1-((trimethylsilyl)methyl)azepane: Prepared according to previously 
described procedure, purified by fractional distillation to afford product in 68% 
yield.  
1H NMR (500 MHz, CDCl3) δ: 2.72 – 2.51 (m, 4H), 2.07 (s, 2H), 1.73 – 1.49 (m, 8H), 0.05 (s, 
9H).  13C NMR (125 MHz, CDCl3) δ: 59.56, 50.72, 27.80, 27.23, -1.02. HRMS (ESI-TOF) m/z: 








Reaction Set-up for Photoredox Catalysis 
The photo-reactor consists of an 
ABI 24W blue LED grow light 
(purchased from Amazon), a clip fan, a 
Fisher stir plate, contained in a housing 
made out of a plastic sharp container (8 
gallons, 30 ×25×35 cm). Three 20×20 
cm windows were cut out at front, left, 
and right sides of the sharp container 
using a razor blade or scissors. As shown 
in the pictures, the modified housing is 
put upside down on the Fisher stir plate 
with a window facing front for loading 
samples. The blue LED light and clip fan 
are stuck into the container through the 
side windows, and supported by the 
clamps. A 10×10 cm platform is made out of cardboard, wrapped with aluminum foil, and 
covered with transparent tape to help holding the reaction vials. The front window is cover with 
a foldable cardboard. 
The photoreactions are set-up in 4 mL vials (Chemglass, CG-4904-05) and placed on the 
platform, about 5-8 cm away from the LED light and 15-20 cm from the clip fan. The 




Image 3.1 Photo-reactor set-ups 
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Selected Optimization Tables 
Table 3.5 Screening of photocatalysts and proton sources for hydroaminomethylation. a   
 
Entry Photocatalyst Proton Source H+ Yield b 
1  PC 4 H2O 22 
2 PC 4 MeOH 46 
3 PC 4 IPA 40 
4 PC 4 HOAc 45 
5 PC 1 MeOH 32 
6 PC 1 HOAc 12 
7 PC 2 MeOH 8 
8 PC 2 HOAc 11 
9 PC 3 MeOH 75 
10 PC 3 HOAc 61 
 
a Standard conditions are alkene (0.1 mmol, 1.0 equiv), amine (1.5 equiv), photocatalyst (2.0 mol %), proton source 
















2 mol % PC
2.0 equiv proton source






General procedure for hydroaminomethylation of alkenes  
 
General procedure A: [Ir(ppy)2(dtbbpy)]PF6 (PC 3, 0.9 mg, 0.001 mmol, 0.5 mol %), alkene 
(0.2 mmol, 1.0 equiv), α-TMS amine (0.22 mmol, 1.1 equiv), and DMF (2.0 mL) were added to 
a 4 mL vial equipped with a stir bar in the glove box under nitrogen atmosphere. The vial was 
then taken out of glove box and injected 8 uL MeOH (0.4 mmol, 2.0 equiv). The resulting 
solution was allowed to stir inside the photo-reactor (described above) with the lamp and fan on 
for 2 to 24 hours. The reaction crude was quenched by the addition of DCM, concentrated in 
vacuo and then purified by basic alumina chromatography to afford the desired product. 
 
 
General procedure B: [Ir(dF(CF3)ppy)2(dtbbpy)]PF6 (PC 4, 1.2 mg, 0.001 mmol, 0.5 mol %), 
alkene (0.2 mmol, 1.0 equiv), tertiary amine (0.4 mmol, 2.0 equiv), and DMF (1.0 mL) were 
added to a 4 mL vial equipped with a stir bar in the glove box under nitrogen atmosphere. The 
vial was then taken out of glove box and allowed to stir inside the photo-reactor (described 
above) with the lamp and fan on for 24 hours. The reaction crude was quenched by the addition 
of DCM, concentrated in vacuo and then purified by basic alumina chromatography to afford the 
desired product. 
 
Ar + TMS N
R2
R1
0.5 mol % PC 3
1.0 equiv 1.1 equiv
2.0 equiv MeOH








0.5 mol % PC 4
1.0 equiv 2.0 equiv








1-(3,3-diphenylpropyl)piperidine (131, Table 3.2): Prepared according to 
General procedure A for 2 hours in 90% isolated yield.  
Column Chromatography Condition: 100 g Al2O3 + 4.5 g H2O, 50 : 1 
hexanes/EtOAc with 0.5% MeOH eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.21 (m, 8H), 7.20 – 7.13 (m, 2H), 3.95 (t, J = 7.0 Hz, 
1H), 2.34 (br, 4H), 2.29 – 2.19 (m, 4H), 1.57 (p, J = 5.7 Hz, 4H), 1.47 – 1.35 (m, 2H).  13C NMR 
(125 MHz, CDCl3) δ: 145.13, 128.54, 128.00, 126.22, 57.98, 54.86, 49.55, 32.99, 26.20, 24.65. 
HRMS (ESI-TOF) m/z: [M+H+] calculated for C20H26N, 280.2065; found, 280.2065.  
 
tert-butyl 4-(3,3-diphenylpropyl)piperazine-1-carboxylate (132, 
Table 3.2): Prepared according to General procedure A for 2 hours in 
95% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/EtOAc with 
0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.21 (m, 8H), 7.20 – 7.14 (m, 2H), 4.00 (t, J = 7.2 Hz, 
1H), 3.53 – 3.33 (m, 4H), 2.40 – 2.30 (m, 4H), 2.30 – 2.18 (m, 4H), 1.45 (s, 9H).  13C NMR (125 
MHz, CDCl3) δ: 154.88, 144.88, 128.60, 127.96, 126.33, 79.71, 56.96, 53.20, 49.14, 32.79, 
28.58.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C24H33N2O2, 381.2542; found, 381.2553.  
 
1-(3,3-diphenylpropyl)-4-methyl-1,4-diazepane (133, Table 3.2): Pre-





Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 15 : 1 hexanes/EtOAc with 
0.5% MeOH to 8 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.22 (m, 8H), 7.21 – 7.13 (m, 2H), 4.02 (t, J = 7.7 Hz, 
1H), 2.70 – 2.65 (m, 4H), 2.65 – 2.61 (m, 2H), 2.61 – 2.55 (m, 2H), 2.41 (dd, J = 8.6, 6.0 Hz, 
2H), 2.35 (s, 3H), 2.21 (q, J = 7.5 Hz, 2H), 1.79 (p, J = 6.0 Hz, 2H). 13C NMR (125 MHz, 
CDCl3) δ: 145.16, 128.54, 128.03, 126.21, 58.34, 57.09, 56.87, 54.93, 54.42, 49.05, 47.26, 33.68, 
27.65.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H29N2, 309.2331; found, 309.2323.  
 
2-(4-(3,3-diphenylpropyl)piperazin-1-yl)pyrimidine (134,Table 3.2)  
Prepared according to General procedure A for 2 hours in 91% isolated 
yield. 
Column Chromatography Condition: 100 g Al2O3 + 4.5 g H2O, 15 : 1 hexanes/EtOAc with 
0.5% MeOH to 8 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.29 (d, J = 4.7 Hz, 2H), 7.31 – 7.26 (m, 7H), 7.26 – 7.24 (m, 
1H), 7.21 – 7.15 (m, 2H), 6.47 (t, J = 4.7 Hz, 1H), 4.01 (t, J = 7.1 Hz, 1H), 3.82 (dd, J = 6.2, 4.0 
Hz, 4H), 2.52 – 2.43 (m, 4H), 2.36 – 2.24 (m, 4H). 13C NMR (125 MHz, CDCl3) δ: 161.74, 
157.83, 144.89, 128.60, 127.95, 126.33, 109.92, 57.13, 53.32, 49.23, 43.82, 32.86. HRMS (ESI-
TOF) m/z: [M+H+] calculated for C23H27N4, 359.2236; found, 359.2236.  
 
Benzyl (3,3-diphenylpropyl)-L-prolinate (135, Table 3.2): Prepared 




Column Chromatography Condition: 100 g Al2O3 + 8 g H2O, 30 : 1 hexanes/EtOAc with 
0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.37 – 7.32 (m, 3H), 7.31 – 7.27 (m, 5H), 7.26 (s, 1H), 7.25 – 
7.22 (m, 4H), 7.20 – 7.15 (m, 2H), 5.11 (d, J = 12.4 Hz, 1H), 5.08 (d, J = 12.3 Hz, 1H), 3.97 (t, J 
= 7.7 Hz, 1H), 3.25 – 3.13 (m, 2H), 2.65 (dt, J = 11.7, 7.5 Hz, 1H), 2.45 – 2.32 (m, 2H), 2.27 (q, 
J = 7.7 Hz, 2H), 2.16 – 2.04 (m, 1H), 2.01 – 1.89 (m, 2H), 1.86 – 1.76 (m, 1H).  13C NMR (125 
MHz, CDCl3) δ: 174.34, 144.94, 144.85, 136.03, 128.65, 128.55, 128.39, 128.32, 128.00, 
127.87, 126.25, 126.23, 66.41, 66.05, 53.76, 53.55, 49.19, 34.63, 29.51, 23.41.  HRMS (ESI-
TOF) m/z: [M+H+] calculated for C27H30N4O2, 400.2277; found, 400.2278.  
 
N,N-dibenzyl-3,3-diphenylpropan-1-amine (136, Table 3.2): Prepared 
according to General procedure A for 2 hours in 95% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 4.5 g H2O, 60 : 1 
hexanes/EtOAc with 0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.27 (m, 5H), 7.27 – 7.25 (m, 2H), 7.25 – 7.23 (m, 1H), 
7.22 – 7.16 (m, 6H), 7.13 – 7.07 (m, 6H), 3.93 (t, J = 7.6 Hz, 1H), 3.53 (s, 4H), 2.41 (dd, J = 8.2, 
6.0 Hz, 2H), 2.24 (td, J = 8.0, 6.0 Hz, 2H).  13C NMR (125 MHz, CDCl3) δ: 145.06, 139.81, 
128.95, 128.48, 128.27, 127.93, 126.87, 126.10, 58.41, 51.73, 48.84, 33.32.  HRMS (ESI-TOF) 
m/z: [M+H+] calculated for C29H30N, 392.2378; found, 392.2372.  
 
N-benzyl-3,3-diphenylpropan-1-amine (137, Table 3.2): Prepared 




Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 15 : 1 hexanes/EtOAc with 
0.5% MeOH to 8 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.34 – 7.20 (m, 13H), 7.20 – 7.15 (m, 2H), 4.04 (t, J = 7.8 Hz, 
1H), 3.73 (s, 2H), 2.62 (t, J = 7.2 Hz, 2H), 2.27 (q, J = 7.4 Hz, 2H), 1.37 (brs, 1H).  13C NMR 
(125 MHz, CDCl3) δ: 144.95, 140.56, 128.58, 128.49, 128.19, 127.97, 127.00, 126.29, 54.07, 
49.15, 47.90, 36.02.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C22H24N, 302.1909; found, 
302.1918.  
 
N-(3,3-diphenylpropyl)cyclohexanamine (138, Table 3.2): Prepared 
according to General procedure A for 10 hours in 80% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 15 : 1 
hexanes/EtOAc with 0.5% MeOH to 8 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.32 – 7.22 (m, 8H), 7.21 – 7.13 (m, 2H), 3.99 (t, J = 7.8 Hz, 
1H), 2.59 (dd, J = 8.4, 6.5 Hz, 2H), 2.35 (tt, J = 10.6, 3.8 Hz, 1H), 2.30 – 2.19 (m, 2H), 1.84 – 
1.76 (m, 2H), 1.68 (dt, J = 13.0, 3.4 Hz, 2H), 1.63 – 1.52 (m, 1H), 1.25 – 1.08 (m, 3H), 1.06 – 
0.94 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 144.87, 128.57, 127.89, 126.29, 56.88, 49.45, 
45.46, 36.05, 33.44, 26.20, 25.16.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H28N, 
294.2222; found, 294.2225.  
 
1-(3,3-bis(4-fluorophenyl)propyl)piperidine(139, Table 3.2):Prepared 
according to General procedure A for 2 hours in 84% isolated yield. 




hexanes/EtOAc with 0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.20 – 7.13 (m, 4H), 6.99 – 6.92 (m, 4H), 3.94 (t, J = 7.5 Hz, 
1H), 2.42 – 2.25 (m, 4H), 2.23 – 2.15 (m, 4H), 1.57 (p, J = 5.6 Hz, 4H), 1.47 – 1.35 (m, 2H). 13C 
NMR (125 MHz, CDCl3) δ: 161.46 (d, J = 244.4 Hz), 140.64 (d, J = 3.1 Hz), 129.26 (d, J = 7.8 
Hz), 115.36 (d, J = 21.1 Hz), 57.64, 54.86, 47.81, 33.26, 26.19, 24.61. 19F NMR (471 MHz, 




141, Table 3.2): Pre-pared according to General procedure A for 2 
hours in 80% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 4 g H2O, 50 : 1 
hexanes/EtOAc with 0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.52 (d, J = 8.1 Hz, 2H), 7.36 (d, J = 8.1 Hz, 2H), 7.32 – 7.27 
(m, 2H), 7.25 – 7.16 (m, 3H), 4.04 (t, J = 7.3 Hz, 1H), 2.58 – 2.11 (m, 8H), 1.57 (p, J = 5.6 Hz, 
4H), 1.46 – 1.36 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 149.18, 144.00, 128.74, 128.49 (q, J 
= 32.3 Hz), 128.29, 127.93, 126.63, 125.50 (q, J = 3.9 Hz), 124.37 (q, J = 272.0 Hz), 57.59, 
54.80, 49.22, 32.68, 26.09, 24.55.  19F NMR (471 MHz, CDCl3) δ: -62.32.  HRMS (ESI-TOF) 





3.2): Prepared according to General procedure A for 8 hours in 85% 
isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 7 g H2O, 30 : 
1 hexanes/EtOAc with 0.5% MeOH to 15:1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.30 – 7.19 (m, 4H), 7.19 – 7.12 (m, 3H), 6.85 – 6.77 (m, 2H), 
3.90 (t, J = 3.7 Hz, 1H), 3.77 (s, 3H), 2.44 – 2.26 (m, 3H), 2.26 – 2.19 (m, 4H), 1.57 (p, J = 5.6 
Hz, 4H), 1.46 – 1.35 (m, 2H), 1.28 – 1.26 (m, 1H).  13C NMR (125 MHz, CDCl3) δ: 157.92, 
145.49, 137.23, 128.84, 128.51, 127.84, 126.11, 113.86, 58.06, 55.32, 54.87, 48.69, 33.14, 26.17, 
24.62.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H28NO, 310.2171; found, 310.2162.  
 
1-(3-(2-bromo-4-fluorophenyl)propyl)piperidine (143, Table 3.2): 
Prepared according to General procedure A for 3 hours in 82% isolated 
yield. 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/EtOAc with 
0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.26 (dd, J = 8.3, 2.7 Hz, 1H), 7.18 (dd, J = 8.5, 6.1 Hz, 1H), 
6.94 (td, J = 8.3, 2.7 Hz, 1H), 2.74 – 2.65 (m, 2H), 2.46 – 2.24 (m, 6H), 1.78 (tt, J = 9.7, 6.6 Hz, 
2H), 1.58 (p, J = 5.7 Hz, 4H), 1.48 – 1.36 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 160.78 (d, J 
= 248.0 Hz), 137.54 (d, J = 3.4 Hz), 131.02 (d, J = 8.2 Hz), 124.16 (d, J = 9.5 Hz), 119.87 (d, J = 




MHz, CDCl3) δ: -115.57 (q, J = 7.7 Hz).  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C14H20NBrF, 300.0763; found, 300.0769.  
 
1-(3-(4-(trifluoromethyl)phenyl)propyl)piperidine (144, Table 3.2): 
Prepared according to General procedure A for 2 hours in 84% isolated 
yield. 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 50 : 1 hexanes/EtOAc with 
0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.52 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 2.67 (t, J = 7.8 
Hz, 2H), 2.46 – 2.23 (m, 6H), 1.83 (tt, J = 9.7, 6.7 Hz, 2H), 1.58 (p, J = 5.6 Hz, 4H), 1.47 – 1.37 
(m, 2H).  13C NMR (125 MHz, CDCl3) δ: 146.54 (q, J = 1.3 Hz), 128.81, 128.18 (q, J = 32.3 
Hz), 125.32 (q, J = 3.8 Hz), 124.50 (q, J = 271.7 Hz), 58.71, 54.68, 33.81, 28.51, 26.08, 24.56. 
19F NMR (471 MHz, CDCl3) δ: -62.25 (s).  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C15H21NF3, 272.1626; found, 272.1628.  
 
1-(4-(3-(piperidin-1-yl)propyl)phenyl)ethan-1-one (145, Table 3.2): 
Prepared according to General procedure A for 3 hours in 83% isolated 
yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 15 : 1 hexanes/EtOAc with 
0.5% MeOH to 8 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.87 (d, J = 8.2 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 2.74 – 2.62 




1.47 – 1.38 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 198.06, 148.35, 135.07, 128.74, 128.62, 
58.82, 54.73, 34.01, 28.48, 26.74, 26.12, 24.58.  HRMS (ESI-TOF) m/z: [M+H+] calculated for 
C16H24NO, 246.1858; found, 246.1851.  
 
1-(3-phenylpropyl)piperidine (146, Table 3.2): Prepared according to 
General procedure A for 24 hours in 63% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 60 : 1 
hexanes/EtOAc with 0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.27 (t, J = 7.7 Hz, 2H), 7.23 – 7.14 (m, 3H), 2.62 (t, J = 7.8 Hz, 
2H), 2.45 – 2.27 (m, 6H), 1.83 (tt, J = 10.1, 6.6 Hz, 2H), 1.58 (p, J = 5.7 Hz, 4H), 1.48 – 1.38 (m, 
2H). 13C NMR (125 MHz, CDCl3) δ: 142.58, 128.62, 128.50, 125.92, 59.22, 54.87, 34.19, 28.96, 
26.29, 24.77.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C14H22N, 204.1752; found, 
204.1762.  
 
1-(3-(o-tolyl)propyl)piperidine (147, Table 3.2): Prepared according to 
General procedure A for 24 hours in 50% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 4 g H2O, 60 : 1 
hexanes/EtOAc with 0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.18 – 7.03 (m, 4H), 2.60 (t, J = 7.8 Hz, 2H), 2.45 – 2.33 (m, 
6H), 2.31 (s, 3H), 1.85 – 1.72 (m, 2H), 1.59 (p, J = 5.7 Hz, 4H), 1.44 (q, J = 6.0 Hz, 2H).  13C 




31.36, 27.68, 26.20, 24.68, 19.43.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C15H24N, 
218.1909; found, 218.1917.  
 
1-(3-(3-methoxyphenyl)propyl)-4-methyl-1,4-diazepane (148, 
Table 3.2): Prepared according to General procedure A for 24 
hours in 57% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 10 : 1 hexanes/EtOAc with 
0.5% MeOH to 5 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.21 (t, J = 7.8 Hz, 1H), 6.80 (dt, J = 7.6, 1.2 Hz, 1H), 6.78 – 
6.71 (m, 2H), 3.81 (s, 3H), 2.77 – 2.69 (m, 4H), 2.67 – 2.59 (m, 6H), 2.55 – 2.48 (m, 2H), 2.37 
(s, 3H), 1.87 – 1.73 (m, 4H).  13C NMR (125 MHz, CDCl3) δ: 159.70, 144.19, 129.34, 120.97, 
114.29, 111.09, 58.23, 58.05, 57.12, 55.25, 54.87, 54.34, 47.28, 33.82, 29.39, 27.58.  HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C16H27N2O, 263.2123; found, 263.2126.  
 
1-(3-(2-methoxyphenyl)propyl)-4-methyl-1,4-diazepane(149, Table 
3.2): Prepared according to General procedure A for 24 hours in 31% 
isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 10 : 1 hexanes/EtOAc with 
0.5% MeOH to 5 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.17 – 7.03 (m, 2H), 6.86 – 6.74 (m, 2H), 3.76 (s, 3H), 2.71 – 




13C NMR (125 MHz, CDCl3) δ: 157.58, 130.95, 129.95, 127.02, 120.43, 110.32, 58.47, 58.25, 
57.17, 55.36, 54.85, 54.36, 47.28, 28.25, 27.81, 27.59. HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C16H27N2O, 263.2123; found, 263.2126.  
 
4-methyl-5-(3-(piperidin-1-yl)propyl)thiazole (150, Table 3.2): Prepared 
according to General procedure A for 4 hours in 47% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 30 : 1 
hexanes/EtOAc with 0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.53 (s, 1H), 2.76 (t, J = 7.6 Hz, 2H), 2.37 (s, 3H), 2.35 – 2.24 
(m, 6H), 1.87 – 1.72 (m, 2H), 1.56 (p, J = 5.7 Hz, 4H), 1.47 – 1.36 (m, 2H). 13C NMR (125 
MHz, CDCl3) δ: 149.00, 148.60, 131.77, 58.25, 54.71, 29.01, 26.13, 24.59, 24.19, 15.00. HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C12H21N2S, 225.1425; found, 225.1420.  
 
2-(3-(piperidin-1-yl)propyl)pyridine (151, Table 3.2): Prepared according 
to General procedure A for 2 hours in 94% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 7 g H2O, 8 : 1 hexanes/EtOAc with 0.5% 
MeOH to 4 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 8.63 – 8.36 (m, 1H), 7.57 (td, J = 7.6, 1.9 Hz, 1H), 7.14 (d, J = 
7.8 Hz, 1H), 7.08 (dd, J = 7.5, 4.8 Hz, 1H), 2.85 – 2.71 (m, 2H), 2.49 – 2.24 (m, 6H), 2.00 – 1.84 
(m, 2H), 1.56 (p, J = 5.7 Hz, 4H), 1.47 – 1.34 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 162.16, 
149.31, 136.36, 122.85, 121.05, 58.98, 54.66, 36.54, 27.17, 26.10, 24.60.  HRMS (ESI-TOF) 




N,N-dibenzyl-3-(pyridin-3-yl)propan-1-amine (152, Table 3.2): 
Prepared according to General procedure A for 7 hours in 91% isolated 
yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/EtOAc with 
0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.40 (dd, J = 4.9, 1.7 Hz, 1H), 8.35 (d, J = 2.3 Hz, 1H), 7.36 (d, J 
= 7.1 Hz, 4H), 7.34 – 7.29 (m, 5H), 7.28 – 7.21 (m, 2H), 7.12 (dd, J = 7.8, 4.8 Hz, 1H), 3.57 (s, 
4H), 2.58 (dd, J = 8.8, 6.8 Hz, 2H), 2.48 (t, J = 6.9 Hz, 2H), 1.90 – 1.67 (m, 2H).  13C NMR (125 
MHz, CDCl3) δ: 150.09, 147.31, 139.85, 137.80, 135.84, 128.96, 128.35, 127.01, 123.28, 58.68, 
52.88, 30.68, 28.92. HRMS (ESI-TOF) m/z: [M+H+] calculated for C22H25N2, 317.2018; found, 
317.2004.  
 
N-benzyl-3-(pyridin-4-yl)propan-1-amine (153, Table 3.2): Prepared 
according to General procedure A for 3 hours in 91% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 8 : 1 hexanes/EtOAc with 1.0% 
MeOH to 4 : 1 hexanes/EtOAc with 2.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.47 (d, J = 6.1 Hz, 2H), 7.39 – 7.19 (m, 5H), 7.09 (d, J = 6.1 
Hz, 2H), 3.78 (s, 2H), 2.67 (t, J = 7.4 Hz, 4H), 1.88 – 1.79 (m, 2H).  13C NMR (125 MHz, 
CDCl3) δ: 151.21, 149.85, 140.51, 128.54, 128.21, 127.09, 123.97, 54.13, 48.68, 33.00, 30.76. 






((±)-156, Table 3.2): Prepared according to General procedure A for 
24 hours in 72% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 99 : 1 hexanes/EtOAc with 
0.5% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.70 (s, 1H), 7.64 (s, 2H), 2.88 (dd, J = 13.4, 3.4 Hz, 1H), 2.67 
– 2.50 (m, 1H), 2.44 -2.18 (m, 4H), 2.12 – 1.99 (m, 3H), 1.65 – 1.48 (m, 4H), 1.47 – 1.37 (m, 
2H), 0.82 (d, J = 5.6 Hz, 3H).  13C NMR (125 MHz, CDCl3) δ: 143.59, 131.21 (q, J = 32.9 Hz), 
129.79 (m), 123.70 (q, J = 272.5 Hz), 119.79 (sept, J = 3.8 Hz), 64.98, 55.04, 40.51, 31.97, 
26.23, 24.72, 17.90.  19F NMR (471 MHz, CDCl3) δ:  -62.82. HRMS (ESI-TOF) m/z: [M+H+] 
calculated for C17H22NF6, 354.1656; found, 356.1652.  
 
N-(2-(1H-indol-3-yl)ethyl)-4-(3-(piperidin-1-yl)propyl) 
benzamide (157, Table 3.2): Prepared according to 
General procedure A for 3 hours in 85% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 2 : 1 hexanes/EtOAc with 0.5% 
MeOH to 1 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.19 (brs, 1H), 7.65 (d, J = 7.9 Hz, 1H), 7.58 (d, J = 8.0 Hz, 2H), 
7.41 – 7.36 (m, 1H), 7.24 – 7.20 (m, 1H), 7.18 (d, J = 8.1 Hz, 2H), 7.16 – 7.10 (m, 1H), 7.08 – 
7.05 (m, 1H), 6.18 (t, J = 5.8 Hz, 1H), 3.80 (q, J = 6.4 Hz, 2H), 3.09 (t, J = 6.7 Hz, 2H), 2.63 (t, J 
= 7.7 Hz, 2H), 2.35 (s, 4H), 2.32 – 2.25 (m, 2H), 1.80 (dq, J = 12.8, 7.6 Hz, 2H), 1.57 (p, J = 5.6 




128.68, 127.50, 127.02, 122.41, 122.24, 119.70, 118.94, 113.27, 111.41, 58.83, 54.77, 40.34, 
33.85, 28.55, 26.18, 25.51, 24.64. 
 
mycophenolic acid derivatives (158, Table 3.2): Prepared 
according to General procedure A for 5 hours in 75% isolated 
yield. 
Column Chromatography Condition: 100 g Al2O3 + 6 g 
H2O, 5 : 1 hexanes/EtOAc with 0.5% MeOH to 3 : 1 
hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.11 (d, J = 7.9 Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 5.16 (s, 2H), 
5.14 (t, J = 6.4 Hz, 1H), 3.81 (s, 3H), 3.60 (s, 3H), 3.53 – 3.27 (m, 2H), 2.71 (t, J = 7.7 Hz, 2H), 
2.45 – 2.27 (m, 8H), 2.25 (s, 3H), 2.23 – 2.15 (m, 2H), 1.86 (p, J = 7.7 Hz, 2H), 1.66 – 1.53 (m, 
7H), 1.49 – 1.37 (m, 2H).  13C NMR (125 MHz, CDCl3) δ: 173.82, 168.14, 164.64, 162.74, 
149.08, 146.40, 146.31, 134.68, 130.67, 129.61, 128.80, 126.51, 123.07, 122.38, 114.07, 68.40, 
61.36, 58.82, 54.77, 51.61, 34.53, 34.18, 32.76, 28.48, 26.21, 24.66, 23.87, 16.35, 11.95. 
 
N,N-diisopropyl-3,3-diphenylpropan-1-amine (159, Table 3.3): Prepared 
according to General procedure B for 20 hours in 76% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 3 g H2O, 99 : 1 
hexanes/EtOAc with 0.5% MeOH to 60 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.23 (m, 8H), 7.20 – 7.13 (m, 2H), 3.96 (t, J = 7.6 Hz, 





Hz, 12H).  13C NMR (125 MHz, CDCl3) δ: 145.38, 128.50, 128.00, 126.13, 49.32, 48.79, 44.08, 
37.45, 20.78. HRMS (ESI-TOF) m/z: [M+H+] calculated for C21H30N, 296.2378; found, 
296.2368.  
 
N,N-diisopropyl-4,4-diphenylbutan-2-amine ((±)-160, Table 3.3): Prepared 
according to General procedure B for 20 hours in 78% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 1.5 g H2O, 99 : 1 
hexanes/EtOAc with 0.2% MeOH as eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.37 – 7.27 (m, 4H), 7.25 – 7.10 (m, 6H), 4.14 (dd, J = 9.2, 5.9 
Hz, 1H), 3.13 (hept, J = 6.6 Hz, 2H), 2.86 – 2.69 (m, 1H), 2.10 – 1.91 (m, 2H), 1.05 (d, J = 6.5 
Hz, 3H), 0.94 (d, J = 6.6 Hz, 6H), 0.91 (d, J = 6.7 Hz, 5H).  13C NMR (125 MHz, CDCl3) δ: 
146.90, 144.69, 128.50, 128.46, 128.37, 128.00, 126.02, 125.88, 48.39, 47.18, 44.44, 42.80, 
24.41, 22.39, 21.04.  HRMS (ESI-TOF) m/z: [M+H+] calculated for C22H32N, 310.2535; found, 
310.2548.  
 
N,N-dimethyl-3,3-diphenylpropan-1-amine (161, Table 3.3): Prepared 
according to General procedure B with 3 equiv trimethylamine•HCl and 3 
equiv DBU for 24 hours in 71% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 9 g H2O, 30 : 1 hexanes/EtOAc with 
0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.22 (m, 8H), 7.20 – 7.15 (m, 2H), 3.99 (t, J = 6.6 Hz, 





58.22, 49.14, 45.74, 33.82. HRMS (ESI-TOF) m/z: [M+H+] calculated for C17H22N, 240.1752; 
found, 240.1747.  
 
N,N-dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine (165, Table 3.3): 
Prepared according to General procedure B with 3 equiv trimethylamine•HCl 
and 3 equiv DBU for 24 hours in 76% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 6 : 1 hexanes/EtOAc with 0.5% 
MeOH to 3 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 8.60 – 8.51 (m, 1H), 7.52 (td, J = 7.7, 1.6 Hz, 1H), 7.36 – 7.30 
(m, 2H), 7.29 – 7.22 (m, 2H), 7.20 – 7.11 (m, 2H), 7.08 – 7.02 (m, 1H), 4.12 (t, J = 7.3 Hz, 1H), 
2.49 – 2.36 (m, 1H), 2.27 – 2.13 (m, 9H).  13C NMR (125 MHz, CDCl3) δ: 163.83, 149.37, 
143.83, 136.48, 128.61, 128.16, 126.52, 122.92, 121.38, 58.04, 51.51, 45.66, 33.06. HRMS 
(ESI-TOF) m/z: [M+H+] calculated for C16H21N2, 241.1705; found, 241.1703.  
 
N,N-dimethyl-3-phenyl-3-(p-tolyl)propan-1-amine (166,  Table 3.3): 
Prepared according to General procedure B with 3 equiv 
trimethylamine•HCl and 3 equiv DBU for 24 hours in 71% isolated yield. 
Column Chromatography Condition: 100 g Al2O3 + 6 g H2O, 30 : 1 hexanes/EtOAc with 
0.5% MeOH to 15 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: δ 7.32 – 7.22 (m, 4H), 7.20 – 7.13 (m, 3H), 7.10 (d, J = 7.8 Hz, 
2H), 3.96 (tt, J = 6.5, 2.6 Hz, 1H), 2.31 (s, 3H), 2.26 – 2.16 (m, 10H).  13C NMR (125 MHz, 




33.86, 21.12. HRMS (ESI-TOF) m/z: [M+H+] calculated for C18H24N, 254.1909; found, 
254.1917.  
 
1-(3,3-diphenylpropyl)azepane (Prozapine, Table 3.4): Prepared 
according to General procedure A with 0.1% PC 3 for 8 hours in 84% 
isolated yield. 
Column Chromatography Condition: 150 g Al2O3 + 7.5 g H2O, 60 : 1 hexanes/EtOAc with 
0.5% MeOH to 30 : 1 hexanes/EtOAc with 1.0% MeOH as gradient eluent. 
1H NMR (500 MHz, CDCl3) δ: 7.31 – 7.22 (m, 8H), 7.19 – 7.13 (m, 2H), 4.03 (t, J = 7.7 Hz, 
1H), 2.67 – 2.51 (m, 4H), 2.40 (dd, J = 8.7, 6.0 Hz, 2H), 2.22 (q, J = 7.5 Hz, 2H), 1.70 – 1.53 (m, 
8H).  13C NMR (125 MHz, CDCl3) δ: 145.28, 128.52, 128.06, 126.17, 56.56, 55.72, 49.16, 
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